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Abstract 
 
 The development of complex tissues is dependent on the specification and 
maintenance of distinct transcriptional identities within populations of equivalent 
progenitors. In the vertebrate neural tube, progenitor identity is specified by the 
spatially organised expression of transcription factors within the dorso-ventral (DV) 
axis of the tissue. A series of selective cross-repressive interactions between 
transcription factors expressed in adjacent domains forms the basis of a gene regulatory 
network (GRN), which acts to define and maintain the boundaries between progenitor 
populations. Pax3 is a key member of the neural tube GRN that is transcribed 
throughout the dorsal domains of the spinal cord and exhibits a ventral boundary of 
expression at the level of the sulcus limitans. The regulatory mechanisms that induce 
Pax3 transcription in neural progenitors and subsequently produce a sharp ventral 
boundary of gene expression are poorly understood. 
 Using a genetic lineage tracing strategy in mice, we show that the position of the 
Pax3 expression domain is established within the neural plate and subsequently 
maintained throughout spinal cord development. Additionally, we demonstrate that V0 
interneuron progenitors transiently express Pax3 during their early development. We 
employ a comparative genomics based approach to investigate the molecular basis of 
Pax3 transcription, revealing several novel enhancers associated with the locus. 
Functional dissection of an early central nervous system (CNS) specific enhancer 
supports the role of the Wnt signaling pathway in the induction of Pax3 transcription. 
Furthermore, we establish the function of direct transcriptional repression in the 
establishment of the Pax3 expression domain. Analysis of a second CNS specific 
enhancer reveals that Pax3 expression is dependent on autoregulation and Pax7 
mediated positive feedback post-neurulation. Together, these data indicate that the 
temporal activity of two distinct enhancers underlies the regulatory logic of Pax3 
expression in the neural tube. 
 
 
 
 
 
 
 
	   4 
Acknowledgements 
 
I would first like to thank my supervisor, James Briscoe, for the support and 
advice he has given me throughout my PhD. I feel very fortunate to have had the 
opportunity to study in his lab. I would also like to thank Vanessa Ribes for her creative 
input at the start of this project and the continued collaboration throughout. I am 
particularly grateful to her for allowing me to include unpublished data in this thesis. I 
would like to thank all members of the Briscoe lab, past and present, for their insightful 
discussions that have greatly contributed to this work. I am grateful for the tools 
provided by Fredéric Relaix, Philip Ingham, Claudia Seger, Javier Terriente, Nipam 
Patel and Simon Hughes that were vital for the completion of this project. Finally, I 
would like to thank Toni and my family whose support made this thesis possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   5 
Contents 
 
Abstract         3 
Acknowledgements         4 
Contents          5 
List of Figures         9 
List of Tables          11 
Abbreviations         12 
 
Chapter 1: Introduction        14 
 
1.1    – The formation and patterning of the neural tube    14 
1.1.1 – The formation of the embryonic central nervous system   14 
1.1.2 – Sonic hedgehog signaling patterns the ventral neural tube  17 
1.1.3 – BMP and Wnt signaling coordinate dorsal patterning   18 
1.1.4 – The spinal cord gene regulatory network     19 
1.2    – The molecular basis of gene regulation     23 
1.2.1 – Enhancer activity is the basis of differential gene expression  25 
1.2.2 – Comparative genomics as a method of enhancer discovery  26 
1.2.3 – Post-genomic methods of enhancer identification    28 
1.2.4 – Enhancers underlie the regulatory logic of developmental processes 30 
1.3    – Pax3 and Pax7 are key members of the neural tube GRN  31 
1.3.1 – The Pax gene family        32 
1.3.2 – Pax3 and Pax7 are expressed in the alar plate of the neural tube 35 
1.3.3 – The function of Pax3/7 in the neural tube     37 
1.3.4 – Regulation of Pax3/7 expression by morphogens    40 
1.3.5 – The molecular basis of Pax3/7 regulation in the neural tube  44 
1.4    – Aims          47 
 
 
 
 
 
 
 
	   6 
Chapter 2: Materials and Methods       48 
 
2.1    – General molecular biology techniques     48 
2.1.1 – Transformation of chemically competent bacteria   48 
2.1.2 – Plasmid DNA preparation       48 
2.1.3 – BAC DNA preparation       48 
2.2    – Defining putative regulatory elements     49 
2.2.1 – Comparative genomic alignments      49 
2.2.2 – Cloning CNEs        49 
2.2.3 – Identifying CNE homology regions      50 
2.2.4 – Defining putative binding sites       50 
2.2.5 – CNE modification by mutagenic PCR     51 
2.3    – Identifying DNA - protein interactions     52 
2.3.1 – In-vitro transcription and translation     52 
2.3.2 – Radiolabelling of double stranded oligonucleotides   52 
2.3.3 – Chick nuclear extractions       52 
2.3.4 – Electromobility shift assays       53 
2.4    – Embryo manipulation       54 
2.4.1 – Maintenance of zebrafish lines      54 
2.4.2 – Zebrafish embryo injection       54 
2.4.3 – Creation of transgenic zebrafish stable lines    54 
2.4.4 – Chick in-ovo electroporation      55 
2.5    – Embryo analysis        55 
2.5.1 – Synthesis of riboprobes       55 
2.5.2 – Wholemount in-situ hybridization      56 
2.5.3 – Zebrafish wholemount immunostaining     56 
2.5.4 – Gelatine embedding for cryosectioning     57 
2.5.5 – Immunostaining cryosections      57 
2.5.6 – Microscopy and image analysis      57 
 
Chapter 3: The establishment of the Pax3 domain in the neural tube  64 
  
3.1 – Pax3Cre/Rosa26-YFP mice as a tool for lineage tracing   64 
3.2 – The Pax3 domain is established by a switch in progenitor identity 67 
3.3 – The position of the Pax3 domain remains constant during development 69 
	   7 
3.4 – The dispersal of Pax3 progeny in the functional spinal cord  74 
 
Chapter 4: Establishing Zebrafish as a model for studying Pax3/7 regulation 79 
 
4.1 – Pax3 paralogs are first expressed in the early neural plate   79 
4.2 – Pax7 paralogs are expressed upon neural tube formation   83 
4.3 – Assessing Pax3/7 protein localisation in zebrafish embryos  86 
4.4 – Characterisation of Pax3 and Pax7 BAC transgenic lines   90 
 
Chapter 5: Identifying and testing putative enhancers     93 
 
5.1 – Comparative genomic analyses of the Pax3 and Pax7 loci   93 
5.2 – Testing CNE activity in-vivo       99 
5.3 – CNE2 and CNE4 activate transcription within Pax3 expressing cells 102 
5.4 – CNE5 is active in the notochord and floor plate    107 
 
Chapter 6: Characterisation of Pax3 CNE1 activity    109 
 
6.1 – CNE1 is active within the Pax3 domain of the CNS    109 
6.2 – CNE1 is a CNS specific enhancer      112 
6.3 – The spatiotemporal profile of CNE1 activity    117 
6.4 –  Zebrafish CNE1 retains function in chick     121 
 
Chapter 7: Molecular analysis of CNE1 regulation    124 
 
7.1 – Identifying regulatory motifs within CNE1     124 
7.2 – Functional dissection of CNE1      130 
7.3 – Motif1 is a functional paired domain binding site    141 
7.4 – CNE1 is conserved between the zebrafish Pax3 paralogs   149 
 
Chapter 8: CNE3 defines the Pax3 expression domain in the neural plate 152 
 
8.1 – CNE3 possess a weak regulatory potential at 24 hpf   152 
8.2 – CNE3 is transiently active in the neural plate    156 
8.3 – Identifying putative repressor binding sites in CNE3   160 
	   8 
8.4 – CNE3 interacts with Nkx6.1 and Foxa2     168 
 
Chapter 9: Discussion        172 
 
9.1 – The Pax3 domain is established by a switch in progenitor identity 173 
9.2 – Progenitor dispersal is restricted during mouse CNS development 174 
9.3 – Conservation of non-coding sequence is predictive of functional  
enhancers          175 
9.4 – CNE3 mediates the induction of Pax3 transcription   178 
9.5 – Pax3 transcription is maintained by CNE1 at later stages of  
development          179 
9.6 – Pax3b expression is dependent on autoregulation and positive  
feedback          184 
9.7 – The pattern generating properties of autoregulation and positive  
feedback          185 
9.8 – Conclusions         187 
9.9 - Future work         191 
 
References          194 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   9 
List of figures 
 
Fig. 1.1 – The dorso-ventral patterning of the vertebrate neural tube  16 
Fig. 1.2 – The ventral neural tube GRN is based on selective cross-repression 22 
Fig. 1.3 – The mechanistic basis of differential gene regulation   24 
Fig. 1.4 – The vertebrate Pax gene family      34 
Fig. 3.1 – Genetic strategy for lineage tracing Pax3 expressing progenitors 66 
Fig. 3.2 – The position of the Pax3 domain is established before E9.5  68 
Fig. 3.3 – The distribution of the Pax3 lineage during neural tube patterning 70 
Fig. 3.4 – Clonal dispersion of Pax3 progeny within the ventral neural tube 71 
Fig. 3.5 – The distribution of the Pax3 lineage during early neurogenesis 72 
Fig. 3.6 – V0 interneurons transiently express Pax3 during their development 73 
Fig. 3.7 – The distribution of the Pax3 lineage at birth    77 
Fig. 3.8 – The position of the Pax3 domain is maintained throughout 
development          78 
Fig. 4.1 – The profile of pax3a expression during zebrafish CNS development 82 
Fig. 4.2 – The profile of pax7a expression during zebrafish CNS development 84 
Fig. 4.3 – The distribution of pax3a and pax7a transcripts within  
the spinal cord         84 
Fig. 4.4 – The profile of pax7b expression during zebrafish CNS development 85 
Fig. 4.5 – DP311 is broadly cross-reactive in the neural tube   88 
Fig. 4.6 – DP312 demonstrates specificity for Pax3/7 recognition in-vivo 89 
Fig. 4.7 – Zebrafish BAC transgenic lines recapitulate Pax3/7 expression  
in the spinal cord         92 
Fig. 5.1 – Comparative genomic analysis of the Pax3 locus   96 
Fig. 5.2 – Comparative genomic analysis of the Pax7 locus   97 
Fig. 5.3 – The MiniTol2-Citrine expression vector    101 
Fig. 5.4 – Annotation of conserved TFBS within Pax3-CNEs   104 
Fig. 5.5 – CNE2 mediated transcription labels dorsal interneurons  105 
Fig. 5.6 – CNE4 enhances transcription within muscle and neural crest cells 106 
Fig. 5.7 – CNE5 is active in the notochord and floor plate   108 
Fig. 6.1 – CNE1 is sufficient to induce transcription within the dorsal neural 
tube           111 
Fig. 6.2 – CNE1 is a CNS specific enhancer     115 
Fig. 6.3 – CNE1 is specifically bound by p300 in CNS derived tissues  116 
	   10 
Fig. 6.4 – CNE1 activity recapitulates Pax3 expression during development  119 
Fig. 6.5 – CNE1 is active in Pax3 expressing cells within the neural plate 120 
Fig. 6.6 – Zebrafish CNE1 retains activity in the chick neural tube  123 
Fig. 7.1 – Clusters of nucleotides within CNE1 are conserved across the span  
of vertebrate evolution        126 
Fig. 7.2 – Motif1 and Motif3 are required for CNE1 function in-vivo  128 
Fig. 7.3 – Quantification of the effects of motif deletion upon CNE1 activity 129 
Fig. 7.4 – CNE1-Motif1 represents a putative PD binding site   134 
Fig. 7.5 – Mutation of the RBPJ or Tead sites associated with Motif1 does not 
affect the transcriptional activity of CNE1     135 
Fig. 7.6 – Quantification of the effects of RBPJ and Tead site manipulations upon 
CNE1 activity         136 
Fig. 7.7 – The 3’ region of Motif1 is required for CNE1 activity   137 
Fig. 7.8 – Quantification of the effects of E-box mutations upon  
CNE1 activity         138 
Fig. 7.9 – Mutation of the HMG box within Motif3 reduces CNE1 activity 
in-vivo           139 
Fig. 7.10 – Quantification of the effects of Motif3 mutations upon  
CNE1 activity         140 
Fig. 7.11 – CNE1-Motif1 is bound by in-vitro synthesised Pax3 and Pax7 145 
Fig. 7.12 – CNE1-Motif1 demonstrates specificity for Pax3/7 binding  146 
Fig. 7.13 – Mutation of the 3’ region of Motif1 reduces its affinity for Pax7 
binding          147 
Fig. 7.14 – CNE1 mediates direct autoregulation and positive feedback 148 
Fig. 7.15 – CNE1 is poorly conserved between the paralogous Pax3 loci 151 
Fig. 7.16 – Pax3b CNE1 retains the primary function of the canonical 
enhancer          151 
Fig. 8.1 – CNE3 is a weak enhancer at 24 hpf     154 
Fig. 8.2 – CNE3 is contained within Pax3-ECR2     155 
Fig. 8.3 – Tcf3 directly binds CNE3/ECR2 in mouse ESC   158 
Fig. 8.4 – CNE3 activity correlates with the temporal profile of Wnt 
signaling          159 
Fig. 8.5 – CNE3 activity is subject to transcriptional repression   164 
Fig. 8.6 – Quantification of the effects of motif deletion upon  
CNE3 activity         165 
	   11 
Fig. 8.7 – Conserved TFBS are required for CNE3 repression in-vivo  166 
Fig. 8.8 – Quantification of the effects of site mutations upon CNE3 activity 167 
Fig. 8.9 – Nkx6.1 and Foxa2 bind CNE3 in-vitro     170 
Fig. 8.10 – Mutations induced in CNE3 preclude the binding of putative 
repressors          171 
Fig. 9.1 –Pax3 CNEs correlate with the chromatin signatures of active 
enhancers          177 
Fig. 9.2 – CNE1-Motif1 represents a more complete definition of the Pax3/7 PD 
binding site          183 
Fig. 9.3 – The regulatory logic of Pax3 expression in the neural tube  190 
 
List of Tables 
 
Table 2.1 – Primers used to clone CNEs      58 
Table 2.2 – Cycling parameters for mutagenic PCRs    59 
Table 2.3 – Primers used to delete motifs from CNEs    59 
Table 2.4 – Primers used to induce mutations in CNEs    60 
Table 2.5 – Constructs used for in-vitro protein synthesis   61 
Table 2.6 – Oligonucleotides used as EMSA probes    62 
Table 2.7 – Primary antibodies used for immunohistochemistry  63 
Table 2.8 - Conversion of  zebrafish developmental stages to hpf  63 
Table 5.1 – CNE location in the zebrafish genome and equivalent  
Condor elements         98 
Table 7.1 – Identification of putative regulatory motifs within CNE1  127 
Table 7.2 – Phylogenetically conserved TFBS associated with 
CNE1-Motif1 and Motif3        134 
Table 8.1 – Annotation of conserved TFBS within CNE3   163 
 
 
 
 
 
 
 
 
	   12 
Abbreviations 
 
32P   = Phosphorus-32 
AP   = Anterior-posterior 
BAC   = Bacterial artificial chromosome 
bHLH   = Basic helix-loop-helix 
BLAST  = Basic local alignment search tool 
BMP   = Bone morphogenetic protein 
bp   = Base pair 
ChAT   = Choline acetyltransferase 
ChIP   = Chromatin immunoprecipitation 
ChIP-chip  = ChIP followed by microarray 
ChIP-seq  = ChIP followed by high-throughput sequencing 
CNE   = Conserved non-coding element 
CNS   = Central nervous system 
CRM   = Cis-regulatory module 
dP   = Dorsal progenitor 
DV   = Dorso-ventral 
E   = Embryonic day 
EC   = Embryonal carcinoma 
ECR   = Evolutionary conserved region 
EMSA   = Electrophoretic mobility shift assay 
ESC   = Embryonic stem cells 
FGF   = Fibroblast growth factor 
FP   = Floor plate 
Fugu   = Takifugu Rubripes 
GFP   = Green fluorescent protein 
GRN   = Gene regulatory network 
H3K27ac  = Acetylation of histone H3 at lysine 27 
H3K27Me3  = Trimethylation of histone H3 at lysine 27 
H3K4Me1  = Monomethylation of histone H3 at lysine 4 
H3K4Me3  = Trimethylation of histone H3 at lysine 4 
HD   = Homeodomain 
HH   = Hamburger and Hamilton stage 
hpe   = Hours post-electroporation 
	   13 
hpf   = Hours post-fertilisation 
kb   = Kilobases 
LB   = Luria-Bertani 
Lef   = Lymphoid enhancer factor 
MiniTol2-Citrine = MiniTol2 TKProm Gal4-UAS Citrine expression vector 
NCE   = Neural crest enhancers 
p   = Progenitor domain 
P   = Postnatal day 
Pax   = Paired box containing 
Pax3/7   = Pax3 and Pax7 
PBS   = Phosphate buffered saline 
PCR   = Polymerase chain reaction 
PD   = Paired domain 
PFA   = Paraformaldehyde 
PSPM   = Position specific probability matrix 
Ptc   = Patched 
RA   = Retinoic acid 
RBPJ   =  recombination signal binding protein for immunoglobulin 
    kappa J 
RP   = Roof plate 
Shh   = Sonic hedgehog 
Sim   = Single-minded 
Smo   = Smoothened 
Tcf   = T-cell factor 
TFBS   = Transcription factor binding sites 
YFP   = Yellow fluorescent protein 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 – Introduction 
	   14 
Chapter 1: Introduction 
 
1.1 – The formation and patterning of the neural tube 
 
The spinal cord is an anatomically and functionally specialised tissue that enables 
vertebrates to perceive multiple forms of stimuli, relay this information to higher brain 
levels and execute the appropriate motor responses. Sensory interneurons contained 
within the grey matter of the dorsal horn receive inputs from primary afferent neurons 
via the dorsal root ganglion. These signals can either be directly relayed to motor 
neurons within the ventral horn in the form of a spinal reflex or conveyed to higher 
processing centres via ascending white matter tracts. Motor commands from the brain 
are subsequently relayed to the appropriate level of the ventral spinal cord via 
descending tracts in order to coordinate the activity of specific muscle groups (Goulding 
et al., 2002). Centuries of anatomical and physiological studies have resulted in a wealth 
of knowledge describing the spinal cord in great detail. By comparison, our 
understanding of the cellular and molecular mechanisms that act to define and 
subsequently maintain molecularly unique territories within the developing tissue is less 
complete. 
 
1.1.1 – The formation of the embryonic central nervous system 
 
The presumptive CNS is induced within the dorsal ectoderm of the blastula stage 
embryo by the activity of bone morphogenetic protein (BMP) pathway inhibitors (Stern, 
2005). Following gastrulation, these cells reside dorsally along the length of the embryo 
as an epithelial sheet, known as the neural plate. Neural progenitors are initially 
specified to an anterior identity and are subsequently posteriorised by the graded 
activity of the Wnt, fibroblast growth factor (FGF) and retinoic acid (RA) signaling 
pathways in the caudal regions of the neural plate (Durston et al., 1989 ; Kiecker and 
Niehrs, 2001 ; Nordstrom et al., 2002 ; Storey et al., 1998). Anterior neuronal identities 
are maintained by the activity of secreted pathway antagonists, revealed by the loss of 
anterior structures in embryos lacking these factors or by misexpression of 
posteriorising signals across the anterior-posterior (AP) axis (Böttcher and Niehrs, 2005 
; Maden, 2007 ; Niehrs, 2004). 
Following AP patterning, the neural plate is transformed by a stereotypical series 
of morphogenetic movements during neurulation. This process is initiated by the 
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bending of the lateral edges of the neural plate at the point of contact with the non-
neural ectoderm, giving rise to the neural folds. The lateral folds of the neural plate 
elevate towards to the midline where they fuse and subsequently segregate from the 
overlying non-neural epithelium to form the dorsal midline of the neural tube (Copp et 
al., 2003). This sequence of morphogenetic movements is initiated at the boundary 
between the presumptive hindbrain and spinal cord, before proceeding anteriorly to give 
rise to the brain and its respective subdivisions and posteriorly to form the embryonic 
spinal cord (Copp et al., 2003). 
 The developing neural tube is one of the best-studied examples of 
developmental patterning as it represents an experimentally tractable model in which a 
population of genetically equivalent progenitors give rise to a stereotypic distribution of 
neuronal subtypes across the DV axis of the tissue (Jessell, 2000). The process of DV 
patterning is initiated by the graded activity of several morphogens secreted from the 
roof plate (RP) and floor plate (FP) organising centres within the dorsal and ventral 
midlines of the tissue, respectively (Fig. 1.1). Morphogen signaling acts to establish a 
spatially organised transcription factor code consisting of homeodomain (HD) and basic 
helix-loop-helix (bHLH) containing proteins within the ventricular zone of the neural 
tube (Lewis, 2006) (Fig. 1.1). The patterned distribution of transcription factors across 
the DV axis of the neuroepithelium creates 11 molecular distinct progenitor domains (p) 
within the tissue, which directly correlate with the neuronal subtype a given progenitor 
is fated to form during neurogenesis (Fig. 1.1) (Briscoe et al., 2000). Each of the 6 
dorsal progenitor domains (dP) within the neural tube gives rise to the sensory 
interneurons of the spinal cord. Within the ventral neural tube, pMN progenitors give 
rise to motorneurons whereas the remaining 4 domains give rise to ventral classes of 
interneurons (Fig. 1.1). In the following sections, I will outline the morphogen signaling 
pathways that act to pattern the neural tube and discuss the key studies that provided 
insight into their function. 
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Fig. 1.1 – The dorso-ventral patterning of the vertebrate neural tube 
Progenitors within the neural tube are subject to Shh signaling from the FP and BMP/Wnt 
signaling from the RP. The combined activity of morphogens in the neural tube establishes 11 
molecularly distinct progenitor domains across the DV axis of the tissue. The transcriptional 
identity of progenitors directly correlates with the subtype of neurons they are fated to give rise 
to during the process of neurogenesis. 
Figure adapted from Lewis, 2006. 
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1.1.2 – Sonic hedgehog signaling patterns the ventral neural tube 
 
 Sonic hedgehog (Shh) ligand is initially produced by the notochord, a rod-like 
structure of mesodermal cells that underlies the floor plate. Signaling from the 
notochord induces a second source of Shh secretion within the FP of the ventral neural 
tube (Marti et al., 1995). The secretion of Shh from the FP creates a gradient of ligand 
throughout the ventricular zone of the neural tube, resulting in a high concentration 
ventrally that decreases as it spreads dorsally (Fig. 1.1) (Chamberlain et al., 2008). The 
Shh pathway functions by modifying the activity of the Gli family transcription factors, 
which are processed to repressive forms in the absence of ligand. Shh binding to its 
receptor patched (Ptc) results in the de-repression of the transmembrane protein 
smoothened (Smo). Once active, Smo signals intracellularly by promoting the 
processing of the Gli transcription factors to activator forms, which enter the nucleus 
and induce the transcription of Shh target genes (Ingham and McMahon, 2001). 
 The cellular interpretation of the Shh gradient in the neural tube was shown to be 
dependent on both the concentration of ligand and the duration of signaling, due to 
temporal adaption within the pathway (Dessaud et al., 2007). In this model, cells are 
initially hypersensitive to Shh and consequently high levels of positive Gli 
transcriptional activity are produced in response to a low concentration of the ligand. 
Over time, cells become less responsive to a stable concentration of Shh via a negative 
feedback loop, in which cells receiving Shh signaling induce the expression of Ptc. The 
effect of this pathway mediated feedback is the desensitisation of the cell to Shh by 
increasing the number of receptors available for ligand binding, consequently reducing 
the Gli activity achieved by a constant level of Shh over time. In order to maintain a 
high level of Gli activity, cells must receive a high concentration of Shh over time to 
compensate for the increase in Ptc expression that pathway activity induces (Dessaud et 
al., 2007). 
 Shh signaling in the ventral neural tube acts to repress genes expressed dorsally 
and induce the transcription of ventral markers; commonly referred to as class I and 
class II genes, respectively (Briscoe and Ericson, 2001). The morphogen activity of Shh 
was determined in a series of experiments in which explanted neural plate tissue was 
cultured in the presence of exogenous ligand. These data revealed that class I genes are 
repressed by increasing concentrations of Shh at a threshold that is indicative of their 
expression domain, for example Pax7 was shown to be repressed at a lower 
concentration than Irx3 (Fig. 1.1) (Briscoe et al., 2000 ; Ericson et al., 1996). 
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Conversely, the class II genes Nkx6.1 and Nkx2.2 were induced in a concentration 
dependent manner according to their expression profile in the ventral neural tube 
(Briscoe et al., 2000). Loss of Shh signaling in the neural tube is characterised by the 
de-repression of class I genes and a failure of class II gene induction (Briscoe and 
Ericson, 2001 ; Chiang et al., 1996 ; Ericson et al., 1996 ; Wijgerde et al., 2002). 
Conversely, ectopic expression of Shh, Smo or Gli has been shown to be sufficient to 
induce the expression of class II genes throughout the neural tube at the expense of class 
I genes (Ericson et al., 1996 ; Hynes et al., 2000 ; Stamataki et al., 2005 ; Ribes et al., 
2010). Taken together, these studies demonstrate the requirement of graded Shh 
signaling for the correct assignment of progenitor identity in the ventral neural tube and 
the repression of dorsally expressed genes. 
 
1.1.3 – BMP and Wnt signaling coordinate dorsal patterning 
 
 Experiments performed in chick embryos revealed the instructive role of 
morphogens secreted from the RP by demonstrating that this tissue was sufficient to 
induce the expression of dorsal interneuron markers in neural plate explants (Liem et 
al., 1997). Subsequent studies in transgenic mice confirmed the requirement for RP by 
genetically targeted expression of diptheria toxin, revealing the respecification of dI1 
and dI2 neurons to a dI3 identity (Lee et al., 2000). These data established the RP as the 
second organising centre of the neural tube, whose activity was required for the correct 
assignment of dorsal neuronal identities. 
 The patterning activity of the RP is achieved, in part, by the secretion of several 
members of the bone morphogenetic protein family (Lee et al., 2000 ; Liem et al., 
1997). BMP signaling is activated by ligand binding to a heterodimer of type I and type 
II receptors, which in turn phosphorylate Smad1/5/8, the downstream effectors of the 
pathway. Phosphorylated Smad1/5/8 form complexes with Smad4 that translocate to the 
nucleus to regulate gene expression (Massague et al., 2005). The role of BMP signaling 
in DV patterning was established in experiments that demonstrated the induction of 
dorsal interneuron markers in neural plate explants cultured with exogenous ligand 
(Liem et al., 1997). Expression of activated forms of BMP receptors 1A or 1B 
throughout the chick neural tube revealed that BMP signaling is sufficient to induce the 
expression of class I genes in the ventral spinal cord and consequently alter the fate of 
these cells (Timmer et al., 2002). In the converse experiment, inhibition of BMP 
signaling using the pathway antagonist noggin or RNAi targeted to Smad4 revealed the 
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loss of dI1 interneurons and a compensatory dorsal shift of the dI2-4 populations 
towards the RP (Chesnutt et al., 2004). 
 In addition to BMPs, the RP also secretes members of the Wnt family of 
morphogens (Hollyday et al., 1995 ; Parr et al., 1993). The Wnt signaling pathway 
regulates target genes by modulating the stability of its transcriptional effector, β-
catenin. In the absence of ligand, intracellular β-catenin is degraded by the activity of 
the destruction complex. Wnt binding to its receptor complex acts to stablise β-catenin 
within the cell by sequestering key components of the destruction complex at the 
membrane. Once stabilised, β-catenin translocates to the nucleus where it acts in concert 
with T-cell factor (Tcf)/ lymphoid enhancer factor (Lef) family transcription factors to 
regulate gene expression (Logan and Nusse, 2004). Mice lacking both Wnt1 and Wnt3a 
revealed a loss of dI1 and dI2 markers and a compensatory increase in dI3 neurons, a 
phenotype comparable to that observed in RP ablation experiments (Lee et al., 2000 ; 
Muroyama et al., 2002). Moreover, loss of both Wnt1 and Wnt3a did not affect the 
expression of BMP ligands in the roof plate, suggesting that the Wnt pathway is 
epistatic to BMP in the dorsal neural tube (Muroyama et al., 2002). Ectopic expression 
of Wnt ligands or activated β-catenin was shown to result in the dorsalisation of the 
neural tube, assessed by both progenitor identity and neuronal subtype (Alvarez Medina 
et al., 2008 ; Muroyama et al., 2002 ; Zechner et al., 2007). Together, these studies 
demonstrate the function of RP derived morphogens in assigning positional identity 
within the dorsal spinal cord and the repression of ventral fates. 
 
1.1.4 – The spinal cord gene regulatory network 
 
The combined activity of morphogen signaling in the ventricular zone of the 
neural tube results in the establishment of 11 progenitor domains along the DV axis, 
each of which expresses a distinct complement of HD and bHLH transcription factors 
(Fig. 1.1) (Briscoe et al., 2000). This transcription factor code forms the basis of the 
neural tube GRN, which functions to establish and maintain gene expression boundaries 
between adjacent domains by cross repression (Dessaud et al., 2008). One of the best 
described repressive circuits within the neural tube GRN acts to delineate the p0, p1 and 
p2 domains of interneuron progenitors. The p2 marker Nkx6.1 was shown to repress the 
p1 markers Nkx6.2 and Dbx2 in both gain and loss of function studies (Fig. 1.2A) 
(Briscoe et al., 2000 ; Sander et al., 2000 ; Vallstedt et al., 2001). This interaction was 
shown to be mutually cross-repressive in the case of Dbx1 by gain of function in the 
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chick neural tube (Fig. 1.2A) (Briscoe et al., 2000). The ventral boundary of the p0 
domain was shown to be dependent upon the repression of Dbx1 by Nkx6.2, expressed 
in the adjacent p1 domain (Fig. 1.2A) (Vallstedt et al., 2001). Thus, these data 
demonstrate how a series of selective repressive interactions between 4 transcription 
factors are sufficient to define and maintain the boundaries of 3 adjacent interneuron 
progenitor domains. 
The boundary of the p3 and pMN domains of the ventral neural tube are 
established and maintained by a similar repressive mechanism involving the 
transcription factors Nkx2.2, Olig2 and Pax6. Ectopic expression of the p3 marker 
Nkx2.2 by chick in-ovo electroporation was shown to repress both Pax6 and Olig2 (Fig. 
1.2B) (Briscoe et al., 2000 ; Novitch et al., 2001). Pax6, a class II gene expressed at low 
levels in the pMN domain, was shown to repress Nkx2.2 in loss of function studies, 
establishing a mutually cross-repressive interaction (Fig. 1.2B) (Ericson et al., 1997). 
Gain and loss of function of the pMN determinant Olig2 revealed repressive 
interactions with both Pax6 and Nkx2.2 (Balaskas et al., 2012). Together, this network 
of repressive interactions at the p3/pMN boundary acts to delineate the progenitors of 
V3 interneurons from motor neurons (Fig. 1.2B). 
 Recent work has highlighted the importance of the GRN and demonstrated that 
the Shh response in the ventral neural tube is an emergent property of the network 
architecture (Balaskas et al., 2012). These data demonstrate that at the onset of 
patterning, low levels of pathway activation cannot induce the expression of either 
Olig2 or Nkx2.2 and consequently Pax6 is expressed throughout the ventral neural tube. 
The concentration of extracellular Shh increases over time, raising the level of positive 
Gli transcriptional activity intracellularly within the ventral spinal cord (Balaskas et al., 
2012 ; Chamberlain et al., 2008). Olig2 transcription is induced at a moderate level of 
Gli activity, resulting in the repression of Pax6 ventrally (Fig. 1.2B) (Balaskas et al., 
2012). Nkx2.2 cannot be induced by moderate levels of Gli transcriptional activity, due 
to the repressive interactions of both Olig2 and Pax6 (Fig. 1.2B) (Balaskas et al., 2012). 
The activation of Nkx2.2 transcription is achieved at the maxima of Gli activity, 
resulting in a switch in the GRN by its repression of both Olig2 and Pax6 (Fig. 1.2B) 
(Balaskas et al., 2012). The level of extracellular Shh ligand continues to increase in the 
neural tube during development, however intracellular Gli activity decreases to a level 
below that required for Nkx2.2 activation, due to temporal adaption within the pathway 
(Balaskas et al., 2012 ; Chamberlain et al., 2008 ; Dessaud et al., 2007). Despite the 
reduction in intracellular pathway activity, the expression profiles of genes within the 
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ventral neural tube remain stable (Balaskas et al., 2012). This robustness was shown to 
be due to the ability of Nkx2.2 to repress both Olig2 and Pax6, meaning lower levels of 
Gli activity are required to maintain Nkx2.2 expression than induce its transcription 
within a repressive network (Balaskas et al., 2012). Thus, the architecture of the GRN in 
the ventral neural tube provides a mechanism for translating a non-linear gradient of 
intracellular shh pathway activity to bistable expression states and confers robustness to 
neural patterning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 – Introduction 
	   22 
 
 
Fig. 1.2 – The ventral neural tube GRN is based on selective cross-repression 
The boundaries between the p2, p1 and p0 domains of interneuron progenitors are defined and 
maintained by a series of repressive interactions between Nkx6.1, Nkx6.2, Dbx1 and Dbx2 (A). 
Similarly, the boundary between the p3 and pMN domains is defined and maintained by the 
repressive interactions between Nkx2.2, Olig2 and Pax6 (B). Recent studies have shown that the 
cellular interpretation of Shh signaling in the neural tube is an emergent property of this 
repressive network (Balaskas et al., 2012). 
Figure 1.2A adapted from Dessaud et al., 2008. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 – Introduction 
	   23 
1.2 – The molecular basis of gene regulation 
 
Tissue patterning during embryonic development is achieved by the highly 
coordinated spatiotemporal expression profiles of transcription factors within a 
population of progenitors, which acts to impart cells with a unique molecular identity 
and consequently determines their fate. Mechanistically, the expression profile of a 
given gene over time is the result of a series of interactions between the non-coding cis-
regulatory modules (CRMs) associated with the locus. Thus, considerable research 
effort in the field of developmental biology is devoted to the elucidating the molecular 
interactions that underlie the regulatory logic of tissue patterning networks. Central to 
this process is the core promoter, a specialized CRM located immediately upstream of 
the transcriptional start site of a gene. This region provides a docking site for the core 
transcriptional machinery, permitting the binding of RNA polymerase II and the 
initiation of transcription (Fig. 1.3A). The transcriptional activity of promoters is 
coordinated by enhancers. These CRMs provide a platform of transcription factor 
binding sites (TFBS) that determine the expression profile of a given gene over time by 
directly contacting the promoter and initiating transcription (Fig. 1.3B). Finally, the 
specificity of enhancer-promoter interactions is determined by insulators, which 
function to restrict enhancer binding to specific domains within the genome (Fig. 1.3C). 
In the following section, I will discuss the role of transcriptional enhancers in defining 
the spatiotemporal expression profile of developmental genes and highlight the 
properties of these CRMs that facilitate their identification within the genome. 
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Fig. 1.3 – The mechanistic basis of differential gene regulation 
Proximal promoters recruit the general transcriptional machinery to the transcription start sites 
of genes (A). Enhancers are a distal class of CRM that provide binding sites for cell-type 
specific transcription factors. Once active, enhancers physically interact with promoters to 
coordinate their spatiotemporal activity (B). Insulators regulate the specificity of enhancer – 
promoter interactions by limiting enhancer translocation to defined regions within the genome 
(C). 
Figure adapted from Noonan and McCallion, 2010. 
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1.2.1 – Enhancer activity is the basis of differential gene expression 
 
 Transcriptional enhancers were first described in studies investigating the 
regulatory function of a 72 base pair (bp) repeat within the SV40 viral genome (Banerji 
et al., 1981 ; Moreau et al., 1981). Cells transfected with recombinant plasmids 
harbouring this element were shown to exhibit a significantly increased level of 
transcription over controls, regardless of its orientation or position to either an 
endogenous or heterologous promoter (Banerji et al., 1981 ; Moreau et al., 1981). 
Subsequent studies performed within metazoan genomes revealed that enhancers could 
be located within the introns of their associated genes, as demonstrated for the murine 
immunoglobulin heavy chain locus (Banerji et al., 1983 ; Gillies et al., 1983). These 
investigations were also the first to demonstrate that enhancers possess the ability to 
regulate transcription in a cell type specific manner, by assaying the activity of the 
immunoglobulin enhancer in lymphocytes and fibroblasts (Banerji et al., 1983 ; Gillies 
et al., 1983). These data decoupled the spatiotemporal regulation of transcription from 
the core promoter and established distal enhancers as the basis of differential gene 
expression. 
 The initial observation that enhancers could be located distally to their 
endogenous promoter was shown to be a common property of these CRMs in 
subsequent investigations. This feature is highlighted by a series of studies assessing the 
regulation of Shh transcription in the developing limb bud, which was shown to be 
dependent on an enhancer located over 1 megabase away from its promoter (Lettice et 
al., 2002 ; Lettice et al., 2003). Mutation of this enhancer was shown to be the 
underlying cause of the human congenital limb malformation preaxial polydactyly 
(Lettice et al., 2003). Transgenic mice lacking this CRM exhibit a complete loss of Shh 
expression in the limb bud, resulting in severe limb truncations (Sagai et al., 2005). 
These data demonstrate the essential roles that enhancers perform in the coordination of 
tissue patterning and their emerging roles in human disease. However, they also raise 
important questions concerning the mechanism of enhancer-promoter interactions over 
large genomic intervals. 
The prevailing model of gene regulation mediated by distal enhancers is 
commonly termed ‘looping’ (Ptashne, 1986). In this model, the expression profile of a 
given gene is determined by the physical association of a cell type specific enhancer 
with the promoter, achieved by the rearrangement or ‘looping out’ of the intervening 
DNA (de Laat et al., 2008 ; Ptashne, 1986). This hypothesis has been extensively 
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supported by investigations utilising novel techniques designed to assess the 3 
dimensional structure of chromatin, such as the chromosome conformation capture 
assay and its subsequent variations (Dekker et al., 2002 ; Miele and Dekker, 2008). The 
first of these studies to validate the looping hypothesis in-vivo demonstrated that 
regulatory modules associated with the murine β-globin locus were physically 
associated with the promoter in erythroid cells, in which the gene cluster is expressed. 
Conversely, this interaction was not observed in non-expressing brain tissue (Tolhuis et 
al., 2002). This mechanism of enhancer-promoter interaction was subsequently 
demonstrated to be a general principle of transcriptional regulation, validating the 
looping model as the basis of differential gene expression (Amano et al., 2009 ; Miele 
and Dekker, 2008 ; Splinter and de Laat, 2011). 
Despite significant advances in the functional description of enhancers, the de 
novo identification of these regulatory elements is complicated by their ability to 
function from any position in the locus. Consequently, studies attempting to identify 
enhancers were frequently based on the serial deletion of a large genomic fragment with 
an established regulatory function. Putative minimal enhancers were subsequently 
assayed for regulatory potential by their ability to activate the transcription of a reporter 
gene when placed proximally to a minimally active promoter (Epstein et al., 1999 ; 
Sasaki and Hogan, 1996). Although this is a reliable method of enhancer identification, 
it is both labour intensive and gene centric, prohibiting the genome wide identification 
of putative regulatory regions. 
 
1.2.2 – Comparative genomics as a method of enhancer discovery 
 
 The first study to suggest that the conservation of non-coding sequence might be 
predictive for the identification of functional CRMs was based upon the hypothesis that 
enhancers, like coding sequence, were maintained under negative selective pressure 
during evolution (Aparicio et al., 1995). This theory was tested by comparing the 
sequence of the Hoxb-4 locus in the mouse and Takifugu Rubripes (fugu) genomes, 
which last shared a common ancestor approximately 430 million years ago (Aparicio et 
al., 1995). These data revealed the presence of a 92 bp conserved non-coding element 
(CNE) located within an intron and two CNEs within the 3’ region of the locus 
(Aparicio et al., 1995). These CNEs resided in regions of the locus that had previously 
been shown to contain the regulatory elements that coordinated Hoxb-4 expression in 
mice (Whiting et al., 1991). Analysis of the activity mediated by the defined fugu CNEs 
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demonstrated that these regions were both necessary for the function of previously 
defined enhancers and sufficient to direct transgene expression within the endogenous 
Hoxb-4 domain of mouse embryos. (Aparicio et al., 1995). Together, these data 
established the conservation of non-coding sequence as a predictive feature of 
enhancers, regardless of their position within the genome. Furthermore, this report was 
the first to demonstrate the value of including the fugu genome in this type of 
comparative genomic study. 
 The publication of several model genomes facilitated the application of 
comparative genomics as a high-throughput method of de-novo enhancer discovery. 
One of the first studies to assess the genome wide conservation of non-coding sequence 
identified 481 mammalian ultraconserved elements, defined as being 100% homologous 
over at least 200 bp in the human, mouse and rat genomes (Bejerano et al., 2004). 
Ultraconserved regions were shown to be enriched within the loci of transcription 
factors or developmental regulators in the human genome, suggesting that they may 
function as enhancers, however the in-vivo function of these regions was not assessed 
during this study (Bejerano et al., 2004). 
The publication of the fugu genome permitted the genome wide assessment of 
non-coding sequence conservation over large spans of vertebrate evolution (Aparicio et 
al., 2002). The first study to utilise this evolutionary distance to predict functional 
regulatory elements was based upon pairwise alignments of the human and fugu 
genomes, revealing 1,373 CNEs of at least 100 bp in length (Woolfe et al., 2005). The 
authors noted that these CNEs were conserved with an average identity of 84%, 
indicating that the integrity of these regions were maintained under a negative selection 
comparable to that observed within coding exons (Woolfe et al., 2005). Analysis of the 
location of each CNE within the human genome revealed that these 1,373 regions were 
not randomly distributed and instead clustered into 165 groups, each containing 
multiple CNEs. 93% of CNE clusters were shown to be associated with the loci of key 
regulators of embryonic development (Woolfe et al., 2005). The regulatory potential of 
defined CNEs was assessed in zebrafish embryos, a relatively high-throughput method 
previously validated for this type of study (Müller et al., 1997 ; Müller et al., 1999 ; 
Woolfe et al., 2005). These data revealed that 92% of the selected CNEs functioned as 
enhancers in-vivo, capable of directing transcription in a profile that frequently 
recapitulated the expression domain of their associated genes (Woolfe et al., 2005). 
 The predictive power of comparative genomics was further demonstrated by a 
study that compared the in-vivo activity of human-fugu CNEs and mammalian 
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ultraconserved regions (Pennacchio et al., 2006). 137 human-fugu CNEs with at least 
70% identity between the two genomes were assessed for transcriptional activity in 
mouse embryos at embryonic day (E) 11.5, 42% of which were shown to function as 
tissue specific enhancers (Pennacchio et al., 2006). The CNE dataset was compared 
with the activity of 84 mammalian ultraconserved elements, of which 60% were shown 
to act as enhancers (Pennacchio et al., 2006). The authors demonstrated that these two 
datasets significantly overlapped, such that 39% of the human-fugu CNEs assessed 
were also perfectly conserved over at least 200 bp in mammalian genomes. 61% of 
human-fugu-ultraconserved elements were shown to be tissue specific enhancers at 
E11.5 in mice, a figure that is highly likely to underestimate the regulatory potential of 
these regions by assaying at only one developmental stage (Pennacchio et al., 2006). 
 These studies established the conservation of enhancers as a fundamental 
property of genome evolution, which acts to ensure the correct regulation of 
developmental genes during embryogenesis. This hypothesis is supported by a number 
of mutations within conserved enhancers that have been shown to disrupt gene 
expression, resulting in human disease and developmental defects (Kleinjan and Van 
Heynigen, 2005). In contrast to these findings, however, a study has demonstrated that a 
selected set of ultraconserved enhancers are not required for the correct regulation of 
key developmental genes during mouse embryogenesis (Ahituv et al., 2007). Targeted 
deletions of elements associated with the Pax6, Arx, Sox3 and Dmrt1/ Dmrt3 loci 
resulted in the production of viable mice that did not exhibit any of the severe 
developmental defects associated with the mutation of these genes (Ahituv et al., 2007). 
These data demonstrate that the degree to which a regulatory element is conserved is 
not a reliable predictor of the requirement for its activity in-vivo. Furthermore, these 
results suggest that certain loci might harbour several functionally redundant enhancers, 
which act to provide robustness to developmental transcription. 
 
1.2.3 – Post-genomic methods of enhancer identification 
 
 The development of high-throughput techniques, such as chromatin 
immunoprecipitation (ChIP) followed by microarray (ChIP-chip) or sequencing (ChIP-
seq), facilitated the annotation of CRMs on a genome wide scale based on their 
chromatin signatures. The survey of 1% of the human genome performed by the 
ENCODE consortium revealed that active promoters are associated with high levels of 
trimethylation of histone H3 at lysine 4 (H3K4Me3) (The ENCODE project consortium, 
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2007). In contrast, enhancers are marked by monomethylation of histone H3 at lysine 4 
(H3K4Me1), a feature that was shown to be predictive of their regulatory function (The 
ENCODE project consortium, 2007 ; Heintzman et al., 2007). 
In addition to the methylation status of lysine 4, the acetylation of histone H3 
lysine 27 has been shown to be predictive of transcriptionally active enhancers 
(Creyghton et al., 2010 ; Rada-Iglesias et al., 2011). This chromatin signature of 
enhancer activation was established by assessing the histone modifications present on 
enhancers within human embryonic stem cells (ESC), revealing two distinct classes 
(Rada-Iglesias et al., 2011). Enhancers associated with genes actively transcribed in 
ESC were marked by H3K4Me1 and acetylated histone H3 lysine 27 (H3K27ac) (Rada-
Iglesias et al., 2011). In contrast, non-transcribed developmental genes were marked by 
H3K4Me1 and the polycomb mediated repressive signature, histone H3 lysine 27 
trimethylation (H3K27Me3) (Rada-Iglesias et al., 2011 ; Spivakov and Fisher, 2007). 
Upon ESC differentiation to a neuronal progenitor fate, the chromatin status of 
developmental enhancers was observed to be enriched for K3K4Me1 and H3K27ac in 
the absence of H3K4Me3, suggesting that the temporal activity of these regulatory 
elements is reflected by their histone code (Rada-Iglesias et al., 2011). Furthermore, the 
activity of developmental enhancers, identified by their poised chromatin signature, was 
shown to be both temporally and spatially restricted in transgenic zebrafish embryos 
(Rada-Iglesias et al., 2011). 
The binding of the transcriptional coactivator p300 was shown to correlate with 
the location of active enhancers in cell culture assays (Heintzman et al., 2007). The 
predictive power of this association was revealed in a study that assessed the genome 
wide binding of p300 in tissue isolated from the forebrain, midbrain and limb buds of 
E11.5 mouse embryos by ChIP-seq (Visel et al., 2009). The transcriptional activity of 
86 p300 bound genomic regions was determined using a transgenic mouse assay, of 
which 87% were shown to function as enhancers (Visel et al., 2009). These data also 
revealed that the tissue specific binding of p300 was correlated with the activity of a 
given enhancer in-vivo, such that 78% of forebrain, 82% of midbrain and 80% of limb 
derived elements were active in their tissue of origin (Visel et al., 2009). Furthermore, 
approximately 90% of all ChIP-seq peaks were shown to overlap with regions that are 
conserved between the human, mouse, rat, chick and fugu genomes (Siepel et al., 2005 ; 
Visel et al., 2009). 
 Together, these investigations highlight the ability of high throughput genomics 
to identify the chromatin signatures of enhancers and their association with key 
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transcriptional co-activators genome wide. Both of these properties have been shown to 
be predictive of enhancer function in-vivo and can be used to predict the spatiotemporal 
activity of regulatory regions. The data produced from these techniques differs from that 
obtained from comparative genomics, as it is only applicable to the cell type in which 
the experiment is performed. Conversely, comparative genomics is sufficient to identify 
putative regulatory elements but cannot provide any indication of the tissue specificity 
or temporal activity of these regions in-vivo. The observation that 90% of all p300 
ChIP-seq peaks reside in areas of measurable sequence conservation highlights the 
value of employing both comparative and post-genomic techniques to functionally 
annotate the genome, when possible. 
 
1.2.4 – Enhancers underlie the regulatory logic of developmental processes 
 
 The process of embryogenesis is mediated by GRNs, which act to specify and 
maintain cell identity by coordinating the expression of transcription factors. Enhancers 
are central to this process as they provide a mechanistic link between the transcriptional 
state of a cell and its spatiotemporal gene expression profile. Consequently, one of the 
major goals of developmental biology is to understand the cis-regulatory logic that 
governs developmental processes. The DV patterning of the syncytial Drosophila 
embryo represents one of the best examples of how the modification of enhancer 
architecture is sufficient to establish the basis of differential gene expression during 
development. This system is based on the interpretation of a nuclear concentration 
gradient of the transcription factor Dorsal, which is induced ventrally within the embryo 
(Moussian and Roth, 2005). The Dorsal gradient regulates the expression of over 40 
transcription factors in a concentration dependant manner to define the mesoderm, 
neurogenic ectoderm and the dorsal ectoderm of the early embryo. The expression 
profiles of Dorsal induced transcription factors are classified into a total of 6 spatial 
domains across the DV axis (Hong et al., 2008). 
The regulatory logic that decodes the nuclear Dorsal gradient into distinct 
expression domains was determined in a series of bioinformatics and ChIP-chip 
analyses of the enhancers associated with DV markers (Markstein et al., 2002 ; 
Papatsenko and Levine., 2005 ; Zeitlinger et al., 2007). These studies revealed that 
genes expressed in the ventral presumptive mesoderm are induced by high levels of 
Dorsal, in concert with its early target gene Twist (Jiang et al., 1991). The enhancers 
associated with this class of genes are characterised by the presence of multiple low-
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affinity Dorsal and Twist binding sites (Hong et al., 2008). In contrast, markers of the 
neurogenic ectoderm are induced by intermediate levels of Dorsal and low levels of 
Twist. All of the enhancers associated with this class of genes contain a conserved 
binding module consisting of a high affinity Dorsal site adjacent to an asymmetric 
Twist site. This structural arrangement of binding sites is crucial for the cooperative 
transcriptional activity of these regulators (Hong et al., 2008 ; Markstein et al., 2004). 
Dorsal ectoderm markers are induced by low levels of Dorsal in the absence of Twist, 
which is reflected in their CRMs by the presence of high affinity Dorsal sites (Hong et 
al., 2008). These 3 major classes of enhancers are elaborated upon by the addition of 
binding sites for spatially restricted transcriptional activators or repressors, which act in 
concert with Dorsal to generate a further 3 expression domains (Hong et al., 2008). 
Studies investigating the cellular interpretation of the Dorsal gradient revealed 
many of the common properties that allow enhancers to coordinate spatiotemporal gene 
expression during development. These include the presence of sites with different 
affinities for transcription factor binding, a feature that is likely to be fundamental to the 
interpretation of morphogen gradients in the neural tube (Dessaud et al., 2008). The 
presence of binding modules that permit the stereotyped interaction of transcription 
factor complexes, such as those observed for Dorsal and Twist, provides a further 
mechanism by which a limited number of key regulators might coordinate differential 
gene activation within a pool of progenitors. Finally, the interaction of both positive and 
negative transcriptional regulators upon the same enhancer was shown to modify the 
expression domain of the associated gene. This property of enhancers is likely to be 
central to the molecular interpretation of the ventral neural tube GRN, which is built 
upon positive Shh input and locally expressed transcriptional repressors. Despite 
significant advances in the field, the cis-regulatory logic that underlies the activity of 
the neural tube GRN remains poorly described. 
 
1.3 – Pax3 and Pax7 are key members of the neural tube GRN 
 
Studies exploring the series of repressive interactions that form the basis of the 
neural tube GRN have focused upon the assignment and maintenance of ventral 
progenitor identity. These investigations have revealed the ability of this repressive 
network to interpret a gradient of Shh activity over time and confer robustness to 
neuronal patterning (Balaskas et al., 2012). By comparison, the regulatory logic that 
defines and maintains the identity of interneuron progenitors within the dorsal neural 
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tube is poorly understood. In the following section I will introduce the Pax family of 
transcription factors and the unique structural domains that define their protein 
products. I will outline the expression profiles of Pax3 and Pax7 (Pax3/7) within the 
dorsal neural tube before exploring their function and transcriptional regulation during 
the process of CNS patterning. 
 
1.3.1 – The Pax gene family 
 
The paired locus was identified in a seminal study of mutations affecting the 
segmental pattern of Drosophila larva (Nüsslein-Volhard and Weichaus, 1980). 
Mutation of this locus was shown to result in the deletion of alternating body segments 
within the embryo, the defining feature of the pair-rule class of developmental 
patterning genes (Nüsslein-Volhard and Weichaus, 1980). The paired gene was 
subsequently cloned (Kilchherr et al., 1986) and sequenced (Frigerio et al., 1986), 
correlating its expression profile with the dramatic effects of the mutation in-vivo. The 
protein produced from the paired locus was demonstrated to encode two DNA binding 
domains, an extended homeobox and a novel 128 amino acid paired box (Bopp et al., 
1986). Studies performed in Drosophila determined that the gooseberry segment 
polarity gene also encoded a domain with homology to the paired box, the sequence of 
which was used to identify and clone the mouse Pax (paired box containing) 1 gene 
(Baumgartner et al., 1987 ; Deutsch et al., 1988). Biochemical studies subsequently 
demonstrated that the product of the paired box, the paired domain (PD), interacted with 
DNA independently of the paired-type HD, establishing the PD as the defining feature 
of a novel class of transcription factors (Treisman et al., 1991). 
 The majority of vertebrate genomes contain 9 Pax genes, all of which encode a N-
terminal PD that identifies the family (Chi and Epstein, 2004). Analyses of the 
structures of the Pax6 and paired PD complexed with DNA revealed that the PD is 
composed of two helix-turn-helix subdomains, commonly referred to as PAI and RED 
(Jun and Desplan, 1996 ; Xu et al., 1995 ; Xu et al., 1996). The structure of the Pax6 PD 
demonstrated that it makes contacts with successive major grooves in the target 
sequence, such that the N-terminal PAI unit binds a 5’ half site whereas the C-terminal 
RED unit interacts with 3’ sequence (Xu et al., 1996). A series of biochemical studies 
defined the PD consensus binding site as (G/T)T(T/C)(C/A)(C/T)(G/C)(G/C) (Jun and 
Desplan, 1996), however individual Pax genes have been shown to have specific 
preferences for positions within this sequence (Czerny et al., 1993 ; Epstein et al 1994). 
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Furthermore, the oligonucleotides used to crystallize the paired and Pax6 PD were 
between 15-20 bp in length, suggesting that the binding site occupied by the PD may be 
significantly larger than the 7 bp represented by the consensus sequence (Xu et al., 1995 
; Xu et al., 1996). In addition to the PD, all Pax genes encode a C-terminal 
proline/serine/threonine rich weak transactivation domain that is thought to be partly 
responsible for the activation of target gene expression (Chalepakis et al., 1994 ; Glaser 
et al., 1994 ; Robichaud et al., 2004). 
 Despite sharing common features, vertebrate Pax genes are subdivided into four 
groups based on the composition of additional structural domains within their protein 
products (Fig. 1.4) (Balczarek et al., 1997). With the exception of the group IV genes, 
all Pax proteins contain a short octapeptide domain (Fig. 1.4). Deletion of this motif 
from Pax2 was shown to increase its transcriptional activity, suggesting that it might 
function as a transcriptional repressor (Lechner and Dressler, 1996). Sequence analysis 
of the octapeptide domain encoded by group II Pax genes revealed homology to the 
repression domains of the Engrailed and Goosecoid transcription factors, both of which 
are known to recruit members of the Groucho family of transcriptional repressors to 
DNA (Eberhard et al., 2000 ; Smith and Jaynes., 1996). Consistent with this sequence 
analysis, the octapeptide domain of group II genes has also been shown to directly 
interact with Groucho proteins, providing a molecular mechanism of Pax target gene 
repression (Eberhard et al., 2000 ; Patel et al., 2012). 
 Pax proteins are also classified according to the presence and type of HD they 
contain. Group I genes do not encode a HD and therefore rely upon the PD for sequence 
recognition (Chi and Epstein, 2002 ; Deutsch et al., 1988). Group III and IV encode an 
extended paired-type HD, whereas group II encode a truncated domain that contains 
only the first helix (Fig. 1.4). Both the full and partial HDs present within vertebrate 
Pax genes have been demonstrated to directly interact with the TATA-binding protein, 
linking Pax gene function to the direct recruitment of the basal transcription machinery 
(Cvekl et al., 1999 ; Eberhard et al., 1999). The DNA sequence preferentially occupied 
by the HD of Pax genes is defined as a palindrome of the canonical homeobox motif 
separated by 2-3 free positions in the form of TAAT(N2-3)ATTA, both by in-vitro selex 
(Wilson et al., 1993) and ChIP-seq (Soleimani et al., 2012). The presence of both a PD 
and a HD within the majority of Pax genes greatly increases the number of putative 
target sites within the genome, a feature that is further complicated by cooperative 
interactions between these DNA binding domains during sequence recognition (Jun and 
Desplan, 1996). 
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Fig. 1.4 – The vertebrate Pax gene family 
The 9 vertebrate Pax genes are classified into 4 groups based on the composition of structural 
domains in their protein products. All genes encode a DNA-binding PD, which is the defining 
feature of the family. Group I, II and III proteins contain an octapeptide domain that is capable 
of directly recruiting Groucho family repressors to DNA. Group I do not encode a HD, whereas 
Group II encode a partial domain consisting of the first helix. Both group III and IV genes 
contain a full paired-type HD. 
Figure adapted from Robson et al., 2006. 
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1.3.2 – Pax3 and Pax7 are expressed in the alar plate of the neural tube 
 
Studies characterising the expression profiles of Pax genes during mouse 
embryogenesis revealed that both Pax3 and Pax7 are expressed within the progenitor 
cells of the dorsal spinal cord (Goulding et al., 1991; Jostes et al., 1990). Furthermore, 
these reports demonstrated that both genes share a sharp ventral boundary of expression 
coinciding with the sulcus limitans, a longitudinal widening of the lumen that divides 
the CNS into a dorsal alar and a ventral basal plate. This anatomical division of the 
embryonic CNS was first documented in pioneering histological studies performed by 
Wilhelm His in the late 19th century (His. 1888). As a result of these studies, His 
proposed that the sulcus limitans marked the lineage restriction of neuronal progenitors 
within the embryonic alar plate to sensory neuronal fates and those within the basal 
plate to motor associated fates (His. 1888). This theory is supported by subsequent 
investigations demonstrating the regionalised expression of cell adhesion molecules at 
the level of the sulcus limitans in the ventricular zone of the spinal cord. The dorsal 
limit of Cadherin-7 expression was shown to be localised at the sulcus limitans of the 
developing chick spinal cord between Hamburger and Hamilton stage (HH) 16-28 
(Hamburger and Hamilton, 1951 ;Nakagawa and Takeichi, 1995 ; Nakagawa and 
Takeichi, 1998) and was also demonstrated to be coincident with the ventral boundary 
of Pax7 expression at HH stage 19 (Ju et al., 2004). Studies in Xenopus embryos 
demonstrated that F-cadherin is expressed at the sulcus limitans in the developing 
spinal cord and furthermore, that the expression of this cell adhesion molecule is 
initiated within the neural plate (Espeseth et al., 1995). These data begin to establish a 
molecular basis to the anatomical observations made by Wilhelm His and suggest that 
any lineage constraint imposed by the sulcus limitans may be enforced by restricted cell 
migration between the alar and basal plates. 
Analysis of clonal dispersion during CNS development supports the hypothesis 
that the temporal expression of cell adhesion molecules in the neuroepithlium enforces 
restricted cell migration between the alar and basal plates. In one such study, donor cells 
expressing LacZ were transplanted into the presumptive alar or basal plate of a host 
Xenopus embryo prior to gastrulation and assessed following neurulation. These data 
demonstrated that clones made within either the presumptive alar or basal plates prior to 
neurulation readily disperse throughout these compartments but are restricted from 
crossing the sulcus limitans, consistent with the expression of F-cadherin in the 
Xenopus neural plate (Espeseth et al., 1995 ; Espeseth et al., 1998). A similar study of 
Chapter 1 – Introduction 
	   36 
clonal dispersion during zebrafish neurulation supported the hypothesis that progenitor 
cells are restricted to either the alar or basal plates prior to neurulation, consistent with 
the temporal expression profile of cadherin-7 during zebrafish CNS development (Liu 
et al., 2007 ; Papan and Campos-Ortega, 1999).  
In opposition to these conclusions, experiments performed in chick embryos 
suggested that the alar/basal division of the neuroepithelium is not established in the 
neural plate. Clones made in the open neural plate at HH stage 8 and assessed following 
neurulation at HH stages 19-29 were shown to readily disperse throughout the DV axis 
and cross the sulcus limitans (Erskine et al., 1998 ; Leber and Sanes, 1995). These 
studies also documented a progressive restriction of cell mixing in the chick ventricular 
zone following neurulation, such that cells labelled at HH stages 14-20 did not migrate 
between the alar and basal plates (Erskine et al., 1998 ; Leber and Sanes, 1990). The 
observed period in which cell mixing in the DV axis of the chick ventricular zone is 
restricted broadly correlates with the defined expression profile of Cadherin-7 at the 
sulcus limitans (Nakagawa and Takeichi, 1995 ; Nakagawa and Takeichi, 1998). Taken 
together, these reports suggest that the spatiotemporal expression of cell adhesion 
molecules within the neuroepithelium, rather that the anatomical formation of the sulcus 
limitans, might be the major determinant of progenitor cell dispersion during CNS 
development. 
Both Pax3 and Pax7 are expressed in the dorsal spinal cord and exhibit a ventral 
boundary that coincides with the sulcus limitans, as previously described. Despite this 
shared boundary, the spatiotemporal dynamics of gene expression within the spinal cord 
is not conserved between these paralogous genes. Pax3 transcript is first detected during 
neurulation, within the neural folds and along the closed dorsal neural tube of E8.5-9 
mouse embryos (Goulding et al., 1991). By E10, expression is observed in all cells 
within the dorsal progenitor domains of spinal cord and the RP along the entire AP axis 
of the embryo. A sharp ventral boundary of gene expression at the level of the sulcus 
limitans was observed from E10 and was shown to be maintained at this DV position 
within the neural tube until E13, after which cells become committed to neuronal 
lineages and extinguish Pax3 expression (Goulding et al., 1991). 
Pax3 expression in chick embryos is initiated at a comparatively earlier stage of 
CNS development than reported in mice. Transcripts are first observed in the primitive 
streak at HH stage 7 and throughout the medio-lateral axis of the neural plate caudal to 
the node between HH8-9 (Bang et al., 1997 ; Goulding et al., 1993). Expression is 
extinguished in medial regions of the neural plate by HH stage 10 and is restricted to the 
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tips of the neural folds during neurulation (Goulding et al., 1993 ; Liem et al., 1995). 
Serial sectioning of embryos at HH stage 10 revealed that that Pax3 expression expands 
ventrally to reach its final limit at a point midway between the roof and floor plates 
(Goulding et al., 1993). 
Pax7 expression is first detected in the neural tube following neurulation at E9 
in mice (Jostes et al., 1990). Transcription is observed in the dP2-dP6 progenitor 
domain and shares a ventral limit with the sulcus limitans, however it is excluded from 
the dP1 domain and the RP (Jostes et al., 1990). This expression profile in the spinal 
cord is evident between E9-E13 in the dorsal spinal cord, after which progenitor cells 
undergo differentiation and Pax7 transcript is no longer detected. These data indicate 
that Pax7 is not a direct molecular correlate of the alar plate in mouse embryos, despite 
sharing a ventral boundary of expression with both the sulcus limitans and Pax3. 
Expression studies in chick revealed a comparable temporal profile of Pax7 
transcription to that observed during in mouse embryogenesis. Accordingly, Pax7 is 
first expressed in the dorsal neural tube following neurulation at HH stage 10 
(Kawakami et al., 1997). In contrast to the observed expression profile in the spinal cord 
of mice, Pax7 was shown to be expressed throughout the entire alar plate of chick 
embryos (Kawakami et al., 1997). 
 
1.3.3 – The function of Pax3/7 in the neural tube 
 
Despite their broad expression domain within the neural progenitors cells of the 
dorsal spinal cord, the functions of Pax3/7 during CNS patterning and neurogenesis are 
poorly defined. Analysis of the naturally occurring splotch allele in mice demonstrated 
that this mutation was homozygous lethal at approximately E14, with embryos 
exhibiting severe neural tube defects including a failure to complete neurulation both 
anteriorly and posteriorly (Auerbach, 1954). Subsequent studies cloned the splotch 
mutation to the Pax3 locus, establishing this gene as a putative regulator of neural tube 
closure (Epstein et al., 1991 ; Epstein et al., 1993). Loss of Pax3 expression during 
neurulation was shown to result in the activation of apoptosis within the neural folds, 
suggesting that the primary function of Pax3 in this process is to facilitate cell survival 
(Phelan et al., 1997). Consistent with this hypothesis, knockdown of the p53 tumor 
suppressor gene, either genetically or pharmacologically, was sufficient to rescue the 
neural tube defects observed in splotch homozygotes to wild type ratios (Pani et al., 
2002). 
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 Mice carrying a targeted insertion of LacZ within the Pax7 locus, resulting in the 
loss of transcript in homozygous offspring, do not exhibit any defects in neurulation 
(Mansouri et al., 1996). The lack of a neural tube defect in these mice was reasoned to 
be due to the expression of Pax3 at an earlier stage within the neuroepithelium, which 
may compensate for the loss of Pax7 following neural tube closure (Goulding et al., 
1991 ; Jostes et al., 1990 ; Mansouri et al., 1996). This hypothesis was tested in 
experiments that assessed the functional redundancy between Pax3 and Pax7 by 
replacing the Pax3 coding sequence with Pax7 cDNA in transgenic mice (Relaix et al., 
2004). This investigation clearly demonstrated that Pax3/7 perform redundant functions 
during neurulation and furthermore, that Pax7 cDNA expressed under the control of 
Pax3 regulatory elements can rescue neural tube closure in a splotch mutant background 
(Relaix et al., 2004). 
The observed functional redundancy of Pax3/7 within the spinal cord has limited 
the opportunity to study the requirement of these genes during CNS patterning and 
neurogenesis, as these investigations require the generation of double mutant mice. 
These constraints have resulted in the publication of a single report documenting the 
distribution of interneuron subtypes in the spinal cord of Pax3;Pax7 mutant embryos 
(Mansouri and Gruss, 1998). These embryos exhibit a severe neural tube closure defect 
and die before E11, however the authors reported that the transcription of the RP 
derived signaling molecules Wnt1, Wnt3 and Wnt3a remained unchanged (Mansouri 
and Gruss, 1998). The expression domain of the V1 interneuron marker En1 was shown 
to be expanded dorsally, suggesting that loss of both Pax3/7 results in a de-repression of 
ventral neuronal fates (Mansouri and Gruss, 1998). However, this shift was not 
recapitulated by the V0 marker Evx1, which was limited to its endogenous domain 
(Mansouri and Gruss, 1998). The generation of a novel splotch allele by LacZ insertion 
to the Pax3 locus enabled the authors to demonstrate that Pax3 is expressed in a 
population of commissural interneurons within the dorsal spinal cord (Mansouri and 
Gruss, 1998). A similar expression profile of LacZ labelling was observed in mice 
carrying the previously described targeted Pax7 mutant allele (Mansouri et al., 1996 ; 
Mansouri and Gruss, 1998). LacZ expression within these commissural neurons was 
lost in Pax3/Pax7 mutant embryos, resulting in the conclusion that both Pax3 and Pax7 
are required for the specification of this population of dorsal interneurons (Mansouri 
and Gruss, 1998). These data provided evidence that Pax3/7 are required for the 
repression of ventral neuronal identities and the specification of dorsal subtypes, 
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however the patterning mechanisms that underlie these phenotypes were not extensively 
investigated during this study. 
A more extensive analysis of the role of Pax3 in the acquisition of progenitor 
identity was performed in transgenic mice expressing Pax3 cDNA under the control of 
the Hoxb-4 enhancer A region (Tremblay et al., 1996 ; Whiting et al., 1991). This 
experimental manipulation resulted in the expression of Pax3 throughout the DV axis of 
the spinal cord in regions posterior to the forelimb (Tremblay et al., 1996). Transgenic 
embryos exhibited an expansion of Pax7 expression into the ventral half of the spinal 
cord at E12.5, however the distribution of transcript did not extend to the RP dorsally or 
beyond the pMN domain ventrally (Tremblay et al., 1996). These data suggest that the 
repression of Pax7 transcription within these domains cannot be overcome by Pax3 
overexpression. In contrast, Pax6 transcripts were observed at the ventral midline of the 
neural tube (Tremblay et al., 1996). Ectopic Pax3 transcription was shown to 
completely extinguish the expression of Shh and HNF3β (Foxa2), indicating that either 
Pax3 or Pax6 possess the ability to repress the key determinants of floor plate identity 
(Tremblay et al., 1996). Finally, the authors demonstrated that transgenic mice exhibited 
a 50% reduction in the number of motor neurons at E13.5, consistent with the lack of 
molecular markers of the floor plate and the dorsalisation of the neuroepithelium 
(Tremblay et al., 1996). These data demonstrate that Pax3 expression imparts a dorsal 
identity upon neuronal progenitor cells but do not provide any mechanistic insights into 
the function of this gene within neural progenitors. 
Analysis of neural crest explant cultures prepared from splotch mutant mice at 
E10 demonstrated that these cells undergo increased neurogenesis when compared to 
wild type controls (Nakazaki et al., 2008). The converse result was obtained in explants 
taken at E12.5, suggesting that the premature neurogenesis in these cultures does not 
persist due to progenitor depletion (Nakazaki et al., 2008). These data are in agreement 
with a previous report documenting a significant reduction in neurogenesis within 
splotch explant cultures assessed at E12 (Koblar et al., 1999). In-situ hybridisation 
experiments revealed that splotch mutant embryos lacked expression of Hes1, a key 
effector of the notch pathway that is involved in the maintenance of cells in a progenitor 
state (Nakazaki et al., 2008 ; Kageyama and Ohtsuka, 1999). The authors also 
demonstrated that expression of Ngn2, a bHLH transcription factor involved in the 
acquisition of neuronal fates, was absent in the spinal cord of splotch mutants (Nakazaki 
et al., 2008 ; Bertrand et al., 2002). Furthermore, the regulation of both Hes1 and Ngn2 
by Pax3 was shown to be direct in both ChIP and electrophoretic mobility shift assays 
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(EMSAs) (Nakazaki et al., 2008) These data led the authors to hypothesise that Pax3 
functioned within the dorsal neural tube to coordinate the balance of proliferation and 
differentiation within neural progenitors. 
A subsequent study proposed that the acetylation state of Pax3 underlies the 
dual function of this transcription factor during CNS development (Ichi et al., 2010). At 
E9.5, deacetylated Pax3 was shown to activate Hes1 transcription and repress Ngn2, 
promoting the maintenance of cells in a progenitor state (Ichi et al., 2010). Conversely, 
acetylated Pax3 was observed to induce Ngn2 expression at E12.5 and repress 
transcription from the Hes1 promoter, facilitating cell cycle exit and neurogenesis (Ichi 
et al., 2010). The temporal switch in the acetylation state of Pax3 was shown to be 
regulated by the activity of the histone deacetylase SIRT1, which was associated with 
both the Hes1 and Ngn2 promoters at E9.5 but absent from both at E12.5 (Ichi et al., 
2010). 
Taken together, these data provide the first mechanistic insights into the function 
of Pax3 expression in spinal cord progenitors. Furthermore, they suggest that this 
transcription factor may primarily act to temporally regulate the balance of proliferation 
and differentiation within neuronal progenitors, consistent with its well described roles 
in neural crest and muscle development (Lang et al., 2005 ; Buckingham and Relaix, 
2007). 
 
1.3.4 – Regulation of Pax3/7 expression by morphogens 
 
The establishment of the Pax3/7 expression domain is one of the earliest 
patterning events to occur during neural tube development and molecularly divides the 
tissue into dorsal and ventral domains. This is a key event in the establishment of 
ventral progenitor identities within the spinal cord and is therefore commonly used to 
assess the state of the neural tube GRN in response to manipulations of morphogen 
signaling pathways. In addition to providing mechanistic insights into the role of 
morphogens in neural tube patterning, these experiments are also informative when 
interpreted in the context of Pax3/7 regulation. 
The Shh pathway is the major determinant of progenitor identity within the 
ventral neural tube and consequently represents a good candidate to play a role in the 
establishment of the Pax3/7 expression domain. The first study to implicate this 
signaling pathway in the regulation of Pax3/7 expression removed the notochord from a 
defined region of the chick embryo following neurulation and assessed the effect of this 
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manipulation on the expression of Pax3 and Pax6 (Goulding et al., 1993). These data 
revealed that notochord removal results in the failure of FP induction and a prominent 
ventral expansion of both Pax3 and Pax6, indicating the neural tube was dorsalised in 
the absence of Shh (Goulding et al., 1993). In the converse manipulation, the authors 
grafted explants of either notochord or FP tissue to one side of the neural plate and 
demonstrated that that the transcription of both Pax3 and Pax6 was repressed (Goulding 
et al., 1993). Direct evidence supporting the requirement of the Shh pathway in the 
ventralisation of the neural tube was subsequently provided in a study that determined 
the response of neural plate explants to pathway manipulation ex-vivo (Ericson et al., 
1996). These data revealed that 95% of cells within an explant of neural plate tissue 
taken at HH stage 10 express Pax7 and that this expression is extinguished if either 
notochord explants, or exogenous Shh is added to the culture (Ericson et al., 1996). 
Furthermore, electroporation experiments in which activated forms of the Gli 
transcription factors are expressed throughout the neural tube revealed the cell 
autonomous repression of Pax7 expression within its endogenous domain (Stamataki et 
al., 2005). Together, these investigations established the basis of a model in which Shh 
signaling is required to repress Pax3/7 during the early stages of neural tube patterning 
to ventralise the tissue. 
Mouse models in which Shh itself or key components of the signal transduction 
pathway are mutated provide support for this model of Pax3/7 regulation in the neural 
tube. Shh-/- embryos were shown to exhibit an expansion of both Pax3 and Pax7 
expression throughout the entire DV axis of the neuroepithelium, highlighting the key 
role of the ligand in ventral patterning (Litingtung and Chiang, 2000 ; Wijgerde et al., 
2002). Clonal loss of the pathway transducer Smo was shown to result in the cell 
autonomous induction of Pax7 expression within the ventral domains of the spinal cord 
(Wijgerde et al., 2002). Futhermore, electroporation of a dominant inhibitory form of 
the Gli3 transcription factor in the chick neural tube revealed a cell autonomous 
induction of Pax7 expression in the ventral spinal cord (Meyer and Roelink, 2003 ; 
Persson et al., 2002). 
The hypothesis that Shh signaling acts to establish the expression domain of 
Pax3/7 is complicated by the results of studies in which both the positive and negative 
regulators of the pathway are inactivated. Shh-/-;Gli3-/- mutant mice, in which both the 
ligand and the negative regulator of the pathway are mutated, exhibit a ventral boundary 
of Pax3 and Pax7 expression at the level of the sulcus limtans (Litingtung and Chiang, 
2000 ; Persson et al., 2002). In agreement with this result, loss of both Smo and Gli3 
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was shown to restore the ventral boundary of Pax7 expression to its endogenous 
position (Wijgerde et al., 2002). These data indicate that the Pax3/7 domain is 
established at the correct DV position within the neural tube in the absence of all forms 
of hedgehog signaling. Further evidence in support of this hypothesis was provided by 
analysis of spinal cord patterning in mutants affecting the structure and function of the 
primary cilium, which has been shown to be required for all Shh signaling in vertebrates 
(Goetz and Anderson, 2010). Mice carrying mutations in ift88 (polaris), ift172 
(wimple), or C2cd3 (Hearty) exhibit a complete loss of Shh signaling in the neural tube 
but express Pax7 within its endogenous domain (Hoover et al., 2008 ; Huangfu and 
Anderson, 2003). 
 The role of the Wnt signaling pathway in the positive regulation of Pax3 
expression was established in experiments performed in chick and Xenopus embryos 
(Bang et al., 1997 ; Bang et al., 1999). The authors demonstrated that the posterior non-
axial mesoderm of HH stage 8 chick embryos was sufficient to induce Pax3 expression 
in neuralised Xenopus animal caps (Bang et al., 1997). Subsequent experiments 
determined that the ability of theis tissue to induce Pax3 expression is dependent on the 
activity of Wnt8 (Bang et al., 1999). The expression profiles of Pax3 and Wnt8 were 
shown to overlap in the Xenopus presumptive neural plate and furthermore, over 
expression of Wnt8 resulted in the expansion of Pax3 transcription (Bang et al., 1999). 
The converse experiment revealed that knockdown of Wnt8 in the neural plate 
extinguishes Pax3 expression (Bang et al., 1999). These data suggest that the Wnt 
signaling pathway is both necessary and sufficient for Pax3 expression in the lateral 
neural plate. 
 Subsequent investigations have built upon this hypothesis by demonstrating that 
ectopic expression of Wnt1 and Wnt3a in the chick spinal cord is sufficient to expand 
the Pax7 domain at the expense of ventral progenitor markers on the electroporated side 
(Alvarez-Medina et al., 2008). A similar expansion of the Pax7 domain is observed in 
electroporation experiments employing a constitutively active form of the Wnt pathway 
effector β-catenin (Alvarez-Medina et al., 2008 ; Zechner et al., 2007). In contrast, 
mouse embryos in which the transcriptional activity of β-catenin is specifically 
inactivated exhibit a strong reduction of Pax3 expression in the dorsal spinal cord at 
E12.5 (Valenta et al., 2011). The requirement of the Wnt signaling pathway for Pax3/7 
expression is further highlighted in chick studies employing a dominant negative form 
of the Wnt pathway effector Tcf3, which revealed a cell autonomous repression of both 
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Pax3 and Pax7 within their endogenous domains (Alvarez-Medina et al., 2008 ; Lee and 
Deneen, 2012). 
These data are consistent with the hypothesis that the Wnt signaling pathway is 
both necessary and sufficient for Pax3/7 expression in the neural tube, however there is 
also evidence to suggest that this interaction may be indirect. Overexpression of Wnt1 
and Wnt3a in the chick neural tube was shown to result in the induction of Gli3 
transcription and when this interaction is blocked, the Wnt pathway can no longer 
induce Pax7 expression (Alvarez medina et al., 2008). Furthermore, either 
electroporation of dominant negative Tcf3 in chick or Wnt1-/-;Wnt3a-/- mutant mice was 
shown to result in the loss of Gli3 expression in the dorsal spinal cord (Alvarez medina 
et al., 2008). Together, these data suggest that the interaction of the Shh and Wnt 
signaling pathways within the neural tube might play a role in the regulation of Pax3/7 
expression. 
The BMP signaling pathway is also thought to positively regulate the expression 
of Pax3/7 in CNS progenitors, however this has not been as extensively studied. The 
role of this pathway in Pax3/7 regulation was established in a series of ex-vivo 
experiments that demonstrated the ability of the epidermal ectoderm to induce Pax3 
transcription in the underlying neural plate (Liem et al., 1995). The identities of the 
inducing factors were subsequently defined as BMP4 and BMP7 (Liem et al., 1995). 
Experiments investigating the role of BMP signaling in the specification of progenitor 
identity in the chick spinal cord revealed that retroviral mediated expression of an 
activated form of BMP receptor 1b throughout the neural tube results in an a slight 
ventral expansion of Pax7 on the electroporated side (Timmer et al., 2002). 
Comparatively greater expression levels of BMP receptor 1b, driven by the 
cytomegalovirus promoter produce a greater expansion of Pax7 expression, however 
these results are difficult to interpret as apoptosis is induced in this experiment (Timmer 
et al., 2002). In contrast to these conclusions, knockdown of BMP7 in the chick spinal 
cord has been shown to have no effect on Pax7 expression (Le Dréau et al., 2012). 
Similarly, RNAi mediated knockdown of Smad1 and Smad5 in chick did not reduce the 
Pax7 expression domain (Le Dréau et al., 2012). Finally, the boundary of Pax7 
expression in BMP7-/- mice was shown to be identical to wild type (Le Dréau et al., 
2012). Taken together, these reports suggest that the BMP signaling pathway is 
sufficient but not necessary for the expression of Pax3/7. 
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1.3.5 – The molecular basis of Pax3/7 regulation in the neural tube 
 
 Several studies have attempted to define the regulatory mechanisms that act to 
initiate Pax3 transcription in the neural plate and restrict its activity to the dorsal half of 
the spinal cord, all of which are focused upon a 1.6 kilobase (kb) region located 
upstream of the Pax3 transcription start site in the mouse genome. The first report to 
suggest that this region possessed a regulatory potential was based on the differentiation 
of P19 embryonal carcinoma (EC) cells into either Pax3 expressing neuroectoderm or 
mesoderm, achieved by culture in the presence of RA or DMSO, respectively (Natoli et 
al., 1997 ; Pruitt. 1994). A 14 kb fragment of 5’ Pax3 sequence, fused to a 
chloramphenicol acetyltransferase reporter gene, was shown to activate transcription in 
either RA or DMSO treated cells (Natoli et al., 1997). Serial deletion of this fragment 
revealed that 1.6 kb of sequence located proximal to the Pax3 promoter retained the 
ability to induce reporter expression in cells differentiated into either neuroectoderm or 
mesoderm (Natoli et al., 1997). 
Transgenic mice expressing LacZ under the control of either the 1.6 kb or 14 kb 
fragments of upstream sequence demonstrated that these regulatory regions were 
transcriptionally active at E8.5 in the neural plate and recapitulated the dorsal restriction 
of Pax3 expression within the spinal cord (Natoli et al., 1997). The authors noted that 
the expression mediated by the 1.6 kb construct was observed throughout the mesoderm 
of the tail bud, in contrast to Pax3 transcription, which is restricted to the neural plate 
(Natoli et al., 1997). This observation led the authors to conclude that the 1.6 kb region 
located proximal to the Pax3 transcriptional start site was sufficient to recapitulate gene 
expression in the dorsal spinal cord, however additional elements located within the 14 
kb fragment were required to repress Pax3 expression from the tail bud mesoderm 
(Natoli et al., 1997). 
A series of EMSA experiments, performed using a series of overlapping 
fragments within the 1.6 kb CRM, identified 4 sites in the element occupied by nuclear 
extract prepared from P19 EC cells differentiated to neuroectoderm (Pruitt et al., 2004). 
Subsequent analysis of each individual site by EMSA demonstrated that 2 sites, termed 
sites I and II, were bound by the POU class homeobox genes Brn1 and Brn2 (Pruitt et 
al., 2004). Sites A and B were shown to interact with the Hox cofactors Pbx and 
Meis1/2 (Pruitt et al., 2004). Mutation of either site I or site II in the context of the 1.6 
kb Pax3 CRM was shown to reduce the level of reporter transcription in transgenic 
mice, however the domain of expression within the dorsal neural tube was retained 
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(Pruitt et al., 2004). Similarly, mutation of site A was also demonstrated to have no 
effect upon transgene expression in-vivo. LacZ expression was observed to be 
downregulated in the anterior regions of the neural tube of site B mutants at E9.5 and 
completely extinguished in the tissue by E11.5 (Pruitt et al., 2004). These results led to 
the conclusion that the Pbx/Meis motif represented by site II modulates the expression 
of Pax3 in the AP axis of the CNS (Pruitt et al., 2004). 
A subsequent investigation assessed the conservation of the 1.6 kb Pax3 CRM 
between the human and mouse genomes to identify two regions, named neural crest 
enhancers (NCE) 1 and 2 (Millewski et al., 2004). Removal of either of these regions 
from the 1.6 kb fragment was shown to result in a complete loss of transgene expression 
in mice at E10.5, suggesting that both are independently required for CRM activity 
(Millewski et al., 2004). A 454 bp construct containing only NCE1 and 2 was shown to 
recapitulate Pax3 expression in the somites, however activity within the spinal cord was 
dorsally restricted in comparison to endogenous transcript and did not exhibit a sharp 
ventral boundary (Millewski et al., 2004). The authors used the mouse sequence of 
NCE2 as bait in a yeast one-hybrid screen to identify Tead2, a transcriptional effector 
the Hippo signaling pathway whose expression profile overlaps with Pax3 in the dorsal 
spinal cord (Millewski et al., 2004). Tead2 was shown to bind NCE2 via a consensus 
Tead motif in EMSAs and induce transcription from NCE2 in luciferase assays 
(Millewski et al., 2004). Expression of a dominant negative form of Tead2 under the 
control of the Wnt1 promoter revealed a slight reduction in Pax3 expression in the 
neural tube at E10.5, however these data are difficult to interpret as the morphology of 
the neuroepithlium was severely affected in this experiment (Millewski et al., 2004). A 
subsequent report assessing the requirement of Tead2 during neurulation clearly 
demonstrated that Pax3 transcription is not affected in Tead2-/- mice (Kaneko et al., 
2007). 
 A recent study assessed the requirement of both NCE1 and NCE2 for Pax3 
expression in mice by replacing the region containing these elements with a neomycin 
resistance gene by Cre mediated recombination (Degenhart et al., 2010). Homozygous 
transgenic embryos exhibited severe neural tube defects, a lack of limb musculature and 
a dramatic reduction in Pax3 expression within the dorsal spinal cord, suggesting that 
removal of NCE1 and NCE2 extinguished Pax3 expression in-vivo (Degenhardt et al., 
2010). However, subsequent experiments demonstrated that targeting the neomycin 
resistance gene to the locus resulted in the creation of a null Pax3 allele and 
furthermore, that removal of this cassette by homologous recombination completely 
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restored Pax3 expression throughout the embryo (Degenhardt et al., 2010). These data 
clearly demonstrated that both NCE1 and NCE2 are not required for the induction of 
Pax3 transcription in the neuroepithelium or its restriction to the dorsal half of the spinal 
cord (Degenhardt et al., 2010). This led the authors to propose that the Pax3 locus 
contains multiple, functionally redundant CRMs that act in concert to define the Pax3 
expression domain within the dorsal spinal cord (Degenhardt et al., 2010). 
 A comparative genomics investigation of the Pax3 locus, based on the 
conservation of non-coding sequence between the mouse and chicken genomes, 
revealed the presence of 8 evolutionary conserved regions (ECRs) with at least 50% 
identity over at least 200 bp (Degenhardt et al., 2010). A 967 bp element located within 
the 4th intron of the locus, named Pax3-ECR2, was shown to be sufficient to induce 
transcription within the neural plate of mice assessed at E8.5, consistent with the 
temporal induction of Pax3 expression in the CNS (Degenhardt et al., 2010 ; Goulding 
et al., 1991). The authors also demonstrated that transgene expression mediated by 
ECR2 was localised to the dorsal spinal cord of mice between E9.5 – E12.5 in a profile 
consistent with that observed for Pax3 (Degenhardt et al., 2010). ECR2 was shown to 
be transcriptionally active in zebrafish embryos at 24 hours post fertilisation (hpf) with 
an expression profile that overlapped with that of Sox10, a marker of the neural crest 
lineage (Degenhardt et al., 2010). Furthermore, the activity of ECR2 was shown to be 
dependent upon the integrity of 5 Tcf/Lef binding sites, which when mutated in the 
context of a 403 bp minigene resulted in a complete loss of transgene activation in 
zebrafish (Degenhardt et al., 2010). 
These data were the first to provide a mechanistic link between the effects of 
Wnt pathway manipulation on Pax3 expression and the molecular basis of gene 
regulation. This study also revealed that, at least within the mouse genome, the 
expression profile of Pax3 in the CNS is governed by the activity of several functionally 
redundant cis-regulatory modules. However, the regulatory logic that defines the ventral 
boundary of the Pax3 expression domain was not explored during this investigation 
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1.4 – Aims 
 
 The expression profile of Pax3 within the embryonic CNS and the results of 
studies describing its function suggest that this transcription factor might play a critical 
role in the development of dorsal interneuron progenitors within the alar plate. Despite 
being one of the first patterning genes expressed by neural progenitors, the molecular 
basis of Pax3 transcriptional initiation within the lateral neural plate is poorly 
understood. Similarly, the regulatory mechanisms that produce a sharp boundary of 
expression at the level of the sulcus limitans cannot be described by a cross-repressive 
interaction, as no ventrally expressed genes share a boundary with Pax3 in the neural 
tube. This study aims to address these issues by determining the position of Pax3 within 
the neural tube GRN. 
 This investigation will begin by testing the hypothesis proposed by Wilhelm 
His, which states that alar plate progenitors are fated to give rise to sensory neurons in 
the adult tissue (His. 1888). This will be be achieved by employing Cre/LoxP 
technology in transgenic mice to trace the lineage of Pax3 expressing progenitors from 
the early stages of neural tube patterning to the establishment of functional sensory-
motor connections at birth. These data will also be utilised to study the mechanisms 
through which a sharp boundary of Pax3 expression is produced in the spinal cord by 
comparing the distribution of Pax3 protein to cells derived from this lineage. 
The molecular basis of Pax3 expression in the spinal cord will be examined in a 
comparative genomics study; which will identify CNEs associated with the locus. 
Transgenesis experiments, performed in zebrafish and chick embryos, will be employed 
to determine the regulatory potential of each CNE in-vivo. These studies will aim to 
reduce the complex profile of Pax3 expression to the enhancer activity of discrete 
CRMs. CNEs which exhibit transcriptional activity within spinal cord progenitors will 
be selected for functional dissection, guided by the in-silico annotation of regulatory 
motifs and TFBS within these regions. Finally, the interactions of regulatory sequences 
with putative transcription factors will be investigated in-vitro in order to determine the 
regulatory logic that governs Pax3 expression in the neural tube. 
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Chapter 2 – Materials and Methods 
 
2.1 – General molecular biology techniques 
 
2.1.1 – Transformation of chemically competent bacteria 
 
 1-5 µl of plasmid DNA was added to a 50 µl aliquot of lab stock chemically 
competent DH5-α bacteria and incubated on ice for 15 mins. The mixture was heat 
shocked at 42 ºC for 45 seconds and returned to ice for 2 mins. 1 ml of Luria-Bertani 
(LB) medium was added to the cells, which were then incubated at 37 ºC for 1 hour on a 
shaker. The transformed cells were then amplified in a 250 ml culture or spread onto LB 
agar plates for the identification of single colonies under the appropriate antibiotic 
selection.  
 
2.1.2 – Plasmid DNA preparation 
 
 Large-scale DNA preparations of 250ml bacteria cultures were performed using 
the Qiafilter plasmid Maxi kit (Qiagen) according to manufacturers instructions. Small-
scale preparations of 6ml bacterial cultures were performed using the Qiaprep spin 
miniprep kit (Qiagen). The concentration of all DNA preparations was determined using 
a Nanodrop ® spectrophotomer (LabTech) and supporting software before storage at 4 
ºC. 
 
2.1.3 – BAC DNA preparation 
 
 A 250 ml culture inoculated with a sample from a BAC glycerol stock and the 
appropriate antibiotic was incubated overnight at 30 ºC. DNA preparations were 
performed using a NucleoBond BAC 100 kit (Machery Nagel) according to the 
manufacturers instructions. The integrity of DNA was assayed by gel electrophoresis 
before the concentration was determined by spectrophotometry. BAC preparations were 
stored at 4 ºC and handled carefully to minimize the risk of DNA shearing. 
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Luria-Bertani media (1L) -10 g Tryptone, 5 g Yeast Extract, 10 g NaCl, pH 7.0 
Ampicillin – 100 µg/ml 
Kanamycin – 50 µg/ml 
 
2.2 – Defining putative regulatory elements 
 
2.2.1 – Comparative genomic alignments 
 
 Human genomic sequence (Hg18) containing the desired locus and all 
surrounding intergenic sequence was locally aligned to the equivalent regions in the 
mouse (Mm9), zebrafish (Zv5) and fugu (Fr2) genomes. Chromosome location and 
feature annotation was exported from the UCSC genome browser 
(http://genome.ucsc.edu/) and uploaded to the Mulan alignment tool 
(http://mulan.dcode.org/) with the appropriate repeat masking parameters selected. The 
computed phylogenetic tree was accepted as it accurately reflected the evolutionary 
relationships between the input genomes. Sequences were forwarded to the multiple 
threaded blockset alignment algorithm of the Mulan tool and the output was displayed 
as a graphical conservation profile. The preliminary alignment was refined to display 
CNEs that were present in all of the aligned sequences with at least 65% homology over 
at least 40 bp. The entire alignment was then restructured in order to map the location of 
CNEs to the zebrafish genome. 100 bp of genomic sequence was added to each end of 
these CNEs before the sequence was extracted. 
 
2.2.2 – Cloning CNEs 
 
 Conserved regions were amplified from BAC preparations using the Expand 
High Fidelity Polymerase chain reaction (PCR) System (Roche). The optimal 
Oligonucleotides used for PCR amplification were selected by forwarding the sequence 
of CNEs to the Primer3 tool (http://biotools.umassmed.edu/bioapps/primer3_www.cgi). 
Primer pairs were designed to initiate amplification in the 100 bp of non-conserved 
genomic sequence added to each end of the CNE of interest. Each primer pair was 
modified to introduce a HindIII site at the 5’ end of the amplicon and an SbfI site at the 
3’ end to facilitate ligation proximal to the promoter in the MiniTol2 TKProm Gal4-
UAS Citrine (MiniTol2-Citrine) expression vector. The primers used to clone each CNE 
from the Pax3 and Pax7 loci are listed in Table 2.1. 
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 Successful amplification of CNEs was confirmed by gel electrophoresis before 
the correct sized reaction product was excised with a scalpel on a long wave light box 
(365 nm). DNA was extracted from the gel using a Qiaquick gel extraction kit (Qiagen) 
according to manufacturers instructions and eluted in a volume of 20µl. Both the vector 
and insert were digested with HindIII and SbfI for 2 hours at 37 ºC before the vector 
was dephosphorylated with calf intestinal phosphatase for a further 30 mins to reduce 
the probability of re-ligation. The amount of insert DNA required in each ligation was 
calculated based on a 10:1 ratio of insert to vector in the reaction. A 20 µl reaction 
containing 50 ng of dephosphorylated vector, 1x T4 ligase buffer, 5U of T4 DNA ligase 
(Roche) and the required amount of insert was incubated for 1 hour at room 
temperature. 5 µl of the ligation mixture was transformed and spread onto LB agar 
plates for the identification of single colonies. Successful cloning was confirmed by 
sequencing the DNA preparations from at least 10 colonies using the MiniTol2 3’ 
reverse primer listed in Table 2.1. 
 
2.2.3 – Identifying CNE homology regions 
 
 The coverage of comparative genomic alignments was expanded by the 
identification of homology regions in additional vertebrate genomes. The Human 
sequence representing the minimal conserved region was used as the query sequence for 
all Basic Local Alignment Search Tool (BLAST) searches using the nucleotide BLAST 
algorithm of the Ensembl genome browser (http://www.ensembl.org/). The search was 
optimized for the identification of matches in distant genomes using the predefined 
settings accessed in the search sensitivity tab of the input page. The genomic location of 
BLAST hits was verified before the sequence was extracted and stored.  
 
2.2.4 – Defining putative binding sites  
 
 The variance within CNE sequences present in available vertebrate genomes 
was analysed using the DNA function of the ClustalW2 multiple sequence alignment 
tool (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Expanding the width of the alignment 
facilitated the identification of blocks of single nucleotides that are highly conserved 
across numerous vertebrate genomes, these regions were hypothesized to represent 
candidates for functional TFBS.  
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 Conserved motifs within putative regulatory regions were identified by 
comparative genomic analysis of homologous sequences using the MEME suite 
(http://meme.nbcr.net/meme/cgi-bin/meme.cgi). Statistically overrepresented motifs 
with a minimum width of 6 bp and a maximum of 15 bp that were present at least once 
in each of the query sequences were identified. Motifs were displayed as a consensus 
sequence and a position specific probability matrix (PSPM), calculated from the 
occurrence of each nucleotide within the motif across all input sequences. The PSPM 
representing each identified motif was compared to annotated TFBS in the Jaspar 
(http://jaspar.cgb.ki.se/) and uniPROBE (http://thebrain.bwh.harvard.edu/uniprobe/) 
databases using the TOMTOM search tool (http://meme.nbcr.net/meme4/cgi-
bin/tomtom.cgi). TFBS databases were queried for similarity to discovered motifs using 
the Pearson correlation coefficient function and a significance threshold of E<10. The 
results were visualized as a graphical alignment of the predicted TFBS to the query 
motif and ranked according to probability. 
 
2.2.5 – CNE modification by mutagenic PCR 
 
 15 bp evolutionary conserved motifs were deleted from CNEs using the 
Quickchange II XL site-directed mutagenesis kit (Stratagene) and the oligonucleotides 
listed in Table 2.3. The PCR strategy utilized complimentary primers that spanned the 
region of interest but omitted the central 15 bp, resulting in the production of a template 
in which the motif was not present. The manufacturers suggested cycling parameters 
were modified in order to increase the efficiency of the reaction, the optimized 
programme is outlined in Table 2.2. 10U of DpnI was used to digest the methylated 
template DNA before successful mutagenesis was visualized by gel electrophoresis. 5 
µl of the reaction was transformed and spread onto LB agar plates and at least 10 
colonies were sequenced for each motif deletion performed. 
 Targeted disruption of conserved TFBS within functional motifs was also 
performed using the Quickchange II XL site-directed mutagenesis kit (Stratagene). 
Nucleotides within TFBS identified by TOMTOM searches were mutated according to 
published data where available. The PSPM defining the TFBS of interest was used to 
design mutations in cases where published data was not accessible. The primers listed in 
Table 2.4 were used to introduce defined changes in CNEs using the cycling parameters 
outlined in Table 2.2. DNA preparations from at least 10 individual colonies were 
sequenced to confirm successful mutagenesis.  
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2.3 – Identifying DNA - protein interactions 
 
2.3.1 – In-vitro transcription and translation 
 
 The full-length cDNA clones of the transcription factors listed in Table 2.5 were 
used as templates for in-vitro protein synthesis. Proteins were produced using the TnT 
coupled rabbit reticulocyte lysate system (Promega) in a 50 µl reaction containing 27.5 
µl of rabbit reticulocyte lysate and 1µg of DNA template, according to manufacturers 
instructions. The reactions were snap frozen in liquid nitrogen upon completion and 
stored at -80 ºC until required. 
 
2.3.2 – Radiolabelling of double stranded oligonucleotides 
 
 The single stranded oligonucleotides listed in Table 2.6 were resuspended in 
dH2O to a final concentration of 100 mM. Complementary Oligonucleotide pairs were 
mixed in a 1:1 ratio with 10x annealing buffer in a total volume of 100 µl. The mixture 
was heated to 95 ºC for 5 mins in a hot block before being allowed to return to RT over 
a period of 1 hour. Successful annealing was confirmed by electrophoresis on a 4% 
agarose gel before stocks were stored at -20 ºC. 
 The 5’ end of annealed oligonucleotides was radiolabelled by the addition 
phosphorus 32 (32P) using T4 polynucleotide kinase. A 20 µl reaction containing 500 ng 
of oligonucleotide, 1x T4 polynucleotide buffer (Promega), 10U of T4 polynucleotide 
kinase (Promega) and 2 µl of 32P-γATP (3000 ci/mmol at 10 mCi/ml) (Hartman 
Analytic) was incubated at 37 ºC for 30 mins. 180 µl of TE was added to the reaction 
before purification on an illustra microspin G-25 column (GE Healthcare) according the 
manufacturers instructions. Radiolabelled oligonucleotides were stored at 4 ºC and used 
within one half-life. 
 
2.3.3 – Chick nuclear extractions 
 
 36 fertilised chick eggs were incubated at 37 ºC and allowed to develop until 
embryonic day 3. Embryos were removed from the egg and transferred to petri dishes 
containing phosphate buffered saline (PBS) on ice. The embryos were carefully 
dissected using number 5 forceps, leaving only the somites and spinal cord intact. The 
trunk tissue was dissected to small pieces with a scalpel and transferred to a 2 ml tube in 
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PBS. The mixture was centrifuged at 13,200 rpm for 30 seconds and the PBS was 
replaced with 500 µl of lysis buffer. The tissue was homogenized by passage through a 
25-gauge needle and centrifuged at 11,000 g for 20 mins at 4 ºC. The nuclei were 
resuspended in 150 µl of extraction buffer and incubated for 30 mins at 4 ºC before 
centrifugation at 21,000 g. The resulting supernatant was stored in 20 µl aliquots, which 
were snap frozen in liquid nitrogen and kept at -80 ºC until required. 
 
2.3.4 – Electromobility shift assays 
 
 Binding reactions included 10 µl of 2x binding buffer, 2 µl of 1 µg/µl poly dIdC 
(Thermo Scientific), 3 µl of in vitro translated protein or 3 µl of nuclear extract and 2 µl 
of radiolabelled oligonucleotides in a final volume of 20 µl. The concentration of ficoll 
was reduced to 4 % in the binding buffer of reactions containing nuclear extract as it 
was found to greatly improve complex resolution. Supershift assays were performed by 
the addition of 1 µl of primary antibody to the binding reaction either before or 10 
minutes after the addition of the radiolabelled probe, depending on the antibody 
required. Competition assays were performed by the titration of a non-labelled probe to 
a final 4-fold excess in the reaction. 
 Binding reactions were incubated on ice for 1 hour, following which the 
complexes were resolved on a 4 % non-denaturing polyacrylamide gel ran in 0.25x 
TBE. The gel was dried under vacuum at 80 ºC for 1 hour and exposed to X-ray film 
(Thermo Scientific) for 3 - 16 hours, depending on the strength of signal achieved. 
Films were developed for 2 mins using a FPM-3800A processor (FugiFilm) and 
digitally archived using a V750 pro scanner (Epson) linked to Photoshop (Adobe).  
 
10x annealing buffer: 100 mM Tris pH 8.0, 10 mM EDTA and 1 M NaCl 
Lysis buffer: 100 mM HEPES, 15 mM MgCl2, 100 mM KCl and 1 M DTT. 
Extraction buffer: 20 mM HEPES, 1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM EDTA and 
25 % glycerol. 
2x binding buffer: 8 % Ficoll, 40 mM HEPES, 60 mM KCL, 2 mM DTT and 0.2 mM 
EDTA. 
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2.4 – Embryo manipulation 
 
2.4.1 – Maintenance of zebrafish lines 
 
Wild type (WT) lines were created and maintained through pair mating of 
LondonAB and LondonTP stocks. Pax3 - GFPI150 and Pax7 - GFPI131 BAC transgenic 
stable lines were gifts from the Ingham laboratory at the University of Sheffield. These 
transgenic lines were maintained by outcrosses to WT and the progeny were sorted by 
the presence of GFP. 
 
2.4.2 – Zebrafish embryo injection 
 
 Wild type stocks were pair mated, separated by a barrier overnight. The 
following morning, barriers were removed and embryos were collected every 15 
minutes. The eggs were transferred to a 2.5 % agarose mould and orientated to allow 
easy visualization of the cell. Putative regulatory regions were injected at a 
concentration of 20 ng/µl in sterile water. Transposase mRNA was coinjected with all 
constructs contained in the MiniTol2 TKProm Gal4-UAS GFP vector at a final 
concentration of 14 ng/µl. Embryos were transferred to petri dishes containing aquarium 
water supplemented with methionine blue dye and incubated at 28.5 ˚C. Embryos were 
manually dechorionated and fixed with 4% paraformaldehyde (PFA) in PBS at the 
appropriate stage. A conversion between the embryonic stages of zebrafish development 
defined within Kimmel et al., 1995 to hpf of embryos maintained at 28.5 ˚C is provided 
in Table 2.8. 
 
2.4.3 – Creation of transgenic zebrafish stable lines 
 
 WT embryos were injected with reporter constructs at the 1 cell stage; the 
resulting transient transgenics were sorted at 24 hpf on the basis of Citrine expression. 
Embryos were incubated 28.5 ºC until they were transferred into the care of the 
institute’s aquatics facility at 6 days post fertilization. Injected embryos were 
maintained in the aquarium for approximately 4 months before being screened for 
germline transgenesis in outcrosses with WT stocks. Founder fish with stable germline 
transgene intergration were identified and maintained in single tanks. The GFP positive 
progeny of outcrosses between founders and WT stocks were used to expand each line 
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in tanks of no more than 50 fry. Pair mating of F1 fish with wildtype stocks was used to 
assess the activity of CNE driven trangenes. 
 
2.4.4 – Chick in-ovo electroporation 
 
 Fertilized chick eggs were incubated at 37 ˚C for 40 h to allow the embryos to 
develop to embryonic stage 11-13 (Hamburger and Hamilton, 1951). 5 ml of albumin 
was removed from the egg before the shell was windowed with scissors and Indian ink 
was injected under the embryo to allow easy visualization and staging. Putative 
regulatory elements were injected at a final concentration of 500 ng/µl with transposase 
mRNA at 14 ng/µl, pCAGGS LacZ at 1.5 µg/µl and 5% fast green dye. DNA constructs 
contained in either the pCAGGS or RCAS expression vectors were injected into the 
lumen of the neural tube at a concentration of 1.5 – 4 µg/ml in H2O with 5% fast green 
dye. Platinum electrodes were placed adjacent to the embryo to deliver 50 millisecond 
pulses at 30 V, following which the egg was sealed with a layer of clear tape. Embryos 
were returned to 37 ˚C until fixation at the appropriate stage in 4 % PFA/PB.  
 
2.5 – Embryo analysis 
 
2.5.1 – Synthesis of riboprobes 
 
 Pax3a, pax3b, pax7a and pax7b antisense riboprobes were synthesised from 
plasmids provided by Professor Simon Hughes. Previous reports have demonstrated the 
specificity of these reagents for each of the zebrafish paralogous genes (Minchin and 
Hughes, 2008). 2 µg of plasmid DNA was digested with the appropriate restriction 
endonuclease (Roche and NEB) for 2 hours. Linearisation of the plamid was determined 
by gel electrophoresis before DNA purification using the Ilustra GFX PCR DNA and 
Gel Band Purification Kit (GE Healthcare). 1 µg of linear template was used in a 20 µl 
in-vitro transcription reaction containing 1x transcription buffer (Roche), 1x DIG 
labelling mix (Roche), 40U of RNasin (Promega) and 60U of the required RNA 
polymerase (Roche and Promega). The reaction was incubated at 37 ºC for 2 hours 
before 10U of RNase free DNase 1 (Promega) was added. The reaction was allowed to 
proceed for a further 15 mins to ensure all template DNA had degraded. The successful 
production of riboprobes was confirmed by gel electrophoresis, before the RNA was 
purified on a G-50 column (GE Healthcare) and stored at -20 ºC. 
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2.5.2 – Wholemount in-situ hybridization 
 
Fixed embryos were transferred through a methanol series (25-100%) and stored 
at -20 ˚C for at least 24h. Embryos were rehydrated through 5 minute washes in 
methanol/PBS (100-25% series) followed by 4 washes in PTW at RT. Proteinase K (10 
µg/ml) treatment was performed according to developmental stage, following which the 
embryos were re-fixed in 4 % PFA for 20 mins at RT. Embryos were washed 5x 5 mins 
in PTW before a brief rinse in hybridization solution followed by a 1-3h pre-
hybridization step at 75 ˚C. Embryos were then incubated in hybridization solution 
supplemented with yeast tRNA (25 mg/ml), heparin (50 mg/ml) and the appropriate dig 
labeled probe (1:200 – 1:400 dilution) overnight at 75 ˚C. 
The following day embryos were washed at 75 ˚C in hybridization solution/2x 
SSC for 20 mins, 2x SSC for 20 mins and twice in 0.2x SSC for 60 mins. RT washes 
with PBT/ 0.2x SSC for 10 mins and PBT for 10 mins were followed by a blocking step 
of 1-3h in PBT. Anti-DIG fab fragments (Roche) were diluted in PBT (1:2000) and the 
embryos were incubated overnight at 4 ˚C. 
On the final day, the embryos were washed 4x 30 mins in PBT at RT before 
being transferred to a 12 well culture dish. The samples were equilibrated in staining 
buffer by 4x 10 mins washes before the addition of BCIP (3.5 µl/ml) and NBT (4.5 
µl/ml) to the staining buffer. The culture plate was wrapped in foil to allow the staining 
reaction to proceed in the dark at RT for several hours. When satisfactory staining had 
been achieved, the embryos were washed in PTW 3x for 5 mins and fixed in 4 % PFA 
at 4 ˚C overnight in the dark.  
 
2.5.3 – Zebrafish wholemount immunostaining 
 
 Fixed embryos were washed 3X 5 mins in PBT before a blocking step of 1-3h in 
PBDT at RT. The required primary antibodies were diluted in PBDT and the embryos 
were incubated at 4 ˚C overnight with constant agitation. Washes with PBT for 30 mins, 
repeated 4 times, were used to remove any excess primary antibody before a second 
blocking step of 1-3h in PBDT at RT. Alexa fluor conjugated secondary antibodies 
(Invitrogen) were diluted 1:400 in PBDT and the embryos were incubated at 4 ˚C 
overnight in the dark. On the final day the embryos were again washed in PBT 4x for 30 
mins before being transferred through a glycerol series (15-75%) and stored at 4 ºC. 
 
Chapter 2 – Materials and Methods 
	   57 
2.5.4 – Gelatine embedding for cryosectioning 
 
 Fixed embryos were washed 2x 5 mins in PTW before being incubated in a 
cryoprotective sucrose solution at 4 ºC overnight. The samples were transferred to 
embedding solution with a pair of forceps and incubated at 40 ºC until they had passed 
through the solution and settled at the bottom of the tube. The embryos were transferred 
to a plastic mould and orientated according to the desired plane of dissection before the 
solution solidified at RT. The blocks of gelatine were trimmed with a scalpel before 
being frozen at -42 ºC in isopentane and stored at -80 ºC until required. 
 
2.5.5 – Immunostaining cryosections 
 
 Sections of 14 µm were prepared on a Hyrax C60 cryostat (Zeiss) and the slides 
were stored at -20 ˚C until required. Gelatin was removed from the samples by 5 washes 
in PBS at 42 ˚C before the slides were washed briefly in PBT. The tissue was blocked 
for 1-3 hours in PBDT at RT before the slides were incubated overnight at 4 ºC in a 
solution containing the required primary antibodies, diluted in PBDT. The following 
day, slides were washed with PBT 3x for 5 mins, blocked for 1-3h with PBDT and 
incubated with the appropriate secondary antibodies for 2-3h in the dark at RT. Slides 
were washed with PBT 3x for 5 mins, briefly dried and mounted in either Vectashield 
(Vector Labs) or Prolong Gold (Invitrogen) before the application of a coverslip. The 
antibodies used for immunohistochemistry during this investigation are listed in Table 
2.7. 
 
2.5.6 – Microscopy and image analysis 
 
 Images of in-situ hybridization experiments were acquired using an Axioplan 2 
compound microscope equipped with an Axiocam HRC digital camera and supporting 
software (Zeiss). Zebrafish whole mount immunostainings were imaged using a 
M205FA automated stereo-microscope equipped with a DFC360FX camera and 
supporting software (Leica). Immunostainings on sectioned tissue were imaged using a 
TCS SP2 confocal microscope and supporting software (Leica). All of the acquired 
images were processed using both Image J and Photoshop CS4 (Adobe). 
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Sucrose solution: 0.12M PB with 15% sucrose 
Embedding solution: 0.12M PB, 15% sucrose, 7.5% gelatine 
PTW: PBS with 0.1% Tween 20 
PBT: PBS, 0.1% Tween, 2% Goat serum, 0.2% BSA 
PBDT: PBS, 0.1% Tween, 2% Goat serum, 0.5%BSA, 0.25 Triton-X, 0.5% DMSO 
Hybridization solution: 50% Formamide, 5x SSC, 0.1% Tween 20, 9mM citric acid, 
dH20. 
Staining buffer: 0.1M Tris pH9.5, 0.05M MgCl2, 0.1M NaCl, 0.1% Tween 20, dH20. 
 
Table 2.1 – Primers used to clone CNEs 
 
Name Sequence (5’ to 3’) 
CNE1 FW GGGCCCAAGCTTAGTGTTGCGTTTGGCTCTTT 
CNE1 RE CCAGGTGTCATTGAGCCTCTGGACGTCCGGGCCC 
CNE2 FW GGGCCCAAGCTTAAAGCCGCAACAACAAAGAG 
CNE2 RE TCCAGTCACGCTCTAGTCCAGGACGTCCGGGCCC 
CNE3 FW GGGCCCAAGCTTTTTCTCTCCCCTCCTTCACC 
CNE3 RE AAACCGTGCATCATTTCCACGGACGTCCGGGCCC 
CNE4 FW GGGCCCAAGCTTTCACCCCCAAAAATATCTGC 
CNE4 RE TGACAATCCTCGAGCCTCATGGACGTCCGGGCCC 
CNE5 FW GGGCCCAAGCTTACTGCCTTTTCCCAGACAAA 
CNE5 RE GTTTGCAGTGGGCTGATTCTGGACGTCCGGGCCC 
CNE6 FW GGGCCCCCTGCAGGAAATCACCTCCACATTTATCGT 
CNE6 RE AGCGTTTTTGTGCCTTTTTCGGACGTCCGGGCCC 
MiniTol2 3’ reverse CTGGCTAGAATCTTACTTGAG 
Pax3b CNE1 FW TTTATTGGGTCGTCTCTGTGTG 
Pax3b CNE1 RE AGCTCCTCAGGGGCAGGT 
TOPO> MiniTol2 FW GGGCCCAAGCTTTTGGTACCGAGCTCGGATCCA 
TOPO> MiniTol2 RE TCTAGATGCATGCTCGAGCGGGGACGTCCGGGCCC 
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Table 2.2 – Cycling parameters for mutagenic PCRs 
 
Number of cycles Temperature Time 
1 95ºC 1 minute 
 
20 
95ºC 50 seconds 
58ºC 50 seconds 
68ºC 10 minutes 
1 68ºC 7 minutes 
 
 
Table 2.3 – Primers used to delete motifs from CNEs 
 
Name Sequence (5’ to 3’) 
CNE1∆Motif1FW GTGACTGAGCTCTTTGGAGTCTGATAGGCTCCATGAGCTGG
GTCCGGG 
CNE1∆Motif1RE CCCGGACCCAGCTCATGGAGCCTATCAGACTCCAAAGAGC
TCAGTCAC 
CNE1∆Motif2FW TGGGTCCGGGCAGCATTGAGGCCCACAATGAGGGCTGGAC
GCAGGGCA 
CNE1∆Motif2RE TGCCCTGCGTCCAGCCCTCATTGTGGGCCTCAATGCTGCCC
GGACCCA 
CNE1∆Motif3FW TTTCGGGGAGTTCTTTGGCAGTCTTAGTGAGAATGGTGACT
GAGCTCT 
CNE1∆Motif3RE AGAGCTCAGTCACCATTCTCACTAAGACTGCCAAAGAACT
CCCCGAAA 
CNE1∆Motif4FW GTAGGCTCCATGAGCTGGGTCCGGCTGTCACCTGCCTGGCA
GGGGGCG 
CNE1∆Motif4RE CGCCCCCTGCCAGGCAGGTGACAGCCGGACCCAGCTCATG
GAGCCTAC 
CNE3∆Motif3FW GCTCCCCCCACTTCAAAGATGGTTTCCTTTGAATTAATATTT
GAGGATCA 
CNE3∆Motif3RE TGATCCTCAAATATTAATTCAAAGGAAACCATCTTTGAAGT
GGGGGGAGC 
CNE3∆Motif5FW AGATGGTTTGCATTCATTAATTGTTTGAGGATCACAATGCT
GGTGCCAGG 
CNE3∆Motif5RE CCTGGCACCAGCATTGTGATCCTCAAACAATTAATGAATGC
AAACCATCT 
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Table 2.4 – Primers used to induce mutations in CNEs 
 
Primer Name Sequence (5’ to 3’) 
Target 
site 
Mutated 
product 
CNE1Motif1EboxMut1FW 
GATTTCCACGCTTTGTCCAT
AGGCTCCATGAG 
CCATCTG TTGTCCA 
CNE1Motif1EboxMut1RE 
CTCATGGAGCCTATGGACAA
AGCGTGGAAATC 
CNE1Motif1EboxMut2FW 
GATTTCCACGCTTTGTCTGTA
GGCTCCATGAG 
CCATCTG TTGTCTG 
CNE1Motif1EboxMut2RE 
CTCATGGAGCCTACAGACAA
AGCGTGGAAATC 
CNE1Motif1EboxMut3FW 
GATTTCCACGCTCCATCCAT
AGGCTCCATGAG 
CCATCTG CCATCCA 
CNE1Motif1EboxMut3RE 
CTCATGGAGCCTATGGATGG
AGCGTGGAAATC 
CNE1Motif1RBPJMutFW 
GCTCTTTGGAGTCTGATTTC
GCGCTCCATCTGTAGGCTCC 
TTCCACG TTCGGCG 
CNE1Motif1RBPJMutRE 
GGAGCCTACAGATGGAGCG
CGAAATCAGACTCCAAAGA
GC 
CNE1Motif1TeadMut1FW 
CTGATTTCCACGCTCCATCT
GTATTCTCCATGAGCTGGGT
CCGGG 
TAGGCT TATTCT 
CNE1Motif1TeadMut1RE 
CCCGGACCCAGCTCATGGAG
AATACAGATGGAGCGTGGA
AATCAG 
CNE1Motif1TeadMut2FW 
CCACGCTCCATCTGTAGGCT
AAATGAGCTGGGTCCGGGCA
GC 
CTCCAT CTAAAT 
CNE1Motif1TeadMut2RE 
GCTGCCCGGACCCAGCTCAT
TTAGCCTACAGATGGAGCGT
GG 
CNE1Motif3Mut1FW 
GAGTTCTTTGGCAGTCTATA
GTTGGCCTGTTTAGTGAGAA 
TTTGTT ATAGTT 
CNE1Motif3Mut1RE 
TTCTCACTAAACAGGCCAAC
TATAGACTGCCAAAGAACTC 
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CNE1Motif3Mut2FW 
GAGTTCTTTGGCAGTCTTTTG
CCGGCCTGTTTAGTGAGAA 
TTTGTT TTTGCC 
CNE1Motif3Mut2RE 
TTCTCACTAAACAGGCCGGC
AAAAGACTGCCAAAGAACT
C 
CNE3Motif3HoxMutFW 
AGATGGTTTGCATTCATTCC
TTGTCCTTTGAATTAATA 
TTAATT TTCCTT 
CNE3Motif3HoxMutRE 
TATTAATTCAAAGGACAAGG
AATGAATGCAAACCATCT 
CNE3Motif3FoxMutFW 
AAGATGGTTTGCATTCACCC
ATTGTCCTTTGAATTAAT 
CATTAAT CACCCAT 
CNE3Motif3FoxMutRE 
ATTAATTCAAAGGACAATGG
GTGAATGCAAACCATCTT 
CNE3Motif5HoxMutFW 
CATTAATTGTCCTTTGAATTC
CTATTTGAGGATCACAATGC 
TAATA TCCTA 
CNE3Motif5HoxMutRE 
GCATTGTGATCCTCAAATAG
GAATTCAAAGGACAATTAA 
 
 
Table 2.5 – Constructs used for in-vitro protein synthesis 
 
cDNA Source Vector RNA Polymerase 
Hoxa5 ImaGenes pCMV-SPORT6 Sp6 
Hoxa7 Imagenes pCMV-SPORT6 Sp6 
Lef1 Imagenes pCMV-SPORT6 Sp6 
Pax3 ImaGenes pCR-BluntII-TOPO Sp6 
Pax7 ImaGenes pCR-BluntII-TOPO Sp6 
Pbx1 ImaGenes pYX-Asc T7 
Six2 Dr Eva Kutejova PcDNA3 T7 
Sox2 
Lovell-Badge lab, 
NIMR 
pCI-NEO T7 
Tcf3 ImaGenes pCMV-SPORT6 Sp6 
Tcf7 ImaGenes pCMV-SPORT6 Sp6 
Tead2 ImaGenes pSPORT1 T7 
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Table 2.6 – Oligonucleotides used as EMSA probes 
 
Oligo name Sequence (5’to 3’) 
CNE1Motif1FW 
GAGTCTGATTTCCACGCTCCATCTGTAG
GCTCC 
CNE1Motif1RE 
GGAGCCTACAGATGGAGCGTGGAAATC
AGACTC 
CNE1Motif1E-boxMut3FW 
GATTTCCACGCTCCATCCATAGGCTCCA
TGAG 
CNE1Motif1E-boxMut3RE 
CTCATGGAGCCTATGGATGGAGCGTGGA
AATC 
CNE1Motif3FW 
GGCAGTCTTTTGTTGGCCTGTTTAGTGA
GAATG 
CNE1Motif3RE 
CATTCTCACTAAACAGGCCAACAAAAGA
CTGCC 
CNE3Motif3-5FW 
CCACTTCAAAGATGGTTTGCATTCATTA
ATTGTCCTTTGAATTAATAT 
CNE3Motif3-5RE 
ATATTAATTCAAAGGACAATTAATGAAT
GCAAACCATCTTTGAAGTGG 
CNE3Motif3HoxMutFW 
AGATGGTTTGCATTCATTCCTTGTCCTTT
GAATTAATA 
CNE3Motif3HoxMutRE 
TATTAATTCAAAGGACAAGGAATGAATG
CAAACCATCT 
CNE3Motif3FoxMutFW 
AAGATGGTTTGCATTCACCCATTGTCCTT
TGAATTAAT 
CNE3Motif3FoxMutRE 
ATTAATTCAAAGGACAATGGGTGAATGC
AAACCATCTT 
CNE3Motif5HoxMutFW 
CATTAATTGTCCTTTGAATTCCTATTTGA
GGATCACAATGC 
CNE3Motif5HoxMutRE 
GCATTGTGATCCTCAAATAGGAATTCAA
AGGACAATTAA 
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Table 2.7 – Primary antibodies used for immunohistochemistry 
 
Antibody Species Origin Dilution 
Β-Galactosidase Rabbit 
ABD Serotec 
(AHP1292) 
1:500 
ChAT Rabbit 
Gift from Dr. 
Vassilis Pachnis 
1:1000 
DP311 Mouse 
Gift from Dr. 
Nipam Patel 
1:75 
DP312 Mouse 
Gift from Dr. 
Nipam Patel 
1:75 
GFP Rabbit 
Molecular Probes 
(A11122) 
1:1000 
GFP Sheep Biogenesis 1:1000 
Olig2 Goat 
R&D Systems 
(AF2418) 
1:1000 
Pax3 Mouse DSHB 1:20 
Pax6 Mouse DSHB 1:20 
Pax7 Mouse DSHB 1:20 
Rhodamine 
conjugated 
Phalloidin 
N/A 
Molecular Probes 
(R415) 
1:500 
 
 
Table 2.8 – Conversion of  zebrafish developmental stages to hpf 
 
Developmental stage hpf at 28.5 ºC 
Bud 10 
6 somites 12 
12 somites 15 
18 somites 18 
Prim-5 24 
Prim-15 32 
High-pec 48 
Protruding mouth 72 
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Chapter 3: The establishment of the Pax3 domain in the neural tube 
 
As described in chapter 1.3 ,the anatomical division of the neural tube by the 
sulcus limitans is commonly accepted to mark the division of spinal cord progenitors 
into sensory and motor fates. We aimed to investigate this hypothesis by using 
transgenic mice to genetically trace the progeny of the alar plate from the early stages of 
neural tube patterning to the establishment of functional neuronal circuits within the 
spinal cord at birth. We chose to utilise Pax3 as a molecular marker of the alar plate in 
these studies, as previous reports have demonstrated that it is expressed in all 
progenitors of the dorsal spinal cord and shares a ventral boundary with the sulcus 
limitans between E10-13 in mice (Goulding et al., 1991). We reasoned that the initiation 
of Pax3 transcription within the closing neural folds also provided an opportunity to 
assess progenitor dispersal and the establishment of the Pax3 expression domain before 
the formation of the sulcus limitans. 
 
3.1 – Pax3Cre/Rosa26-YFP mice as a tool for lineage tracing 
 
 Pax3-Cre transgenic mice were obtained as part of a collaboration we initiated 
with the laboratory of Dr Fredéric Relaix. These mice were created by targeted 
replacement of the first exon of Pax3 with Cre recombinase by homologous 
recombination and therefore express Cre under the control of the endogenous Pax3 
regulatory elements (Engleka et al., 2005). The transgenic allele does not produce a 
functional Pax3 protein and homozygous Pax3Cre/Cre mice exhibit severe neural tube, 
neural crest and musculature defects that are comparable to those observed in 
homozygous splotch mutants (Engleka et al., 2005). Heterozygous Pax3Cre/+ embryos 
are viable and develop normally, with the exception of a mild pigment defect that is 
produced as a result of reduced Pax3 protein levels. Pax3-Cre transgenics were crossed 
with mice in which an inducible yellow fluorescent protein (YFP) transgene, localised 
to the cell membrane, is targeted to the Rosa26 locus. This genomic location is 
commonly used in lineage studies as it has been shown to allow unrestricted expression 
of reporter genes (Friedrich and Soriano. 1991; Zambrowicz et al., 1997). The 
expression of YFP from the Rosa26 locus is dependent upon the removal of a floxed 
stop cassette by Cre recombinase, resulting in the persistent expression of YFP in cells 
that have expressed Pax3 at any point during their development (Fig. 3.1). 
Pax3Cre/+/Rosa26-YFP embryos were generated by members of the Relaix lab, collected 
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at the desired stage and genotyped before further analyses were independantly 
performed by both laboratories. 
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Fig. 3.1 – Genetic strategy for lineage tracing Pax3 expressing progenitors 
Mice expressing Cre recombinase under the control of Pax3 regulatory elements were crossed 
with Rosa26 YFP transgenics. In Pax3 expressing cells, Cre mediates a recombination event 
that results in the excision of the stop cassette from the Rosa26 locus and the continued 
expression of YFP in Pax3 progeny. 
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3.2 – The Pax3 domain is established by a switch in progenitor identity 
 
 Pax3 transcription is initiated in the neural plate at E8.5 (Goulding et al., 1991), 
however the earliest stage assessed during this study was E9.5. Anterior regions of the 
spinal cord had completed neurulation by this stage but the sulcus limitans was not yet 
clearly defined, which permitted the analysis of progenitor dispersal in the 
neuroepithelium prior to the establishment of the alar plate. Pax3 antibody staining at 
the hindbrain level was restricted to the dorsal half of the neural tube (n=2) (Fig. 3.2A). 
The GFP labelled Pax3 lineage was also largely restricted to the neural tube, however 
we noted that YFP expressing cells were present beyond the ventral limit of the Pax3 
expression domain (Fig. 3.2B). Analysis of brachial and thoracic sections demonstrated 
that Pax3 was expressed within the dorsal spinal cord and the dermomyotome (Figs. 
3.2C and E), however cells marked by the presence of YFP were also found throughout 
the developing sclerotome (Figs. 3.2D and F). We observed two distinct populations of 
YFP labelled cells that resided ventrally to the Pax3 domain within the spinal cord. The 
first reproducibly spanned 3-4 cells in the DV axis and was located adjacent to the Pax3 
ventral boundary (Arrows in Figs. 3.2D and F), in agreement with our observations at 
hindbrain level. We also observed isolated clones of YFP labelled cells that were 
dispersed in the ventral domains of the spinal cord (Asterisks. in Figs 3.2D and F). The 
distribution of these clones in the neuroepithlium varied both between siblings and 
along the anterior-posterior axis of individual embryos. 
These data were supported by an independent analysis of the Pax3 lineage, 
performed by Dr Vanessa Ribes in the Relaix lab at E9.75. These experiments 
employed a mouse strain in which the Rosa26 locus was targeted with both Tomato and 
GFP reporter genes but used the same Pax3-Cre driver as our study. Her results 
indicated that Pax3 lineage extended beyond the ventral boundary of gene expression in 
the spinal cord (n=3). These data also indicated that GFP labelled cells were located 
both adjacent to the Pax3 expression domain and in clones within the ventral spinal 
cord. These data suggested that the Pax3 lineage was not a molecular correlate of the 
embryonic alar plate, due to a transcriptional switch in cell identity that occured before 
E9.5 in mice. 
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Fig. 3.2 – The position of the Pax3 domain is established before E9.5 
Pax3 protein is expressed in the dorsal neural tube at hindbrain (A), brachial (C) and thoracic 
levels (E) at E9.5. YFP labelling, visualised with a polyclonal GFP antibody, is observed 
beyond the ventral boundary of Pax3 expression at all AP levels assessed (B, D and F). Pax3- 
YFP+ cells are distributed within two populations, a domain of cells adjacent to the ventral 
boundary of Pax3 expression (Arrows in D and E) and as isolated ventral clones (Asterisks in D 
and E). Cells marked by YFP ptotein are also observed throughout the somites and sclerotome 
surrounding the neural tube, indicating that Pax3 is transiently expressed in all mesoderm 
progenitors. 
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3.3 – The position of the Pax3 domain remains constant during development 
 
 The embryonic alar plate is defined in the spinal cord by the formation of the 
sulcus limitans at approximately E10.5 (Goulding et al., 1991 ; Gross et al., 2002). We 
hypothesised that this anatomical division of the neural tube may restrict cell migration 
and contribute to the maintenance of the position of the ventral Pax3 expression 
boundary within the tissue. Consistent with our previous observations, Pax3 protein 
expression was restricted to the dermomyotome at E10.5 (Figs. 3.3A and C) whereas its 
YFP labelled lineage was distributed throughout the surrounding mesoderm (n=2) (Figs. 
3.3B and D). Within the neural tube, GFP staining was reproducibly observed adjacent 
to the ventral boundary of the Pax3 domain along the anterior-posterior axis of both 
embryos assessed at E10.5 (Arrows in Figs. 3.3B and D). Clones of YFP labelled cells 
were also evident in the ventral domains of the spinal cord, supporting our earlier 
observations (Asterisks in Figs. 3.3B and D). We investigated the dispersal of these 
cells within the neuroepithelium in relation to the expression profiles of well-
characterised ventral patterning genes. These studies revealed the presence of GFP 
labelled cells throughout the Pax6 domain of the intermediate spinal cord (Figs. 3.4A 
and B) and isolated clones within the pMN domain marked by Olig2 expression (Figs. 
3.4C and D). 
 Our observations of the Pax3 lineage at E10.5 were supported by independent 
experiments performed by the Relaix lab at E11.75. Sections Pax3Cre/+/Rosa26-
Tomato/GFP embryos exhibited the downregulation of Pax3 expression within the 
dorsal spinal cord that occurs during the process of neurogenesis (n=2) (Figs. 3.5A, C 
and E). This was clearly visible as GFP staining within Pax3 derived neurons in the 
mantle zone (Figs. 3.5B,D and F) and the axons of dI1 and dI2 interneurons that crossed 
the midline at the floor plate (Figs. 3.5B, D and F) (Gross et al., 2002 ; Helms and 
Johnson., 1998). In accordance with our data, the ventral boundary of Pax3 expression 
in the neural tube was located adjacent to a clearly defined domain of cells labelled 
solely by GFP staining (Figs. 3.5B, D and F). Dr Ribes also sought to determine the 
location of these respecified cells relative to V0 interneurons, which are marked by the 
expression of Evx1 (Moran-Rivard et al., 2001). These data demonstrated that all Evx1 
expressing interneurons are derived from cells that have expressed Pax3 during their 
early development (Figs. 3.6A, B and C). Furthermore, she also observed the presence 
of YFP labelled clones dispersed throughout the ventral domains of both embryos 
assessed at E11.75 (Figs. 3.5B, D and F). 
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Fig. 3.3 – The distribution of the Pax3 lineage during neural tube patterning 
Pax3 expression is restricted to the dorsal neural tube at brachial (A) and thoracic (C) levels at 
E10.5. GFP antibody staining labells a domain of cells adjacent to the boundary of Pax3 
expression (Arrows in B and D) and isolated clones within the ventral domains of the neural 
tube (Asterisks in B and D), consistent with data obtained at E9.5 (Fig. 3.2). 
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Fig. 3.4 – Clonal dispersion of Pax3 progeny within the ventral neural tube 
Brachial sections taken at E10.5 reveals Pax6 expression from the dP4 domain dorsally to the 
pMN domain in the ventral neural tube (A). YFP labelling is observed in cells located 
throughout the Pax6 expression domain of the intermediate neural tube (B). Olig2 specifically 
labels motorneuron progenitors within the pMN domain of the ventral neural tube (C). Isolated 
clones of YFP labelled cells are infrequently observed within the pMN domain (D). 
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Fig. 3.5 – The distribution of the Pax3 lineage during early neurogenesis 
Pax3 is expressed in progenitors within the ventricular zone of the alar plate at brachial (A), 
thoracic (C) and lumbar (E) levels at E11.75. GFP labelled cells are present in the ventral spinal 
cord as both a continuous domain adjacent to the Pax3 ventral boundary and as isolated clones 
(B, D and E). GFP staining is also evident in postmitotic neurons within the mantle zone of the 
alar plate and the axons of commissural interneurons that project ventrally towards the FP. 
Data kindly provided by Dr. Vanessa Ribes. 
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Fig. 3.6 – V0 interneurons transiently express Pax3 during their development 
Evx1 antibody staining labels progenitor cells committed to a V0 interneuron fate (A). GFP 
staining at E11.75 reveals that all Evx1 expressing progenitor cells are derived from cells that 
have previously expressed Pax3 (B and C). 
Data kindly provided by Dr. Vanessa Ribes. 
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3.4 – The dispersal of Pax3 progeny in the functional spinal cord 
 
 Highly coordinated programs of neurogenesis, migration and synaptogenesis 
establish functional sensory-motor connections within the spinal cord by birth, also 
known as postnatal day (P)0 of mouse development (Ladle et al., 2007). We sought to 
determine the fate of Pax3 expressing progenitors within the spinal cord at P0 to 
investigate any restriction of this lineage to sensory interneurons. Our previous analyses 
demonstrated that the Pax3 lineage encompassed, but was not restricted to, the 
embryonic alar plate. Consequently, these experiments were not able to directly assess 
any restriction of cell fate that may be imposed by the sulcus limitans at later stages of 
neural tube development. However, we reasoned that analysis of the Pax3 lineage at P0 
might still prove to be informative if interpreted with the knowledge that V0 
interneurons were reproducibly labelled in these samples. 
 Transverse sections of Pax3Cre/+/Rosa26-YFP embryos prepared at the brachial 
and thoracic levels of the spinal cord revealed uniform YFP labelling throughout the 
grey and white matter located dorsally to the central canal (n=2) (Figs. 3.7A and C). 
Extensive GFP labelling was observed within the lateral and ventral fassiculi of white 
matter tracts that surround the ventral horn of grey matter (Figs. 3.7A and B). YFP 
labelled neurons were observed medially within the ventral horn, consistent with the 
position of V0 interneurons in the tissue following their ventral migration (Figs 3.7B 
and D) (Lanuza et al., 2004 ; Moran-Rivard et al., 2001 ; Pierani et al., 2001). We 
reasoned that these labelled cells may also represent populations of dI3 and dI6 
interneurons that migrate into the ventral horn and are thought to provide direct sensory 
input to motor circuits (Avraham et al., 2010 ; Gross et al., 2002). 
We did not observe GFP staining in the lateral regions of the motor horns at P0, 
indicating that these cells had not expressed Pax3 at any stage of their development. We 
hypothesised that these regions might correspond to the location of the basal plate 
derived V1, V2, motor and V3 classes of neurons within the tissue. This point was 
investigated in experiments determining the localisation of YFP labelled cells relative to 
choline acetyltransferase (ChAT) immunostaining. This enzyme is required for the 
production of acetylcholine and is frequently used as a specific marker of motor neurons 
within the spinal cord (Tanabe et al., 1998 ; Arber et al., 1999). Analysis of thoracic 
sections revealed the presence of YFP labelled neurons within the medial region of the 
ventral horn as previously described (Fig. 3.8A), whereas ChAT labelled motor neurons 
were localised at the lateral limit of the grey matter (Fig. 3.8B). These two cell 
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populations appeared to be mutually exclusive, however we frequently observed YFP 
labelled axons both adjacent to and within pools of motor neurons (Fig. 3.8C). 
Identification of the Pax3 derived cells involved in these in these sensory-motor 
interactions was not possible in this investigation because Pax3 transcription is initiated 
in multiple classes of interneurons that are known to synapse with motor neurons. Many 
cells within the ventral horn were not labelled by GFP or ChAT antibody staining, 
consistent with our previously described data which indicated that only V0 interneuron 
progenitors were reproducibly labelled by the Pax3 lineage within the basal plate (Figs 
3.5B,D and F). 
The data produced from our lineage study suggest that Pax3 expression is not a 
molecular correlate of the embryonic alar plate in mouse embryos, due to the initiation 
of transcription within the neural plate and the dynamic changes in cell identity that 
occur within this tissue. We observe two distinct classes of cells that appear to 
extinguish Pax3 expression during their development. The first are randomly dispersed 
throughout the ventral neural tube as clones, in agreement with reports of extensive cell 
mixing across the Pax3 boundary at early stages of chick neural development (Erskine 
et al., 1998 ; Leber and Sanes, 1995). Our data also demonstrate that a domain of Pax3 
labelled cells is respecified to a more ventral p0 progenitor identity, this result is 
consistent both between embryos and along the DV axis of the neural tube. We 
hypothesise that this transcriptional switch in cell identity positions the Pax3 expression 
domain in the neural tube before E9.5. Once established, the position of the domain in 
the tissue appeared to remain constant in our study, possibly due to restricted migration 
enforced by cell adhesion molecules expressed at the sulcus limitans. Our analysis of 
Pax3Cre/+/Rosa26-YFP mice at P0 provide further evidence to support this conclusion, 
as we demonstrated that the Pax3 lineage does not give rise to neither motor neurons 
nor clusters of interneurons within the ventral horn. 
This study raises questions concerning the regulatory logic that establishes the 
Pax3 expression domain during the early stages of neurulation and maintains its 
position in the neural tube during CNS development. Our results clearly demonstrate 
that all cells located within the alar plate are derived from the Pax3 lineage, whereas the 
majority of basal plate progenitors do not express the gene at any point in their 
development. These data indicate that regulatory mechanisms operate at the earliest 
stages of CNS development to initiate Pax3 expression within a restricted population of 
progenitor cells within the neural plate. As discussed in Chapter1.4, the molecular 
events that initiate Pax3 transcription within the neural plate are currently poorly 
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understood. Our studies also revealed transient Pax3 expression within a population of 
ventral interneuron progenitors. These observations correlate with published data 
demonstrating that Pax3 expression is repressed by Shh signaling and the ventral 
patterning genes it induces; however the mechanism of this repressive interaction is 
unknown. We sought to investigate the regulatory logic that governs Pax3 expression 
during CNS development by identifying functional enhancers associated with this locus 
and determining the molecular interactions between these elements and members of the 
neural tube GRN. We also aimed to compare the function of enhancers associated with 
the Pax3 and Pax7 loci in order to investigate the basis of their differing spatiotemporal 
expression profiles. 
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Fig. 3.7 – The distribution of the Pax3 lineage at birth 
YFP labelling is observed throughout the grey and white matter located dorsally to the central 
canal (cc), consistent with the expression of Pax3 in the embryonic alar plate (A and C). The 
lateral and ventral funiculi of white matter tracts surrounding the ventral horn are labelled by 
YFP protein (lf and vf respectively). Populations of V0, dI3 and dI6 interneurons located within 
the medial region of the ventral horn (mvh) are derived from Pax3 expressing progenitors (B 
and D). GFP staining is also observed throughout the dorsal root ganglion (drg), consistent with 
the expression of Pax3 in neural crest derivatives. 
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Fig. 3.8 – The position of the Pax3 domain is maintained throughout development 
YFP labelling is restricted to interneurons within the medial domain of the ventral horn (A), 
whereas ChAT stained motor neurons are located laterally (B). Co-localisation of YFP and 
ChAT labelling reveals that the Pax3 lineage is segregated from motor neuron progenitors from 
the earliest stages of neural plate patterning (C). Populations of cells within the ventral horn are 
not labelled by either GFP or ChAT antibody staining, suggesting that they might represent 
basal plate derived interneurons (C). 
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Chapter 4: Establishing Zebrafish as a model for studying Pax3/7 regulation 
 
 In order to investigate the molecular basis of Pax3/7 regulation, it was first 
necessary to select a model system in which the activity of putative regulatory elements 
could be assessed in-vivo. Zebrafish are increasingly used in functional screens of 
putative enhancers due to the availability of large numbers of optically transparent 
embryos, their comparatively rapid rate of development and a sequenced genome 
(Gomez-Skarmeta et al., 2006 ; Müller et al., 2002). These advantages were the major 
factors in the selection of zebrafish embryos as our in-vivo system for screening putative 
enhancers. 
The cellular mechanism of neurulation in zebrafish embryos differs from that 
observed in mice and chick, as the neural plate does not fold to give rise to the neural 
tube. Instead, cells within the zebrafish neural plate converge at the midline to give rise 
to the neural keel, which subsequently cavitates to form the neural tube (Kimmel et al., 
1994 ; Schmitz et al., 1993). Nevertheless, the fundamental principles of neural tube 
patterning are conserved between zebrafish and higher vertebrates (reviewed by Appel, 
2000 ; Lewis and Eisen, 2003 and Wilson et al., 2002). In agreement with these data, 
Pax3/7 expression in zebrafish embryos has been shown to be repressed by exogenous 
shh ligand (Guner and Karlstrom. 2007). However in contrast to higher vertebrate 
models, a ventral expansion of these genes is not observed in an array of shh pathway 
mutants (Guner and Karlstrom. 2007). Furthermore, pax3 expression has been shown to 
be repressed by the ectopic induction of the Wnt pathway agonist dickkopf1, 
morpholino knockdown of wnt8a or loss of tcf/lef activity (Bonner et al., 2008 ; Garnett 
et al., 2012). Taken together, these data demonstrate that the key concepts of both spinal 
cord patterning and Pax3/7 regulation are conserved in zebrafish embryos, validating 
them as a potential model in which to base our study. 
The zebrafish genome contains two parologous genes for both Pax3 and Pax7, 
as a result of a whole genome duplication in the teleost lineage (Postlethwait et al., 
1998). It was first necessary to define the endogenous expression patterns of each of 
these genes to establish zebrafish embryos as a viable model in which to perform a 
screen of putative regulatory elements. This was achieved through a series of in-situ 
hybridisation experiments and literature searches, which determined the expression of 
each of the Pax3/7 paralogs during the first 48 hours of zebrafish development. 
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4.1 – Pax3 paralogs are first expressed in the early neural plate 
 
 Pax3a transcripts were first observed in the intermediate and lateral regions of 
the posterior neural plate at bud stage (Fig. 4.1A) (Table 2.8). Stripes of medio-lateral 
expression corresponding to the presumptive midbrain and hindbrain were clearly 
visible in the anterior neural plate at this stage. Expression became restricted to the most 
lateral regions of the neural plate by the 6 somites stage and the rostral stripes of 
transcripts were fused at the midline, defining the developing midbrain and 
rhombomeres 2 and 4 of the hindbrain. This expression profile was maintained during 
early segmentation stages until the formation of the neural tube at trunk level (Data not 
shown). As neurulation was nearing completion at the 18 somites stage, pax3a mRNA 
was restricted to the dorsal half of the neural tube (Fig. 4.1C). Transcripts were detected 
across the entire anterior-posterior axis of the CNS, with the exception of the 
developing forebrain. This expression profile was maintained at 24 hpf, at which stage 
transverse sections of trunk tissue clearly demonstrated that pax3a mRNA was 
restricted to the dorsal half of the zebrafish spinal cord (Figs. 4.1D and 4.3A). Pax3a 
was also observed in the newly formed somites within the posterior trunk region at 24 
hpf, consistent with its critical functions during myogenesis (Fig. 4.1D). Transcription 
within the spinal cord appeared to be decreased by 32 hpf as mRNA was localised 
within only the most dorsally located cells (Fig. 4.1E). Anteriorly, the dorsal tectum, 
midbrain and hindbrain expressed pax3a at this stage. Pax3a mRNA was not detected in 
the spinal cord at 48 hpf by in-situ hybridisation, however strong expression persisted in 
the dorsal hindbrain, midbrain and tectum (Fig. 4.1F). 
 Several attempts were made to assess the expression profile of pax3b during 
CNS development by in-situ hybridization, however the quality of the results obtained 
was unsatisfactory and made it difficult to draw any meaningful conclusions (Data not 
shown). A previous report has indicated that pax3b is expressed in the CNS during 
zebrafish development (Minchin and Hughes, 2008). In this study, expression of pax3b 
was first reported in the presumptive midbrain and hindbrain at the 7 somites stage. 
These domains of expression appeared to correlate well with cells expressing pax3a in 
stage matched embryos. Expression of pax3b did not extend to the posterior regions of 
the embryo and appeared to be restricted to the lateral regions of the anterior neural 
plate. Pax3b mRNA was observed in the midbrain and hindbrain at 25 hpf, however the 
anterior limit of expression appeared to be reduced in comparison to pax3a. Sections of 
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spinal cord tissue suggested that pax3b mRNA was dorsally expressed but did not 
extend to the ventral limit of pax3a expression. 
 Together, these data demonstrate that the expression profiles of the zebrafish 
Pax3 paralogs closely correlates with that observed in chick and mouse embryos 
(Goulding et al., 1991 ; Goulding et al 1993), validating zebrafish embryos as a model 
system in which to base our study. As in other species, transcription of Pax3 is first 
observed early during neural tube development in the intermediate and lateral regions of 
the open neural plate. Upon completion of neurulation, pax3a expression appears to 
define the dorsal spinal cord, whereas pax3b appears to exhibit a more restricted profile. 
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Fig. 4.1 – The profile of pax3a expression during zebrafish CNS development 
Pax3a transcripts are first detected at bud stage in medio-lateral stripes within the anterior 
neural plate (anp) and within the intermediate regions of the posterior neural plate (pnp) (A). By 
6 somites, the anterior stripes fuse to define the midbrain (mb) and rhombomeres 2 and 4 of the 
hindbrain (hb) ; expression is restricted to the lateral limit of the posterior neural plate (np) (B). 
At 18 somites (C) and 24 hpf (D), pax3a expression is observed within the midbrain, hindbrain 
and dorsal progenitors (dP) within the spinal cord. Transcription is decreased in the posterior 
neural tube at 32 hpf (E) and absent at 48 hpf (F), however expression is maintained anteriorly. 
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4.2 – Pax7 paralogs are expressed upon neural tube formation 
 
Pax7a transcription was first observed in the presumptive midbrain of the 
zebrafish embryo at the 6 somites stage (Fig. 4.2A) and this restricted pattern of mRNA 
localisation remained evident until the 12 somites stage (Fig. 4.2B). Expression was 
markedly increased within the midbrain and hindbrain at the 18 somites stage and 
mRNA was detected within anterior regions of the spinal cord following neurulation 
(Fig. 4.2C). Both wholemount preparations and transverse sections of trunk tissue at 24 
hpf exhibited pax7a transcription within the neural progenitors of the zebrafish dorsal 
spinal cord (Figs. 4.2D and 4.3B). However mRNA was observed to be excluded from 
the most dorsal progenitor cells in cross sections of the spinal cord (Fig. 4.3B). Pax7a 
mRNA was absent from neural progenitors in the tail bud region of the posterior spinal 
cord at 24 hpf (Fig. 4.2D). Expression was decreased in the anterior spinal cord at 32 
hpf and varying levels of transcript were observed in adjacent cells (Fig. 4.2E). High 
levels of pax7a mRNA were observed in cells within the posterior spinal cord at 32 hpf, 
in contrast to data obtained at 24 hpf. Expression was also observed within migratory 
neural crest cells in the somites and the eye. At 48 hpf, pax7a was transcribed in the 
midbrain and hindbrain but mRNA was not detected in the spinal cord (Fig. 4.2F). 
 Pax7b expression in the early embryo was restricted to the developing midbrain 
until the 12 somites stage, in a pattern that closely correlated to that observed for pax7a 
(Figs. 4.4A and B). Transcriptional induction of pax7b following neurulation was 
comparable to that observed for pax7a, as expression was evident in the midbrain, 
hindbrain and most anterior regions of the spinal cord at the 18 somites stage (Fig. 
4.4C). By 24 hpf, transcription was detected in the dorsal domains of the midbrain, 
hindbrain and spinal cord but was excluded from the tail bud (Fig. 4.4D). Pax7b 
expression was maintained at 32 hpf in midbrain, hindbrain and a small population of 
cells in the posterior region of the spinal cord (Fig 4.4E). No transcription was detected 
in embryos assessed at 48 hpf (Fig 4.3F). 
 The expression profile of Pax7 paralogs during zebrafish spinal cord patterning 
closely resembles that observed during mouse embryogenesis (Jostes et al., 1991). 
Accordingly, transcription is first observed following the completion of neurulation at 
trunk level and is excluded from the most dorsal progenitors within the spinal cord. This 
profile is in contrast to Pax7 expression during chick CNS development, which shares 
similar temporal dynamics but span all dorsal progenitors (Kawakami et al., 1997). 
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Fig. 4.2 – The profile of pax7a expression during zebrafish CNS development 
Pax7a transcription is restricted to the presumptive midbrain (mb) at both the 6 (A) and 12 
somites stages (B). Following neurulation, transcripts are detected in the midbrain, hindbrain 
(hb) and anterior spinal cord (asc) (C). At 24 hpf, pax7a is expressed throughout the midbrain, 
hindbrain and dorsal progenitors (dP) within the neural tube but is excluded from the tail bud 
(D). Transcription is reduced in the anterior spinal cord at 32 hpf but induced posteriorly within 
the tail bud (E). At 48 hpf, pax7a is not expressed in the spinal cord but is maintained within the 
midbrain and hindbrain (F). 
 
 
 
 
Fig. 4.3 – The distribution of pax3a and pax7a transcripts within the spinal cord 
Transverse sections of the zebrafish neural tube at trunk level reveal pax3a transcription in all 
dorsal progenitors (dP) within the neural tube (A). By contrast, pax7a transcripts are excluded 
from the roof plate and the most dorsal progenitor populations (B). In addition, pax7a 
transcription is detected in neural crest (nc) cells that have delaminated from the dorsal neural 
tube (B). 
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Fig. 4.4 – The profile of pax7b expression during zebrafish CNS development 
Pax7b transcription is restricted to the presumptive midbrain at 6 (A) and 12 somites stages (B). 
Expression is restricted to the midbrain, hindbrain and anterior neural tube at 18 somites (C). At 
24 hpf, pax7b is expressed in the dorsal midbrain, hindbrain and neural tube but is excluded 
from the most posterior region of the tissue (D). Transcripts are absent from the anterior neural 
tube at 32 hpf but are detected at the posterior limit of the CNS (arrowhead in E). Pax7b is not 
expressed at 48 hpf (F). 
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4.3 – Assessing Pax3/7 protein localisation in zebrafish embryos 
 
A potential limitation of using zebrafish embryos in a study of this type is the 
lack of antibodies availiable for use in immunohistochemistry, as only a subset of those 
validated for use on mouse and chick tissue recognise the zebrafish antigens. Previous 
investigations have demonstrated that a monoclonal Pax7 antibody can be used to 
visualise protein localisation in zebrafish embryos (Patterson et al., 2010, Stellabotte et 
al., 2007), however there are currently no antibodies raised specifically against Pax3 
that are suitable for immunostainings. In order to assess the distribution of both Pax3 
and Pax7 proteins during CNS development, we sought to utilise two monoclonal 
antibodies, DP311 and DP312, raised against the highly conserved homeodomain of the 
Drosophila Pax3/7 class gene paired (Davis et al., 2005). Previous reports have 
indicated that DP312 has a far greater specificity for the recognition of Pax3/7 class 
genes, due to the ability of DP311 to tolerate amino acid substitutions in position 29 of 
the antigen homeodomain (Davis et al., 2005). Consequently, DP312 has been used as a 
marker of Pax3/7 protein localisation in studies of myogenesis (Feng et al., 2006; 
Hammond et al., 2007; Koudijs et al., 2008; Seger et al., 2011) and neural crest 
specification (Curran et al., 2009; Minchin et al; 2008) in zebrafish embryos. 
Recognition of the zebrafish Pax7 protein by DP312 has been biochemically verified by 
comparison of western blots obtained from whole embryo extracts probed with either 
DP312 or Pax7, revealing a 50kDa Pax7 complex bound by both antibodies (Hammond 
et al., 2007). Pax3 binding was demonstrated by the presence of a 55kDa Pax3 complex 
in embryo extracts probed with DP312 and the subsequent loss of this interaction in 
Pax3 morphants (Minchin et al., 2008). Although DP312 is frequently used as a marker 
of Pax3/7 protein localisation in zebrafish embryos, it has not been employed in studies 
of CNS patterning. Consequently, we sought to examine the specificity of both DP311 
and DP312 in cross sections of zebrafish trunk tissue to determine their suitability for 
use in this investigation. 
DP311 immunostaining strongly labelled subpopulations of superficial and 
medial slow muscle precursor cells within the somites, consistent with the described 
role of Pax3/7 in these cells (Fig 4.5A). Within the CNS, strong immunoreactivity was 
observed in the Pax3/7 expression domain of the dorsal spinal cord as expected. 
Localised DP311 staining was also detected in the FP at the ventral midline of the 
spinal cord. This ectopic labelling was most probably due to antibody cross-reactivity 
with Arx, a well-defined marker of the FP that encodes a paired type homeodomain 
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(Miura et al., 1997). In support of this conclusion, DP311 has previously been shown to 
recognise aristaless, the Drosophila homolog of vertebrate Arx (Davis et al., 2005). 
Comparatively weaker staining was observed in the intermediate region of the spinal 
cord in a pattern consistent with the domain of Pax6 expression. Similar patterns of 
DP311 immunostaining were produced in spinal cord sections of chick and mouse 
embryos assessed at comparable stages (Figs. 4.5B and C). 
DP312 staining highlighted a subset of superficial slow muscle cells in the 
somite but was not observed in the medial pioneer population of muscle precursors (Fig 
4.6A). Immunoreactivity was detected within the dorsal Pax3/7 domain along the entire 
anterior-posterior axis of the CNS. Single cells within the presumptive pMN domain of 
the ventral spinal cord were labelled by DP312 in more anterior sections of spinal cord, 
possibly due to a cross reaction with Pax4 (Nikolaos Balaskas, personal communication 
; Sosa-Pineda et al., 1997). This ventral domain of DP312 reactivity was greatly 
expanded within the hindbrain and included all cells within the presumptive p3 and 
pMN domains, however it did not extend to the floor plate (Fig. 4.6B). Staining was 
also observed within the Pax3/7 domain of the dorsal hindbrain and the two domains 
were clearly delineated. Similar profiles of DP312 immunoreactivity were observed in 
transverse sections of chick and mouse spinal cord tissue assessed at comparable stages 
(Figs. 4.6C and D). 
Taken together, these results indicate that DP311 is too broadly cross-reactive 
within the CNS to be employed in this study as a marker of Pax3/7 protein. The 
observed cross reactivity with Pax6 is particularly problematic as its expression domain 
overlaps with that of Pax3/7, making a clear delineation of the Pax3/7 ventral boundary 
impossible. In contrast, DP312 staining appears to reproducibly label the dorsal half of 
the CNS and shows no cross reactivity with Pax6 in the three sources of tissue 
examined. We reasoned that the single cells labelled in the ventral half of the anterior 
spinal cord are easily discriminated from the Pax3/7 domain and concluded that DP312 
staining provided sufficient specificity to be used as a marker of Pax3/7 protein in this 
investigation. 
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Fig. 4.5 – DP311 is broadly cross-reactive in the neural tube 
DP311 immunoreactivity is observed in superficial and medial populations of slow muscle 
progenitors in the somite (s). Within the neural tube, the Pax3/7 domain of dorsal progenitors 
(dP), the Pax6 domain (p0-p2) and the floor plate (fp) are labelled by DP311 (A). Staining is 
also observed in delaminating neural crest cells (nc) (A). DP311 staining labels the Pax3/7 
domain, the floor plate, populations of ventral interneuron progenitors and ventral interneurons 
(V3) within the chick neural tube (B). In mouse tissue, DP311 labels the Pax3/7 and Pax6 
expression domains , the floor plate and subpopulations of motor neurons (C). 
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Fig. 4.6 – DP312 demonstrates specificity for Pax3/7 recognition in-vivo 
At trunk level, DP312 labels slow muscle fibes within the somites (s), the Pax3/7 domain (dP) 
of the neural tube and single cells within the pMN (A). Within the midbrain, DP312 marks all 
cells within the pMN and p3 domains (p3-pMN) in addition to the Pax3/7 domain (dP) and 
neural crest (nc) (B). In chick (C) and mouse tissue (D), DP312 staining labels the Pax3/7 
domain and both progenitors (p3) and neurons (V3) ventrally. 
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4.4 – Characterisation of Pax3 and Pax7 BAC transgenic lines 
 
In order to gain insight into the molecular regulation of Pax3 and Pax7 we 
established a collaboration with Professor Philip Ingham, whose laboratory has 
previously studied the roles of these genes during muscle development. Among the 
tools created during these studies were bacterial artificial chromosome (BAC) 
transgenic reporter zebrafish lines that have been shown to recapitulate the expression 
of pax3a and pax7a during myogenesis and muscle regeneration (Seger et al., 2011). 
This was achieved by a two-step recombination strategy that first inserted an EGFP 
reporter into the transcription start site of the selected locus. Subsequently, a kanamycin 
resistance gene flanked by IsceI meganuclease sites was targeted to the chlorampheniol 
resistance gene present within the BAC. Previous studies performed in zebrafish have 
demonstrated that the addition of meganuclease sites greatly improves the germline 
integration of large constructs, such as BACs (Grabher et al., 2004 ; Thermes et al., 
2002). Studies in the Ingham laboratory have demonstrated that these targeted BACs 
contain regulatory elements that are sufficient to drive transgene expression within the 
developing dermomyotome and satellite cells of mature myofibres (Seger et al., 2011). 
Transgene expression within CNS tissues had previously been observed during the 
establishment of these lines, however a detailed analysis of their expression within the 
spinal cord has not been performed. 
DKEY-20F20 is a 247 kb fully sequenced BAC, Genbank accession number 
BX085193, that contains the entire zebrafish pax3a coding region. A second locus 
contained within the BAC encodes Acetyl-CoA synthetase family member 3B, an 
enzyme with no defined expression pattern. Analysis of GFP immunostained 
wholemount preparations of Pax3 - GFPI150 embryos at 24 hpf revealed a clear 
correlation between the activity of the transgene and the previously defined distribution 
of pax3a transcript (Fig. 4.7A). GFP labelling was observed within the somites of 
transgenic embryos and throughout the entire anterior-posterior axis of the CNS, 
including the forebrain, which does not appear to express pax3a mRNA at this stage. 
Transverse sections revealed that the activity of the transgene was dorsally restricted in 
neural progenitors and a population of commissural interneurons within the spinal cord. 
Antibody stainings with DP312 demonstrated that the cellular localisation of the BAC 
driven GFP transgene and Pax3/7 completely overlapped in both neuronal progenitors 
and presumptive neural crest cells (Fig. 4.7B). These results indicate that this transgenic 
line recapitulates the endogenous expression profile of pax3a within the spinal cord and 
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that DP312 immunostaining is highly specific for this domain. However, the ectopic 
expression of GFP within the forebrain suggests that additional CRMs are required to 
silence pax3a expression in this tissue. 
Pax7-GFPI131 stable transgenic lines were created by modification of the CH73-
62K19 BAC. Alignment of the sequenced BAC ends suggested that the entire Pax7 
locus, 45 kb of upstream and 105 kb of downstream sequence are contained in this 
genomic interval. Analysis of this stable line at 24h demonstrated that the expression of 
pax7a mRNA in anterior regions of the CNS was recapitulated in all embryos assessed 
(Fig. 4.7C). However, transgene activity within the spinal cord was not visible in live 
embryos or wholemount preparations stained for GFP protein. Sections of spinal cord 
tissue revealed that this BAC was sufficient to drive expression in the dorsal neural tube 
with a ventral limit that coincided with that of DP312 staining (Fig. 4.7D). The most 
dorsal regions of the spinal cord was not labelled by GFP staining in this stable line, as 
demonstrated by the presence of a population of cells that were solely DP312 positive. 
These data are consistent with in-situ hybridisation results, which demonstrated that 
pax7a transcription is excluded from the most dorsal progenitor cells at spinal cord level 
(Fig. 4.3B). 
Taken together, these data indicate that the cis-regulatory modules sufficient for 
pax3a expression in the spinal cord are present in the genomic interval contained in the 
BAC DKEY-20F20. Similarly, CH73-62K19 BAC transgenics recapitulate pax7a 
mRNA expression in spinal cord progenitors. The varied levels of transgene expression 
observed in the CNS of each stable line might be due to the integration site of the BAC 
into the genome. 
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Fig. 4.7 – Zebrafish BAC transgenic lines recapitulate Pax3/7 expression in the 
spinal cord 
The Pax3-GFPI150 stable line recapitulates the expression profile of pax3a in the spinal cord at 
24 hpf (A). However, ectopic GFP staining is observed within the developing forebrain 
(arrowhead in A). Transverse sections at trunk level reveal that GFP co-localises with DP312 
staining in dorsal progenitors (dP) within the spinal cord, presumptive neural crest (nc) and the 
somites (s) (B). The Pax7-GFP131 line displays transgene labelling within the midbrain and 
hindbrain, however GFP is not observed within the spinal cord in whole mount preparations 
(C). A population of Pax7-GFP positive cells co-localise with DP312 staining in transverse 
sections of the neural tube, however the most dorsal Pax3/7 expressing cells are GFP negative 
(D). These data are consistent with the defined expression profiles of pax3a and pax7a in the 
spinal cord. 
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Chapter 5: Identifying and testing putative enhancers  
 
5.1 – Comparative genomic analyses of the Pax3 and Pax7 loci 
 
 In order to investigate the molecular mechanisms that determine the expression 
of Pax3 and Pax7 during CNS development, it was first necessary to identify putative 
regulatory regions associated with each locus. Several methods of CRM identification 
are currently available, discussed in Chapter 1.2. These techniques vary greatly in term 
of the scale of experiment performed and the amount of data produced. As a result, 
studies examining the molecular basis of gene regulation can range from the dissection 
of a known regulatory module to genome wide profiling of chromatin states in multiple 
cell types or species. 
 Phylogenetic conservation of non-coding sequence was chosen as our preferred 
method of CRM discovery as it provides a relatively rapid means of identifying regions 
of interest associated with a single locus. The application of comparative genomics for 
the purpose of CRM discovery has been shown to be particularly suited to studies 
investigating developmental genes, such as Pax3 and Pax7 (Woolfe and Elgar, 2008). 
This observation is hypothesised to be due to the highly conserved expression profile of 
these transcription factors across the vertebrate subphylum during embryogenesis. We 
therefore reasoned that the in-silico identification of CNEs, followed by in-vivo 
assessment of their regulatory potential would be an appropriate means of defining a set 
of CRMs for molecular dissection. 
 Several publically available genome browsers host comparative genomic 
alignments, with the aim of providing a source of putative regulatory elements for 
studies such as ours (Engstrom et al., 2008 ; Ovcharenko et al., 2004). These databases 
were created by pairwise alignments of whole genome assemblies and currently do not 
host any data concerning the functions assigned to these regions. In addition to these 
genome wide resources, several individual research groups curate CNE browsers that 
provide comparative genomic alignments focused on a selective set of developmental 
loci (Visel et al., 2007 ; Woolfe et al., 2007). Although these databases are derived from 
varied data sources and utilise different methods of sequence alignment, in-vivo 
evidence of CRM activity in the groups’ preferred model organism is provided, when 
available. Alignments of both the Pax3 and Pax7 loci are available in each of the 
described databases, however none of the CNEs identified had been functionally 
annotated at the time of this investigation. We sought to perform our own stringent 
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comparative alignments of the Pax3 and Pax7 loci, in order to create a set of CNEs for 
further analysis. We reasoned that the wealth of publically available genome alignments 
would allow us to validate our dataset before proceeding with functional analysis in-
vivo. 
 The large evolutionary distance typically employed in comparative genomics 
has been shown to enhance the predictive power of this technique. However it also 
poses difficulties in ensuring that all CNEs associated with a locus are identified, due to 
genome inversions and local shuffling events that occur during evolution (Ovcharenko 
et al., 2005). We chose to utilise the Mulan suite of comparative genomics tools as our 
preferred method of CNE identification because it takes these issues into account by 
performing a two-step alignment strategy. First, the evolutionary relationship between 
the input dataset is determined by calculating the number of substitutions per kb of 
sequence by pairwise BLAST and represented as an editable phylogentic tree. The 
description of how the input sequences are related to each other is then used to guide the 
threaded blockset alignment algorithm, which locally aligns regions of homology 
between the subject and query genomes independent of their position or orientation 
within the input data (Ovcharenko et al., 2005). This implementation of comparative 
genomics is therefore optimised for the identification of CNEs associated with a single 
locus over large evolutionary distances. 
 Our initial strategy for the selection of genomic regions for analysis was based 
upon the observation that the zebrafish Pax3 and Pax7 paralogs are expressed in 
overlapping domains within the spinal cord. We therefore hypothesised that these loci 
might share common CRMs with sufficient primary sequence homology to be identified 
by comparative genomics. We discovered that that was not the case, as no CNEs could 
be identified in pilot experiments that attempted to align these four loci from the 
zebrafish genome (data not shown). We therefore attempted to align the human genomic 
sequence (Hg18), spanning the desired locus and the surrounding intergenic regions, to 
the corresponding regions of the mouse (Mm9) and either the duplicated Pax3 or Pax7 
loci in the zebrafish (Zv7) genome. We discovered that it was possible to identify CNEs 
within the Pax7 locus employing this strategy and continued to use this alignment 
method in our subsequent analysis. By contrast, we observed that identification of 
CNEs associated with Pax3 was not possible when sequence containing the zebrafish 
pax3b locus was included in the source dataset (data not shown). In order to avoid this 
issue, yet retain the stringency we desired in our genomic analysis, we chose to replace 
the zebrafish pax3b locus with sequence representing the pax3a locus in the Fugu (Fr2) 
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genome. We found that CNEs were readily identified in these alignments and chose to 
pursue this strategy for further analysis of the Pax3 locus. 
 Processed data was viewed in the Mulan visualisation tool, permitting a 
graphical representation of the location of CNEs and their degree of conservation. The 
parameters imposed on the data at this point to improve the stringency of our 
alignments are described in Chapter 2.2. Conserved TFBS present in each CNE were 
annotated using the MultiTF tool of the Mulan suite (Loots and Ovcharenko, 2007). 
Any CNEs that did not contain conserved TFBS were reasoned to be repetitive 
sequence and discarded in this process. This analysis revealed the presence of 6 CNEs 
in the large fourth intron of Pax3, ranging in size from 150 to 500 bp (Fig. 5.1). 
Similarly, 6 CNEs between 50 and 450 bp were associated with the Pax7 locus. These 
regions were located both proximally to the transcription start site and within the third 
intron of the gene (Fig. 5.2). 
 In order to validate our genomic analysis, we interrogated the Condor database 
for the presence of identified CNEs by BLAST (Woolfe et al., 2007). This comparison 
revealed that all CNEs in our dataset overlapped with regions identified by the Condor 
database. This result was expected, as our alignment strategy was based upon the 
parameters previously employed during the creation of the Condor dataset. We often 
found that the larger CNEs identified by our Mulan alignments were represented as 
clusters of several individual Condor elements, separated by small intervals of genomic 
sequence. One such example is Pax3-CNE2, which when compared with the Condor 
data shows homology to two CNEs that are separated by 38 bp of sequence that is not 
recognised as conserved. Accordingly, Positions 20 – 148 of CNE2 are homologous to 
CRCNE00001996, whereas positions 186 – 263 are homologous to CRCNE00001995. 
We reasoned that the discrepancies between our dataset and the Condor database could 
be produced by a combination of the source of input data and the method of alignment. 
Our study searched for CNEs shared between two mammalian genomes and two fish 
genomes, whereas the Condor dataset is based upon the alignment of three mammalian 
genomes to the fugu sequence. The difference in input data coupled with the choice of 
algorithms employed to process the alignment may explain why although all of our 
CNEs are present in the Condor dataset, we identify fewer individual CNEs. The co-
ordinates of the regions selected for functional analysis in the current release of the 
zebrafish genome (Zv9) and the corresponding CNEs in the Condor database are listed 
in Table 5.1. 
 
Chapter 5 – Results 
	   96 
 
 
Fig. 5.1 – Comparative genomic analysis of the Pax3 locus 
Mulan alignment of sequences representing the Pax3 locus in the human (hg18), mouse (mm9), 
zebrafish (Zv7) and fugu (Fr2) genomes. Exons are labelled in blue and CNEs are pink. The 6 
CNEs identified for functional assessment are labelled within the plot. 
Figure cropped from original alignment for clarity. 
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Fig. 5.2 – Comparative genomic analysis of the Pax7 locus 
Mulan alignment of the human (hg18) and mouse (mm9) Pax7 loci with zebrafish pax7a and 
pax7b (Zv7). Exons are labelled in blue, intergenic CNEs are red and intragenic CNEs are pink. 
The 6 CNEs identified for functional assessment are labelled within the plot. 
Figure cropped from original alignment for clarity. 
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Identifier Genomic Location (Zv9) Overlapping Condor CNEs 
Pax3-CNE1 Ch2: 47609549-47609886 CRCNE00001997 
Pax3-CNE2 Ch2: 47602558-47603078 CRCNE00001995 and 
CRCNE00001996 
Pax3-CNE3 Ch2: 47593693-47594345 CRCNE00001990 and 
CRCNE00001994 
Pax3-CNE4 Ch2: 47589982-47590506 CRCNE00001989 
Pax3-CNE5 Ch2: 47587333-47587654 CRCNE00001987 
Pax3-CNE6 Ch2: 47583981-47584491 CRCNE00001984 and 
CRCNE00001985 
Pax7-CNE1 Ch11: 42451808-42452137 CRCNE00009579 
Pax7-CNE2 Ch11: 42453941-42454201 CRCNE00009578 
Pax7-CNE3 Ch11: 42473594-42474048 CRCNE00009577 
Pax7-CNE4 Ch11: 42518191-42518611 CRCNE00009574 and 
CRCNE00009575 
Pax7-CNE5 Ch11: 42530820-42531448 CRCNE00009572, 
CRCNE00009573 and 
CRCNE00009587, 
Pax7-CNE6 Ch11: 42535678-42536200 CRCNE00009570 
 
Table 5.1 – CNE location in the zebrafish genome and equivalent Condor elements 
The location of each CNE identified by comparative genomics in the Zv9 release of the 
zebrafish genome, determined by BLAST, is listed. Many of the CNEs identified by our 
genomic analysis are represented in the Condor database as several individual elements. 
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5.2 – Testing CNE activity in-vivo 
 
 We sought to investigate the regulatory potential of each CNE in-vivo, with the 
aim of reducing the complex spatiotemporal expression patterns of Pax3 and Pax7 to 
the function of a set of discrete CRMs. Individual CNEs were amplified from freshly 
prepared BAC DNA and cloned into the MiniTol2-Citrine expression vector (Fig. 5.3) 
according to the protocol described in Chapter 2.2. This expression vector was selected 
for use in this investigation as it was designed to facilitate the screening of putative 
regulatory elements in zebrafish embryos (Javier Terriente, personal communication). 
 As described in Chapter 1.2, the activity of a putative enhancer is commonly 
examined by placing these regions immediately upstream of a minimally active 
promoter and assaying the transcriptional output with reporter genes. In our assay the 
function of a CNE was assessed by its ability to modulate the activity of a proximal 
Thymidine Kinase promoter, which showed no specific activity in control experiments 
(data not shown). Transcriptional activation is amplified by the Gal4-UAS system 
(Elliott and Brand, 2008) before being visualised as the production of Citrine, a variant 
of YFP. This amplification step was desirable for the purposes of this investigation as it 
ensured that weak or transiently active enhancers could induce sufficient levels of 
fluorophore protein to be visualised in live embryos. Integration of this reporter into the 
genome was facilitated by the employment of the Tol2 transposon system, which is 
frequently used in zebrafish studies to improve the rate of transgenesis (Kawakami, 
2007). Messenger RNA encoding the Tol2 transposase was co-injected into a 1-cell 
stage zebrafish embryo with the MiniTol2-Citrine vector. The transposase is translated 
in-vivo and binds to its minimal recognition sites in the plasmid, resulting in the 
excision of the expression cassette from the donor vector and its integration in the 
genome. 
 Of the 12 CNEs identified by our comparative genomics, 7 were successfully 
cloned into the MiniTol2-Citrine expression vector and sequence verified. 
Amplification of all 6 CNEs from the Pax3 BAC DKEY-20F20 was achieved, however 
CNE6 was not sequence verified. Two CNEs within the Pax7 locus, CNE2 and CNE4, 
were cloned and sequenced. We were not able to clone the remaining Pax7 CNEs from 
the CH73-62K19 or CH211-119A10 BACs, the latter being the source from which the 
Pax7 locus was sequenced during the assembly of the zebrafish genome. The activity of 
each cloned CNE was assessed in-vivo according to the protocol described in Chapter 
2.4. Our screen resulted in the identification of 5 putative CRMs that are able to 
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coordinate transgene expression in a cell type specific manner, all of which are 
associated with the Pax3 locus. Consequently the major focus of this project became the 
study of these CRMs and the molecular basis of Pax3 regulation during spinal cord 
development. 
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Fig. 5.3 – The MiniTol2-Citrine expression vector 
Putative enhancers are cloned into the HindIII-Sbf1 site located proximally to a minimally 
active Thymidine Kinase promoter. CNE mediated transcription is amplified by the Gal4-UAS 
system before being visualised by the production of Citrine. The rate of transgenesis is 
improved by co-injection of Tol2 transposase mRNA, which excises the expression cassette and 
aids its integration within the genome. 
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5.3 – CNE2 and CNE4 activate transcription within Pax3 expressing cells 
 
 CNE2 is a 321 bp element containing phylogenetically conserved TFBS for 
multiple bHLH, Homeodomain and retinoic acid response factors (Fig. 5.4). Our in-vivo 
screen suggests that CNE2 may function as an enhancer that is sufficient to activate 
transcription in specific population of neurons within the spinal cord. At 24 hpf, whole 
mount preparations of embryos immunostained with a polyclonal anti-GFP antibody 
revealed Citrine expression specifically within the spinal cord (n=11) (Fig. 5.5A). The 
profile of reporter gene activation driven by CNE2 was not observed in live embryos, 
suggesting that it possesses a weak regulatory potential. Higher magnification images of 
trunk tissue revealed that the cells marked by CNE2 activity appeared to reside within 
the dorsal half of the spinal cord (Fig. 5.5B). These cells exhibited a polarised 
morphology and frequently sent processes ventrally towards the floor plate (Fig. 5.5B). 
The localisation and morphology of cells marked by GFP staining led us to conclude 
that CNE2 was sufficient to direct transcription within a subset of dorsally located 
postmitotic neurons. We reasoned that the weak regulatory potential of CNE2 and its 
activity in postmitotic cells made it an unsuitable candidate for further analysis in this 
study. 
 CNE4 is a 325 bp element containing several conserved predicted TFBS for 
Hox, Oct and Fox transcription factors (Fig. 5.4). In our initial screen at 24 hpf, we 
observed that CNE4 was sufficient to mediate transcription within a subset of trunk 
skeletal muscle fibres (n=26) (Fig. 5.6A). We also noted transgene activation in a row 
of cells located within the dorsal domain of the spinal cord (Fig 5.6A’). The 
morphology and connectivity of these cells suggested that they might represent Rohon-
Beard neurons, a transient population of neural crest derived mechanosensory neurons 
that are unique to anamniotes (Roberts, 2000). Further molecular characterisation of 
these cells was not undertaken during this investigation. In anterior regions of the 
embryo, transgene expression was detected in clusters of cells that were reasoned to be 
populations of migratory neural crest. 
 Transverse sections of trunk tissue at prepared at 24 hpf revealed the presence of 
Citrine expression in isolated populations of medially located fast fibres and superficial 
slow twitch fibres (n=8) (Fig. 5.6B). Expression was also observed in a number of 
presumptive neural crest cells located at the dorsal midline of the spinal cord. CNE4 
meditated transcriptional activity was present in both the slow and fast twitch classes of 
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muscle fibres and their nuclei at 48 hpf, as demonstrated in whole mount (Fig. 5.6C) 
and lateral flat mount preparations of trunk tissue (Fig. 5.6D). 
The activity of CNE4 within populations of skeletal muscle cells and neural 
crest derivatives was encouraging as it suggested that our CNEs represented discrete 
CRMs whose combinatorial activity defines the expression of Pax3 in multiple tissues. 
However, we concluded that further analysis of CNE4 was not suitable for this 
investigation as it did not exhibit activity in spinal cord progenitors. We shared our 
results with members of the Ingham lab, who created 7 zebrafish transgenic lines that 
stably expressed CNE4. Citrine expression was observed within both slow and fast 
populations of muscle fibres in 5 of these lines, however the activity of CNE4 did not 
appear to be specific and often labelled cells within the developing eye, otic vesicle and 
anterior CNS (Claudia Seger, personal communication). 
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Fig. 5.4 – Annotation of conserved TFBS within Pax3-CNEs 
MultiTF analysis of CNEs associated with the Pax3 locus reveals that these elements are 
composed of clusters of phylogenetically conserved TFBS. 
Figure cropped from original alignment for clarity. 
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Fig. 5.5 – CNE2 mediated transcription labels dorsal interneurons 
Lateral wholemount view of a CNE2 transient transgenic embryo at 24 hpf, stained with a 
polyclonal GFP antibody. Weak transgene labelling is evident along the AP axis of the dorsal 
spinal cord (A). These cells are polarised in the DV axis and extend axons ventrally toward the 
FP, indicating that they represent subpopulations of dorsal interneurons (dI) (B). 
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Fig. 5.6 – CNE4 enhances transcription within muscle and neural crest cells 
Lateral view of a CNE4 transgenic embryo stained with GFP antibody revealing transgene 
localisation within muscle fibres (mf), migrating neural crest (nc) (A). Higher magnifation 
views of trunk tissue reveals GFP labelling of cells with the characteristic morphology of 
Rohon-Beard neurons (A’). Transverse sections at 24 hpf reveals GFP staining in neural crest 
cells and muscle fibres within the somite (B). Citrine expression persists within both fast and 
slow twitch muscle fibres and their nuclei at 48 hpf (C and D). 
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5.4 – CNE5 is active in the notochord and floor plate 
 
 Whole mount preparations of CNE5 transgenic embryos assessed at 24 hpf 
revealed the extensive GFP labelling of the large columnar cells that comprise the 
zebrafish notochord, extending from the otic vesicle to the posterior limit of the trunk 
(n=14) (Fig. 5.7A). We also observed GFP labelling in a row of single cells located 
dorsally adjacent to the notochord and reasoned that these cells might represent the FP 
of the neural tube. Mosaic transgene activity was observed in cells within the dorsal 
spinal cord, hindbrain and forebrain of all embryos assessed at this stage. Transverse 
sections of trunk tissue at 24 hpf confirmed that CNE5 mediated transcriptional activity 
labelled cells of the notochord (n=11) (Fig. 5.7B). Citrine was also localised within cells 
of the FP and a sharp boundary was observed separating these cells from the p3 domain 
of the spinal cord. Transgene labelling within the somites and neural progenitors was 
rarely observed and limited to single cells when present. As CNE5 was demonstrated to 
have such an unexpected regulatory function, we sought to further analyse its activity 
over the first 72 hours of development in live embryos. We first observed transgene 
activation within the notochord at approximately the 6 somites stage which persisted 
until the second day of development (data not shown). The activity of this enhancer 
appeared to be markedly downregulated by 72 hpf, when only a small number of cells 
located within the dorsal aorta and cardiac muscle were labelled by GFP antibody 
staining (n=10) (Fig. 5.7C). 
 The expression pattern generated by CNE5 transcriptional activity in-vivo 
contrasted with the results obtained from our experiments examining the function of 
CNE2 and CNE4, as the majority of cells labelled by CNE5 activity do not reside in the 
Pax3 expression domain. Analysis of the conserved TFBS contained within CNE5 
cannot provide a molecular explanation of its activity, as it does not contain sites for 
key determinants of the notochord or floor plate, such as FoxA2 or Gli family 
transcription factors (Fig. 5.4). We reasoned that some components of the expression 
profile modulated by CNE5, such as is observed in the forebrain, hindbrain and cardiac 
muscle, may be required for the correct profile of Pax3 expression. This hypothesis 
would require the active silencing of this CRM within the trunk of the embryo during 
CNS patterning, a mechanism for which there is currently no molecular evidence. 
Alternatively, this CNE may represent a CRM for a separate gene and function entirely 
independently of the Pax3 locus. 
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Fig. 5.7 – CNE5 is active in the notochord and floor plate 
The large columnar cells of the notochord (nc) are strongly labelled by CNE5 driven transgene 
expression, assessed at 24 hpf by GFP antibody staining (A). Transverse sections demonstrate 
that Citrine protein is restricted to the notochord and the floor plate (fp) of the neural tube, with 
a sharp dorsal boundary at the adjacent p3 domain (B). At 72 hpf, GFP labelling is limited to 
cardiac muscle (cm) and individual cells within the dorsal aorta (C). 
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Chapter 6: Characterisation of Pax3 CNE1 activity 
 
6.1 – CNE1 is active within the Pax3 domain of the CNS 
 
CNE1 is a 170 bp conserved element located within the 3’ region of Pax3 intron 
4 (Fig. 5.1) and is represented in the Condor database as CRCNE00001997 (Table. 5.1). 
MultiTF annotation of this genomic region suggested that it contained a 
phylogenetically conserved binding site for the Notch pathway effector, recombination 
signal binding protein for immunoglobulin kappa J (RBPJ), in addition to sites known 
to favour the binding of bHLH and homeobox containing transcription factors (Fig. 
5.4). Our initial observations of CNE1 mediated transcriptional activity fulfilled the 
aims of our screen, as we reproducibly observed high levels of transgene production 
throughout the AP axis of the CNS in live embryos at 24 hpf. 
Transgenic samples, fixed at 24 hpf and stained with an anti-GFP antibody, 
revealed Citrine expression within the hindbrain and midbrain of all embryos assessed 
(n=67) (Fig 6.1A). Transcriptional activation within the developing forebrain was less 
reproducible than the robust expression evident within the midbrain or hindbrain and 
was often very mosaic. Clusters of GFP positive cells were distributed across the entire 
AP axis of the spinal cord in 98.5% (66/67) of Citrine positive embryos. Higher 
magnification views of whole mount tissue suggested that CNE1 was transcriptionally 
active within multiple cell layers of the spinal cord (Fig. 6.1A’). We hypothesised that 
the majority of these cells resided within the dorsal spinal cord, as they were located 
adjacent to the dorsal limit of the trunk. We observed two broad classes of cells labelled 
by CNE1 activity; the first appeared to be polarised in the DV axis and extended ventral 
processes towards the floor plate. As these cells exhibited a similar morphology to those 
labelled by CNE2 activity, we concluded that they represented a subset of Pax3 derived 
interneurons. The second population of Citrine expressing cells did not exhibit any 
obvious polarisation or processes; we therefore hypothesised that they might be Pax3/7 
expressing neural progenitors. Transgene labelling was rarely observed in non-neural 
tissues and limited to single muscle fibres when present. 
Transverse sections of trunk tissue at 24 hpf confirmed that CNE1 mediated 
transcription was restricted to the dorsal half of the spinal cord in both medially located 
neural progenitor cells and ventrally projecting neurons (n=10) (Fig. 6.1B). We noted 
the presence of GFP positive axons extending from the Pax3/7 expression domain that 
cross the FP to terminate within ventral domains of the contralateral neural tube, 
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consistent with the expression of Pax3 within the progenitors of commissural 
interneurons (data not shown). Co-staining of transverse sections with DP312 revealed 
that the Citrine expression mediated by CNE1 was specifically localised within the 
Pax3/7 expression domain of the neural tube (n=17) (Fig. 6.1C). 
The results of our in-vivo analysis of CNE1 activity established this region as an 
enhancer that possesses sufficient regulatory potential to be readily visualised in the 
CNS of live transient transgenic embryos, in contrast to the comparatively weak 
transcription mediated by CNE2. CNE1 driven transcription was demonstrated to be 
highly specific for the dorsal regions of the zebrafish CNS, in a profile that is consistent 
with that defined for pax3a mRNA and the BAC driven Pax3-GFP reporter described in 
Chapter 4.4. We were able to demonstrate that the activity of CNE1 within the spinal 
cord is restricted to the Pax3/7 domain marked by DP312 staining and furthermore, that 
these cells appear to have a progenitor identity. Taken together, these data suggested 
that CNE1 was a good candidate for an enhancer that may co-ordinate Pax3 expression 
in spinal cord progenitor cells. We therefore chose to select this region for further in-
vivo characterisation, with the aim of determining the spatiotemporal dynamics of 
CNE1 activity throughout the early stages of CNS patterning. 
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Fig. 6.1 – CNE1 is sufficient to induce transcription within the dorsal neural tube 
CNE1 activity is detected along the entire AP axis of the CNS in GFP stained whole mount 
preparations of embryos assessed at 24 hpf (A). Higher magnification imaging suggests that 
both progenitors and neurons are labelled by CNE1 activity (A’). Transverse sections of trunk 
tissue demonstrate that CNE1 activity specifically labels the Pax3/7 domain of dorsal 
progenitors (dP) within the neural tube (B and C). 
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6.2 – CNE1 is a CNS specific enhancer 
 
The in-vivo activity of CNE1 at 24 hpf suggested that this region may play in a 
role in the regulation of Pax3 expression, however we were aware that the mosaic 
transgenesis achieved in our assay imposed limits on our ability to investigate its 
function. This effect was observed to be particularly problematic during the early stages 
of CNS patterning, when pax3a transcript is first detected and becomes restricted to the 
lateral neural plate. A series of pilot experiments was able to determine that CNE1 is 
transcriptionally active at bud stage, however the mosiac nature of the assay made it 
difficult to draw conclusions on the location of these cells within the early embryo 
(Data not shown). Given the results of our lineage studies, described in Chapter 3, we 
reasoned that this stage of development might prove to be critical in the establishment 
of the Pax3 expression domain. We therefore sought to create zebrafish lines in which 
the CNE1 expression cassette was stably integrated into the germline, facilitating 
analysis of this enhancer at early stages of CNS patterning. 
A clutch of CNE1 transient transgenic embryos were sorted at 24 hpf on the 
basis of strong Citrine expression within the spinal cord and maintained at 28.5 °C until 
the fifth day of development. 30 transgenic embryos were transferred to the care of the 
aquatics facility, all of which survived to adulthood. Germline integration was assayed 
in outcrosses of injected founder transgenics to stock wild type strains. The resulting 
transgenic embryos were sorted from siblings at 24 hpf on the basis of Citrine 
expression and transferred to the aquatics facility to be maintained as the F1 generation 
of the stable line. The F0 founder transgenics were maintained in individual tanks to 
enable a preliminary characterisation of each stable line in outcrosses with wild type 
strains. 
Of the 30 injected fry selected for the creation of stable lines, 3 demonstrated 
germline integration of the CNE1 expression construct. Citrine expression was readily 
observed within the CNS tissues of live F2 progeny of each of these lines at 24 hpf, 
however we noted that the levels of flurophore produced was variable. This was 
particularly evident in live L1751 derived embryos, which demonstrated a 
comparatively weaker fluorescence than both L1752 and L1860 transgenics. Whole 
mount GFP staining of outcrossed F2 embryos at 24 hpf revealed the presence of CNE1 
mediated transgene activation along the entire AP axis of the spinal cord in each line, 
consistent with the expression of pax3a mRNA (Figs. 6.2A, B and C). We observed 
subtle differences in the tissues labelled by CNE1 activity in each stable line in 
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comparison to the Pax3-GFPI150 BAC transgenic line. These include the clear loss of 
transgene activation in a defined hindbrain rhombomere of L1751 derived embryos 
(Fig. 6.2A) and the lack of a consistent anterior limit of expression shared by each line. 
We hypothesised that these differences may be a result of a positional effect of reporter 
integration into the genome and the influence of local regulatory elements upon 
transgene activity in each line. We noted the weak labelling of migratory neural crest 
cells at the somite boundaries in embryos from each stable line stained with GFP 
antibody at 24 hpf. These cells did not appear to actively transcribe pax3a mRNA at this 
stage (Fig. 4.1D), however they were clearly labelled in Pax3-GFPI150 transgenic 
embryos stained for GFP localisation (Fig. 4.7A). These data suggested that the 
perdurance of fluorophore proteins might be the main contributor to the labelling of 
these cells. Transverse sections of trunk tissue demonstrated that CNE1 mediated 
transcription was restricted to the spinal cord in each stable line and was never observed 
in developing muscle fibres (Figs. 6.2D, E and F). Cells labelled by GFP staining 
strongly co-localised with DP312 staining in the dorsal half of the spinal cord and did-
not extend ventrally beyond the Pax3/7 boundary. These results strongly suggested that 
CNE1 was specifically active within the Pax3/7 expression domain of the dorsal spinal 
cord and further strengthened our analysis of transient transgenic embryos. 
We sought to independently confirm our findings of CNE1 activity and extend 
them to other model systems through the use of published datasets documenting the 
location of putative enhancers in embryonic tissues. One study that was particularly 
insightful documented the occupancy of the transcriptional co-activator p300, which has 
been shown to be predictive of enhancers associated with actively transcribed genes due 
to its role in the recruitment of the basal transcription machinery (Visel et al., 2009). 
This study was unique within the literature as it attempted to employ a genome wide 
approach to enhancer identification and subsequently predict the activity of these 
regions within defined tissues of the mid-gestation mouse embryo. This was achieved 
by the creation of 3 datasets that detail the occupancy of p300 in dissected preparations 
of forebrain, midbrain and limb tissue at E11.5. We were aware that the developmental 
stage of the tissues utilised in this investigation is comparatively later than our zebrafish 
assay and therefore past the maxima of Pax3 expression in the spinal cord, however 
Pax3 is highly expressed in the midbrain and limb bud at this stage (Goulding et al., 
1991). 
Tracks representing the binding profiles of p300 in each individual tissue were 
accessed via the NCBI GEO browser under the identifier GSE13845. The WIG file of 
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each track, documenting the location of binding peaks above an estimated false 
discovery rate of 0.01, was uploaded to the mm9 (NCBI37) release of the mouse 
genome via the UCSC genome browser and the position of CNE1 was determined by a 
BLAT search. These data clearly demonstrated that the only statistically significant 
peak of p300 binding at E11.5 across the mouse Pax3 locus overlapped with CNE1 in 
the midbrain-derived dataset (Fig. 6.3). We observed a small peak that fell below the 
false discovery threshold in the forebrain sample, however p300 binding was not 
associated with CNE1 in limb tissue. These ChIP-seq results further validated our 
implementation of comparative genomics by identifying CNE1 as a putative enhancer in 
an independent experiment. The observation that the sole statistically significant peak of 
p300 binding was found in midbrain tissue added weight to our hypothesis that this 
region performed a specific role in regulating the expression of Pax3 during CNS 
development. 
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Fig. 6.2 – CNE1 is a CNS specific enhancer 
L1751 CNE1 transgenic zebrafish exhibit Citrine transcription within the dorsal spinal cord but 
lack expression within a single hindbrain rhombomere and the midbrain (arrowheads within A). 
L1752 transgenics also express Citrine within the dorsal spinal cord and hindbrain, however 
transcription in the midbrain is restricted to an isolated cluster of cells (arrowhead in B). L1860 
transgenic zebrafish appear to recapitulate pax3a mRNA expression at 24 hpf (C). Transverse 
sections of each transgenic line at trunk level demonstrate that CNE1 mediated transcription is 
restricted to Pax3/7 expressing progenitors in the dorsal neural tube (dP) (D, E and F). 
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Fig. 6.3 – CNE1 is specifically bound by p300 in CNS derived tissues 
UCSC genome browser plot demonstrating the profiles of p300 binding across the Pax3 locus in 
tissue derived from the mouse limb bud, forebrain and midbrain at E11.5. These data reveal that 
CNE1 is the only enhancer marked by p300 binding and furthermore, that this regulatory 
element is specifically active in CNS derived tissues. 
ChIP-seq datasets published within Visel et al., 2009. 
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6.3 – The spatiotemporal profile of CNE1 activity 
 
We sought to further characterise the spatiotemporal dynamics of CNE1 activity 
in-vivo using our stable transgenic zebrafish lines, in order to assess the function of this 
enhancer in the establishment of the Pax3 expression domain. To this end, we 
performed a series of wholemount GFP antibody stainings at the developmental stages 
previously used to determine the expression profile of pax3a (Fig. 4.1).  
CNE1 driven transgene expression recapitulates pax3a mRNA during the early 
stages of CNS patterning. Accordingly, GFP staining was first observed in dorsal views 
of the anterior and lateral neural plate at bud stage (Fig. 6.4A). Citrine localisation 
became restricted to the lateral edges of the intermediate and posterior neural plate at 
the 6 somites stage, consistent with pax3a expression. However, we noted that the 
segmented pattern of pax3a expression in the anterior CNS was not evident in CNE1 
stable transgenic embryos assessed at this stage (Fig. 6.4B). Transgene labelling within 
the spinal cord closely correlated with the expression of pax3a mRNA at both the 18 
somite stage (Fig 6.4C) and 24 hpf, as previously described (Fig 6.4D). Citrine 
localisation within CNE1 transgenics differed from pax3a expression at later stages of 
development, possibly due to the perdurance of protein within cells. This effect was 
particularly evident at 32 hpf, as robust GFP staining was observed in the spinal cord at 
a stage when pax3a transcription is downregulated (Fig. 4.6E). Similarly, GFP staining 
was retained in tissues of the anterior CNS that do not actively transcribe pax3a at 48 
hpf (Fig. 4.6F). We noted that the number of cells marked by GFP staining in the spinal 
cord was greatly reduced within embryos at 48 hpf, supporting our hypothesis that the 
perdurance of fluorophore protein was the main contributor to these differences. We 
reasoned that this issue could be avoided by assessing Citrine transcription rather than 
protein distribution, however we did not perform this experiment as the data acquired at 
earlier stages was sufficient to establish a role for CNE1 in the induction and 
maintenance of Pax3 expression. A series assaying CNE1 activity in transient 
transgenic embryos demonstrated a similar spatiotemporal profile throughout CNS 
development (data not shown). 
The results from our developmental series of CNE1 stable transgenic embryos 
suggested that the onset of transgene activation coincided with the induction of pax3a 
transcription in the cells of the lateral neural plate. We sought to further analyse this 
point by preparing cross sections of the intermediate neural plate at bud stage and 
determining the cellular localisation of Citrine protein relative to Pax3/7. This analysis 
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confirmed that GFP staining was restricted to the intermediate and lateral regions of the 
open neural plate (n=9) (Fig. 6.5A), co-localising with the majority of Pax3/7 
expressing cells marked by DP312 staining (Fig. 6.5B and C). Sections of anterior 
regions of the CNS demonstrated that cells labelled by GFP were dorsally located 
within the tissue and extended towards the medial limit of the neural plate, whereas 
DP312 staining is not spatially restricted (Data not shown). Taken together, these data 
strengthened our hypothesis that CNE1 functions to co-ordinate transcription 
specifically within the Pax3/7 domain of the developing CNS. Furthermore, the 
observation that Citrine protein was localised within the cells of the lateral neural plate 
as they initiated Pax3 transcription suggested that this regulatory element might play a 
role in this process. 
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Fig. 6.4 –CNE1 activity recapitulates pax3a expression during early development  
Dorsal views of CNE1 transgenic zebrafish at bud stage reveal Citrine labelling within the 
intermediate and lateral regions of the posterior neural plate (A). GFP staining becomes 
restricted to the lateral neural plate in dorsal view of embryos assessed at the 6 somites stage 
(B). In lateral view taken at 18 somites and 24 hpf, Citrine protein is expressed within the 
midbrain (mb), hindbrain (hb) and dorsal progenitors (dP) within the spinal cord (C and D). The 
perdurance of Citrine protein within cells previously labelled by CNE1 transcriptional activity 
might account for the observed GFP staining in the spinal cord at 32 hpf and 48 hpf in the 
absence of pax3a transcription (E and F). 
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Fig. 6.5 – CNE1 is active in Pax3 expressing cells within the neural plate 
Transverse sections of CNE1 transgenic zebrafish at bud stage reveal GFP staining within the 
intermediate and lateral regions of the neural plate (A). Co-labelling with DP312 demonstrates 
that CNE1 activity labels Pax3 expressing cells (B and C). 
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6.4 – Zebrafish CNE1 retains its function in chick 
 
 Our analysis of the transcriptional activity mediated by Pax3-CNE1 suggested 
that it might play a role in both the establishment and maintenance of the Pax3 
expression domain during the early stages of CNS development. Based upon these 
results we chose to investigate this regulatory region further by performing a series of 
targeted sequence manipulations, with the aim of describing its regulatory potential in 
terms of the complement of transcription factors it binds. We reasoned that our transient 
transgenic zebrafish assay would provide the best means of screening a large array of 
mutant constructs in-vivo, however we were aware that the mosaic expression achieved 
in this assay could make the interpretation of expression data problematic. In order to 
alleviate these issues and ensure confidence in our data, we sought to develop a second 
in-vivo assay in which the activity of CNE1 could be determined in relation to an 
internal control of transgenesis. To this end, we performed a series of pilot experiments 
in which our transgenic reporter cassette, driven by zebrafish CNE1 sequence, was 
electroporated into the spinal cords of HH stage 11-12 chick embryos. We co-
electroporated a plasmid encoding a nuclear localised LacZ reporter as an internal 
control of the electroporation efficiency, as it can be easily visualised by antibody 
staining and does not encode a fluorescent reporter. We employed a monoclonal Pax7 
antibody as a marker of the Pax3/7 domain in this assay, as it has been previously 
demonstrated to be more suitable for use in chick tissue than the Pax3 antibody (Ana 
Ribero, personal communication). 
 Transverse sections of chick spinal cord tissue, prepared 24 hours post 
electroporation (hpe), validated this assay as a secondary means of assessing the in-vivo 
activity of a putative enhancer. These data clearly demonstrated that LacZ staining was 
distributed across the entire DV axis of the experimental side of the neural tube, 
however CNE1 transcriptional activity was restricted to neuronal progenitors within the 
Pax3/7 domain (n=12) (Fig. 6.6A). Sections of spinal cord tissue taken at 48 hpe 
demonstrated that CNE1 remained active in the Pax3/7 domain during CNS 
development (n=6) (Fig. 6.6B). We noted that the majority of labelled cells at this stage 
resided within the mantle zone of the spinal cord, suggesting that they were committed 
to a neuronal fate. 
 These data demonstrated that in-ovo electroporation was a viable method of 
screening putative enhancers. We observed that transgene activity in this assay was 
comparably mosaic to that achieved in zebrafish embryos, however the internal control 
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of trangenesis provided by electroporation experiments enabled the relative activity of 
an enhancer to be determined. We were reassured to discover that the zebrafish CNE1 
sequence retained its function in chick embryos, given the high degree with which this 
region is conserved across vertebrate species. Furthermore, we observed that the activity 
of the zebrafish sequence representing CNE1 scaled according to the size of organism in 
which it operated. This is particularly striking when one considers that the Pax3/7 
domain in zebrafish comprises approximately 10 cells, whereas the same domain in 
chick embryos contains approximately 110. These data suggested that the inputs 
received by CNE1 scale, both in terms of the size of the tissue and number of cells it 
contains. This result was expected prior to performing the experiment, as previous 
studies in the lab have demonstrated that the spinal cord GRN scales according to tissue 
size (Ana Ribero and Ani Kicheva. personal communication). 
The major limitations of chick electroporation experiments, in comparison to 
zebrafish injections, are the lack of access to large numbers of embryos, the inability to 
assess enhancer activity outside of the neural tube and the amount of post-experimental 
processing required to extract data. With these considerations in mind, we chose to 
assess our sequence manipulations primarily in whole mount preparations of zebrafish 
embryos at 24 hpf before utilising 24 hpe sections of chick electroporation experiments 
to verify our observations. 
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Fig. 6.6 – Zebrafish CNE1 retains activity in the chick neural tube 
Co-electroporation of zebrafish CNE1 sequence with nuclear localised LacZ reveals that Citrine 
expression is restricted to progenitors within the Pax7 expression domain of the chick neural 
tube at 24 hpe (A). The majority of cells labelled by CNE1 activity reside laterally within the 
mantle zone in embryos assessed at 48 hpe, suggesting that these cells represent neurons (B).  
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Chapter 7: Molecular analysis of CNE1 regulation 
 
7.1 – Identifying regulatory motifs within CNE1 
 
 In-vivo analysis of Pax3-CNE1 established this region as a functional enhancer, 
the activity of which recapitulated the expression profile of pax3a during spinal cord 
patterning. To advance this study, we performed a functional dissection of CNE1 to 
determine the interactions this region mediated between the Pax3 locus and members of 
the neural tube GRN. To this end, we chose to exploit the selective pressure that exists 
in functional regulatory elements to identify highly conserved putative TFBS in CNE1. 
This analysis took advantage of the large evolutionary distances of human-fugu 
comparisons but extended the span of vertebrates analysed to include mammalian, 
amphibian, avian, reptilian and fish genomes. Regions of CNE1 homology were 
identified by cross species BLAST searches and the compiled dataset was aligned using 
the default parameters of the ClustalW2 algorithm (Larkin et al., 2007). 
The aligned data not only confirmed that CNE1 was highly conserved within 
vertebrate genomes, but also revealed that it contained several clusters of nucleotides 
that were completely homologous across the evolutionary span of the dataset (Fig. 7.1). 
We analysed these regions within CNE1 using the MEME suite of sequence analysis 
tools (Bailey et al., 2009). The default parameters of the algorithm were not suited to 
the needs of our study, due to the degree of overall homology that existed within the 
input data, we therefore compensated for this by decreasing the maximum width of 
discovered motifs from 50 bp to 15 bp, which greatly increased the stringency of the 
analysis and produced satisfactory results. MEME analysis of CNE1 revealed the 
presence of 4 highly conserved motifs that correlated with the conserved regions 
previously identified by ClustalW2 (Table 7.1). We hypothesised that these regions 
might represent the binding sites that coordinate the transcriptional activity of CNE1 
and consequently determine Pax3 expression during CNS development. We sought to 
investigate the requirement for each motif in-vivo by creating individual deletions of 
these regions within CNE1. This was achieved by mutagenic PCR of the wild type 
sequence contained in the MiniTol2-Citrine vector using the modified protocol outlined 
in Table 2.2 and the primers listed in Table 2.3. The activity of each deletion construct 
was initially assessed by wholemount GFP antibody stainings of transient transgenic 
zebrafish embryos before transverse sections of electroporated chick embryos were used 
to verify our observations. 
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These data revealed the presence of GFP stained cells within the midbrain of all 
Motif1 deleted transgenic embryos assessed at 24 hpf (n=22) (Fig. 7.2D). CNE1 activity 
was completely absent from neural progenitor cells within the spinal cord at trunk level, 
however GFP labelled cells were observed in the most posterior region of 36% of 
embryos (8/22). Data from chick experiments were consistent with this observation, as 
only 13% of the embryos marked by LacZ staining demonstrated transgene activity 
within spinal cord sections at 24 hpe (n=1/8) (Fig. 7.2E). 95% of zebrafish embryos 
injected with the Motif2 deletion construct exhibited GFP staining throughout the dorsal 
CNS, in a profile consistent with the wild type enhancer (n=37/38) (Fig. 7.2F). 
Furthermore, 66% of LacZ positive chick spinal cords demonstrated transgene 
activation within the dorsal Pax3/7 expression domain (n=4/6) (Fig. 7.2G). A decrease 
in transgene induction throughout the entire AP axis of the CNS was observed in Motif3 
deleted fish, in comparison to the activity of the wild type enhancer (n=26) (Fig. 7.2H). 
Mosaic clusters of GFP positive cells were present within the dorsal trunk of 77% 
(20/26) of these embryos, however these cells were located at the dorsal limit of the 
spinal cord and did not exhibit a characteristic neural progenitor morphology. We did 
not observe any transgene expression in the LacZ positive spinal cord sections of chick 
embryos electroporated with the Motif3 deletion construct, confirming our analysis of 
zebrafish experiments (n=0/5) (Fig. 7.2I). Deletion of Motif4 appeared to result in a 
decrease in the activity of CNE1, as only 40% of transgenic fish exhibited GFP staining 
within the spinal cord (n=8/20). However, we noted that the distribution of Citrine 
expressing cells within the CNS of these samples was comparable to the wild type 
enhancer (Fig. 7.2J). This observation was verified by electroporation of the Motif4 
deletion construct, which resulted in transgene activation within the dorsal spinal cord 
of 80% of chick embryos (n=4/5) (Fig. 7.2K). These data are plotted and statistically 
analysed within Fig. 7.3 
Taken together, the data from our series of Motif deletion experiments suggested 
that Motif1 was specifically required for the correct activity of CNE1 within spinal cord 
progenitor cells whereas loss of Motif3 reduced the transcriptional activity of the 
enhancer throughout the anterior-posterior axis of the CNS. The function of CNE1 was 
largely retained in the context of Motif2 and 4 deletions, suggesting that these regions 
were not critical for the activity of this regulatory element. 
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Fig. 7.1 – Clusters of nucleotides within CNE1 are conserved across the span of 
vertebrate evolution 
ClustalW2 alignment of CNE1 sequences extracted from 12 vertebrate genomes reveals blocks 
of nucleotides that are perfectly conserved. These regions represent putative TFBS that might 
underlie the enhancer activity of CNE1 in-vivo.  
The motifs defined in Table 7.1 are highlighted in the alignment for clarity. 
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Table 7.1 – Identification of putative regulatory motifs within CNE1 
MEME analysis of CNE1 sequences extracted from 12 vertebrate genomes. Statistically over-
represented 15 bp motifs, their location within the zebrafish sequence of CNE1 and within Fig. 
7.1 are listed according to their conservation. 
 
 
 
 
 
 
 
 
 
 
 
 
Name 
Logo (12 vertebrate 
genomes) 
Location within 
CNE1 (zebrafish) 
Location within 
Fig. 7.1 
Motif1 
 
Bases 99 – 114 Position 109-123 
Motif2 
 
Bases 152 -167 Position 164-178 
Motif3 
 
Bases 48-63 Position 34-48 
Motif4 
 
Bases 139-154 Position 148-163 
Chapter 7 – Results 
	   128 
 
 
Fig. 7.2 – Motif1 and Motif3 are required for CNE1 function in-vivo 
Schematic detailing the organisation of motifs within CNE1 (A). The wildtype CNE1 enhancer 
labels cells in the dorsal neural tube of both zebrafish (B) and chick (C) embryos, assessed at 24 
hpf and 24 hpe, respectively. LacZ staining in chick embryos demonstrates the efficiency of 
electroporation and Pax7 staining marks the Pax3/7 domain. Motif1 deletion results in a loss of 
CNE1 activity in the spinal cord progenitors of the zebrafish neural tube (D). A similar loss of 
CNE1 activity is observed in chick embryos electroporated with the Motif1 deletion construct 
(E). Motif2 is not required for CNE1 activity in either zebrafish (F) or chick embryos (G). 
Deletion of Motif3 results in complete loss of CNE1 activity in spinal cord progenitors in both 
zebrafish (H) and chick embryos (I). In contrast, deletion of Motif4 does not affect the spatial 
distribution of Citrine labelling in the dorsal neural tube (J and K). 
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Fig. 7.3 – Quantification of the effects of motif deletion upon CNE1 activity 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted. Similarly, 
the percentages of electroporated chick embryos exhibiting GFP staining in transverse sections 
of brachial to lumbar sections of spinal cord is provided. These data demonstrate that loss of 
Motif1, 3 and 4 results in a highly significant loss of CNE1 activity in zebrafish spinal cord 
progenitors. In constrast, data obtained from chick experiments indicates that loss of Motif4 
does not effect CNE1 activity. These data confirm that Motif1 and Motif3 are required for the 
enhancer activity of CNE1 in-vivo. 
Two-tail Fisher’s exact test (* = P<0.005, ** = P<0.001 and NS = not significant). 
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7.2 – Functional dissection of CNE1 
 
We aimed to utilise the data created by MEME analysis of CNE1 to 
quantitatively assess the similarity of Motifs 1 and 3 to defined transcription factor 
binding matrices. This was achieved by comparing the desired PSPM, representing the 
conservation of each position within the motif, to defined matrices in the JASPAR 
(Sandelin et al., 2004a) and UniPROBE (Newburger and Bulyk, 2009) databases using 
the default parameters of the TomTom motif analysis tool (Gupta et al., 2007) (Table 
7.2). Further analysis of the cross species consensus sequence surrounding each motif 
was performed using the ConSite (Sandelin et al., 2004b) and JASPAR databases. This 
revealed the presence of binding sites for Hox, Tead and Pbx factors within the 10 bp 
immediately downstream of Motif1 (Table 7.2). These candidates were added to our list 
of putative CNE1 regulators as they have previously been demonstrated to bind 
upstream elements associated with the Pax3 locus (Milewski et al., 2004; Pruitt et al., 
2004). 
We were particularly intrigued by the identification of a 14 bp putative Pax6 
binding site within Motif1 by TomTom (Fig. 7.4), as members of the Pax gene family 
are known to participate in selective auto and inter-regulatory interactions (Frost et al., 
2008). Analysis of Motif1 revealed that it did not contain the palindromic site known to 
be preferentially occupied by paired type homeodomains (Soleimani et al., 2012 ; 
Wilson et al., 1993), which raised the possibility that this sequence represented a variant 
of the PD binding site. We tested this hypothesis by determining the homology shared 
between Motif1 and published definitions of PD binding sites occupied by Pax6 
(Epstein et al., 1994), Pax5 (Adams et al., 1992) and paired itself (Treisman et al., 
1991) using ClustalW2. These data indicated that the 5’ region Motif1 shared a high 
degree of homology to the selected PD binding sites and furthermore that all of the 
input sequences were identical over bases 4-8 (Fig. 7.3). The 3’ region of the alignment 
diverged and poor conservation was observed between Motif1 and the Pax6 PD binding 
site. This result was consistent with the hypothesis that Motif1 represented a PD binding 
site, however it also revealed that the site occupied by Pax6 was not identical to this 
sequence. Our in-vivo assessment of the requirement for Motif1 within CNE1 suggested 
that this region facilitated the binding of a positive regulatory input that was required 
for enhancer function in the dorsal spinal cord. Our analysis of the putative PD binding 
site in Motif1, in addition to the fact that Pax6 is not expressed in the majority of cells 
in which CNE1 is active, suggested that this region might not represent a functional 
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Pax6 binding site. Instead, we speculated that Motif1 might represent a PD binding site 
that could mediate the binding of Pax3/7 proteins to the Pax3 locus. 
A site directed mutagenesis screen was performed within Motif1, based upon the 
incidence of annotated TFBS within this sequence. We previously observed that the 
majority of transcription factors were associated with two distinct binding sites, a 5’ 
RBPJ site and a 3’ E-box, both of which were targeted for mutagenesis using the 
primers listed in Table 2.4. The Tead binding site associated with Motif1 was also 
selected for manipulation, as it partially overlapped the sequence deleted in previous 
experiments. We chose not to specifically target the putative PD binding site within 
Motif1, as we reasoned that it would be disrupted by any mutation made within this 
sequence. 
Mutation of the RBPJ site did not recapitulate the effect of Motif1 deletion, as 
88% of fish embryos demonstrated transgene labelling throughout the CNS at 24 hpf 
(n=22/25) (Fig. 7.5D) and 75% of chick embryos exhibited GFP staining within the 
dorsal spinal cord (n=6/8) (Fig. 7.5E). Similar results were obtained in Tead binding site 
manipulations, as 88% (n=29/33) of TeadMut1 and 98% (n=39/40) of TeadMut2 
injected zebrafish embryos retained Citrine labelling throughout the CNS (Figs. 7.5F 
and H). These results were verified in sections of chick spinal cord tissue, in which we 
observed GFP staining in 80% of TeadMut1 (n=4/5) and 88% of TeadMut2 (n=7/8) 
electroporated embryos (Figs. 7.5G and I). These data are plotted in Fig. 7.6. 
The E-box sequence within Motif1 was targeted by combining two published 
manipulations, each of which has been shown to be sufficient to preclude the binding of 
bHLH proteins to the site (Henke et al., 2009 ; Thattaliyath et al., 2002). All GFP 
positive fish embryos injected with the E-boxMut1 construct demonstrated transgene 
labelling within the tissues of the anterior CNS at 24 hpf (n=48/48) (Fig. 7.7D). We 
frequently observed GFP staining in large dorsally located cells within the trunk, 
however we did not consider these cells to be neural progenitors as they appeared to 
reside outside of the spinal cord and did not exhibit the characteristic progenitor 
morphology. 13% of chick embryos electroporated with the E-boxMut1 construct 
retained GFP labelling within the spinal cord (n=1/8) (Fig. 7.7E). These data suggested 
that the E-box binding site within the 3’ region of Motif1 was required for the correct 
activity of CNE1 and furthermore, that the effect of mutating this site recapitulated the 
deletion of Motif1 in-vivo. We chose to further investigate the requirement of this site 
within Motif1 by creating individual mutations in the 5’ (E-boxMut2) and 3’ (E-
boxMut3) regions and assaying their effects on the transcriptional output of CNE1. 
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Transgene induction within spinal cord progenitor cells was observed in 8% of E-
boxMut2 injected zebrafish (n=2/26) (Fig. 7.7F) and 33% of electroporated chick 
embryos (n=2/6) (Fig. 7.7G). In contrast, Citrine labelling was not seen in spinal cord 
progenitors of E-boxMut3 injected fish (n=0/19) (Fig. 7.7H) and was retained in only 
20% of chick embryos (n=1/5) (Fig. 7.7I). These data are plotted in Fig. 7.8. 
 Taken together, these data suggested that the requirement of Motif1 for the 
activity of CNE1 was not dependent upon the integrity of either the 5’ RBPJ or 
downstream Tead binding sites. A large mutation of the 3’ E-box binding site reduced 
CNE1 activity in a manner that was consistent with the effect of deleting the entire 15 
bp motif. Further dissection of this site suggested that E-boxMut3, representing a 2 bp 
substitution in the sequence of CNE1, also recapitulated the deletion of Motif1. These 
data suggested that transcription factors bound CNE1 via the E-box in Motif1 to 
activate or maintain transcription within the spinal cord and furthermore, that the 3’ 
region of the site was dominant in the context of this interaction. 
 Sequence manipulations of the binding sites contained within Motif3 were 
designed to target the 5’ region and synthesised using the primers listed in Table 2.4. 
This site was predicted to facilitate the binding of Fox, Sox and Lef family members, all 
of which are known to play key roles in CNS development (Table 7.2). We 
hypothesised that the binding of these factors could mediate a general positive 
regulatory input upon CNE1, given the reduced level of transcriptional activation 
observed throughout the CNS in Motif3 deleted transgenic zebrafish. Injection of 
Motif3-Mut1 did not reduce GFP staining in anterior CNS tissues, compared to wild 
type CNE1 (n=41) (Fig. 7.9D). We observed GFP staining within spinal cord 
progenitors of 61% (n=25/41) of these embryos, however the distribution of the 
transgene was highly mosaic and limited to small clusters of cells. Electroporation of 
Motif3-Mut1 resulted in transcriptional activation within the spinal cord of 43% of 
chick embryos (n=3/7) (Fig. 7.9E). Motif3-Mut2 appeared to have a greater effect upon 
CNE1 activity in fish embryos and resulted in a general decrease in the level of Citrine 
produced throughout the CNS that was comparable to the effects of Motif3 deletion 
(n=32) (Fig. 7.9F). Transcription within spinal cord progenitors was greatly decreased 
compared to wild type CNE1, as only 19% (n=6/32) of embryos exhibited GFP staining 
in these cells. 40% of chick embryos electroporated with the Motif3-Mut2 construct 
retained transgene expression within the Pax3/7 domain (n=2/5) (Fig. 7.9G). These data 
are summarised and analysed in Fig. 7.10. 
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 Taken together, our analysis of Motif3 mutant constructs provided further 
evidence of a general positive regulatory input that was required for CNE1 activity 
throughout the developing CNS. We hypothesised that this effect may be mediated by 
the binding of candidate Fox, Sox and Lef family transcription factors to the 5’ region 
of Motif3 and that this interaction was destabilised by our second mutation within this 
site. 
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Motif  
TomTom 
Matches 
(E<10) 
Matching Matrices identified by 
TomTom (JASPAR and 
UniPROBE) 
Surrounding consensus 
sites (ConSite and 
JASPAR) 
1 17 
Hkb, Pax6, Arnt:Ahr, ZNF354C, 
Ascl2, HSF1, YY1, Irf6, SP1, Sp4, 
Gata1, Bcl6b, TAL1::TCF3, 
Tcfe2a, Zfp410, Snail, Bhlhb2 
HoxA5, HoxA7, Tead1, 
Pbx1 
3 25 
Foxa2, Foxj3, tll, Mafb, Foxk1, 
Foxl1, FOXD1, FoxA1, HCM1, 
fkh, FKH2, Foxj1, FKH1, br_Z4, 
Sox1, Mafk, Tcf1, RORA, Evi1, 
slp1, AP1, Yap7 
N/A 
 
Table 7.2 – Phylogenetically conserved TFBS associated with CNE1-Motif1 and 
Motif3 
TomTom analysis of the PSPMs representing Motif1 and Motif3 reveals that these regions 
consist of multiple, highly conserved TFBS. These data are supplemented with in-silico 
annotation of the sequence surrounding Motif1, revealing binding sites for several transcription 
factors previously implicated in the regulation of Pax3 expression. 
 
 
 
 
Fig. 7.4 – CNE1-Motif1 represents a putative PD binding site 
Alignment of CNE1-Motif1 with published definitions of the Pax6, Pax5 and paired PD binding 
sites using ClustalW2. These data demonstrate consenus between all input sequences over bases 
4-8, whereas poor conservation is observed in the 3’ region of the alignment. 
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Fig. 7.5 – Mutation of the RBPJ or Tead sites associated with Motif1 does not 
affect the transcriptional activity of CNE1 
Schematic highlighting the mutations induced within the RBPJ and Tead binding sites 
associated with Motif1 (A). Mutation of the RBPJ site does noes result in a loss of CNE1 
activity in the spinal cord of zebrafish (D) and chick embryos (E), compared to wildtype (B and 
C). Similarly, two individual mutations designed to target the Tead binding site located 
immediately 3’ to Motif1 do not affect the distribution of GFP staining in-vivo (F, G, H and I). 
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Fig. 7.6 - Quantification of the effects of RBPJ and Tead site mutations upon 
CNE1 activity 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted. The 
percentages of electroporated chick embryos exhibiting GFP staining in transverse sections of 
brachial to lumbar sections of spinal cord is also provided. These data demonstrate the mutation 
of the RBPJ site within Motif1 does not significantly alter CNE1 activity. 88% of TeadMut1 
transgenic zebrafish exhibit GFP staining in spinal cord progenitors, however this result is 
significantly different from the wildtype control. The mutation of this binding site does not 
produce a significant reduction in CNE1 activity when assessed in chick embryos. TeadMut2 
demonstrates no effect upon CNE1 activity in-vivo. 
Two-tail Fisher’s exact test (* = P<0.005 and NS = not significant). 
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Fig. 7.7 – The 3’ region of Motif1 is required for CNE1 activity 
Schematic outlining the mutations induced within the E-box of Motif1 (A). E-boxMut1results in 
a loss of CNE1 activity in spinal cord progenitors of both zebrafish and chick embryos (D and 
E) compared to th wildtype enhancer (B and C). E-boxMut2 strongly reduces CNE1 activity in 
progenitor cells within the zebrafish neural tube (F), however Citrine labelling is retained in 
60% of chick embryos assessed (G). Consistent with the effects of Motif1 deletion, E-boxMut3 
attenuates GFP staining in zebrafish neural tube progenitors (H) and reduces enhancer activity 
in chick embryos (H and I). 
Chapter 7 – Results 
	   138 
 
 
Fig. 7.8 - Quantification of the effects of E-box mutations upon CNE1 activity 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted. In addition, 
the percentages of electroporated chick embryos exhibiting GFP staining in transverse sections 
of brachial to lumbar sections of spinal cord is also provided. These data demonstrate that all of 
the mutations induced with the E-box of Motif1 result in a highly significant reduction of CNE1 
activity in zebrafish embryos. In chick, EboxMut1 and EboxMut3 produces a loss of CNE1 
activity whereas EboxMut2 is not statistically different from the control experiment. These data 
are in agreement with the conclusion that the 3’ region of the E-box binding site in Motif1 is 
required for CNE1 activity. 
Two-tail Fisher’s exact test (** = P<0.001, * = P<0.005 and NS = not significant). 
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Fig. 7.9 – Mutation of the HMG box within Motif3 reduces CNE1 activity in-vivo 
Schematic outlining the mutations induced within the 5’ region of Motif3 (A). 61% of 
Motif3Mut1 transgenic zebrafish exhibit GFP staining within spinal cord progenitor cells (D). 
43% of chick embryos retain Citrine labelling within the Pax3/7 domain of the neural tube (E). 
Only 19% of Motif3Mut2 transgenic zebrafish exhibit CNE1 activity in neural tube progenitors 
(F), however 40% of chick embryos retain GFP staining in the dorsal neural tube (G)  
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Fig. 7.10 - Quantification of the effects of Motif3 mutations upon CNE1 activity 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted with the 
percentages of electroporated chick embryos exhibiting GFP staining in transverse sections of 
brachial to lumbar sections of spinal cord. These data demonstrate that both mutations induced 
within the 5’ region of Motif3 result in a highly significant reduction in CNE1 activity in 
zebrafish embryos. These sequence manipulations also produce a consistent loss of CNE1 
activity in chick embryos, however these data are not statistically different from control 
experiments. 
Two-tail Fisher’s exact test (** = P<0.001 and NS = not significant). 
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7.3 – Motif1 is a functional paired domain binding site 
 
 In-vivo functional dissection of Pax3-CNE1 resulted in the identification of two 
conserved motifs that were required for the activity of this enhancer. Furthermore, we 
were able to describe the requirement of these motifs in terms of the integrity of the 
discrete binding sites they contain. We aimed to build upon our in-vivo analysis of 
CNE1 regulation by assessing the binding of candidate transcription factors to CNE1 in-
vitro and investigating the effects of our sequence manipulations upon these 
interactions. This was achieved in a series of EMSAs, a technique commonly used to 
investigate the binding of transcription factors to a defined fragment of DNA. Our 
initial experiments were designed to assess the ability of in-vitro synthesised proteins to 
bind 33 bp radioactively labelled double stranded DNA probes, centred upon the desired 
regions of CNE1 within the zebrafish genome. The oligonucleotides and protocols used 
to create each EMSA probe are described in Chapter 2.3 and Table 2.6. 
 Our in-silico analysis of CNE1-Motif1 indicated that it contained, or was 
proximal to, putative binding sites for HoxA5, HoxA7, Pbx1 and Tead1. We chose to 
select these candidates for EMSA analysis as previous studies have implicated members 
of these transcription factor families in the regulation of Pax3 expression (Milewski et 
al., 2004; Pruitt et al., 2004). We synthesised Tead2 protein rather than Tead1 in order 
to maintain consistency with this data (Milewski et al., 2004). Both Pax3 and Pax7 
proteins were selected for analysis in these experiments to test our hypothesis that 
Motif1 represented a binding site for the PD encoded by these transcription factors. 
Six2 protein was synthesised and used as a negative control in this experiment, as it was 
not predicted to bind the sequence contained within the Motif1 EMSA probe. The 
protocols used to synthesise proteins and perform this assay are outlined in Chapter 2.3. 
The results of this experiment suggested that neither Tead2, Pbx1, HoxA5 nor HoxA7 
proteins were able to bind the Motif1 DNA probe, as the distribution of complexes 
observed in the autoradiograph was identical to those present in the negative control 
reaction (Fig. 7.11). In contrast, both Pax3 and Pax7 bound the radiolabelled probe to 
form DNA-protein complexes that were both larger and more abundant than those 
present in the control experiment. Furthermore, the Motif1-Pax7 interaction appeared to 
produce two distinct complexes, which is commonly observed if transcription factors 
are able to dimerise upon DNA (Fig. 7.11). 
These data verified our annotation of Motif1 as a putative PD site that was 
sufficient to facilitate the binding of both Pax3 and Pax7. We investigated this point 
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further by performing an implementation of the EMSA that is based upon the 
interaction of total protein, also known as nuclear extract, with DNA. The protocol used 
to perform nuclear extractions of chick tissue is outlined in Chapter 2.3. DNA-protein 
interactions were identified in this assay by the ability of specific antibodies to interact 
with candidate transcription factors within the nuclear extract, resulting in the formation 
of a larger or ‘supershifted’ complex following gel electrophoresis. The positive control 
reaction for this experiment, in which Motif1 DNA was bound by nuclear extract in the 
absence of antibodies, resulted in the formation of a complex as expected (Fig. 7.12). 
Addition of a mixture containing monoclonal antibodies raised against Pax3 and Pax7 
resulted in a shift of the distribution of labelled probe to a larger complex, indicating 
that these proteins were present within the nuclear extract and bound to DNA (Arrow in 
Fig. 7.12). A supershift was also produced by the addition of DP312 antibody to the 
reaction, which we have previously demonstrated to specifically recognise the paired 
type homeodomains of Pax3 and Pax7 in-vivo (Arrow in Fig. 7.12). Addition of a 
monoclonal Pax6 antibody did not result in a shift of the DNA-protein complex, 
suggesting that the PD binding site in Motif1 was specifically occupied by both Pax3 
and Pax7. This result was consistent with our analysis of DP312 antigen recognition in-
vivo and our in-silico analysis of the PD site represented by Motif1. The final lane in the 
autoradiograph documents the results of a negative control reaction containing labelled 
probe in the absence of protein, which was used to determine the presence of non-
specific experimental artefacts. 
 Functional dissection of Motif1 in-vivo revealed that the integrity of the E-box 
binding site was required for the correct activity of CNE1. We hypothesised that 
mutation of this region may weaken the interaction between Pax3 and Pax7 proteins and 
DNA, providing a molecular basis to our observations. We tested this prediction by 
performing a series of EMSAs in which the wild type Motif1 probe was placed in 
competition for Pax7 binding with non-labelled DNA probes. The control series of 
reactions in this experiment clearly demonstrated that non-labelled Motif1 probe 
effectively bound Pax7 protein (Fig. 7.13). This was visualised as the progressive loss 
of signal from the complex once the amount of non-labelled DNA exceeded 
5ng/reaction, which marked the point of equilibrium between the two probes (asterisks 
in Fig. 7.13). We employed this experimental paradigm to assess the ability of E-
boxMut3 DNA to compete for Pax7 binding against the wild type Motif1 probe. The 
double stranded DNA probe used in these experiments was created by annealing the 
oligonucleotides previously employed in mutagenic PCR. Titration of Ebox-Mut3 DNA 
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to a four fold excess in the reaction did not significantly reduce the binding of Pax7 to 
wild type Motif1, as demonstrated by the persistence of complex formation in the 
presence of 20ng of competitor probe (Fig. 7.13). These data indicated that the 2 bp 
substitution induced by the E-boxMut3 manipulation affected the integrity of the PD 
site in a manner that reduced its affinity for Pax7 binding. 
 The PD binding site within CNE1 appeared to be required for the activation of 
transcription within spinal cord progenitors in-vivo, suggesting that the binding of Pax3 
and Pax7 to Motif1 represented a positive regulatory input upon the enhancer. We 
aimed to test this hypothesis by expressing Pax3 and Pax7 throughout chick spinal cord 
and assessing the ability of these proteins to ectopically induce CNE1 mediated 
transcription. We chose to use the RCAS retroviral vector to induce the expression of 
our desired proteins, as we had previously observed that high levels of ectopic Pax3/7 
greatly affects neural tube patterning and morphology (data not shown). An oncogenic 
fusion of Pax3 and FOXO1A, which has been shown to function as an obligate 
transcriptional activator, was cloned into the Cla1 site of the RCAS vector (Relaix et al., 
2003). Electroporation of this construct was sufficient to induce expression of Pax3 
within the ventral spinal cord at 24hpe (n=9) (Fig. 7.14A). CNE1 was cell 
autonomously activated in Pax3 expressing cells within the ventral spinal cord of Pax3-
FOXO RCAS co-electroporated embryos (Figs. 7.14B and C). A similar experiment, in 
which the RCAS vector was used to express the full length Pax7 cDNA, also resulted in 
the cell autonomous ectopic induction of Citrine transcription within the spinal cord 
(n=7) (Figs. 7.14D,E and F). These data confirmed our hypothesis that Pax3 and Pax7 
bound the PD within CNE1 to induce transcription. 
 A series of experiments were performed to assess the interaction of candidate 
transcription factors with Motif3, with the aim of investigating the molecular basis of 
the reduction in transcription observed throughout the CNS when this region was 
deleted from CNE1. A 33 bp probe representing Motif3 was used in assays with in-vitro 
synthesised transcription factors as previously described. The proteins chosen for 
analysis were the Wnt pathway effectors Tcf3, Tcf7 and Lef1 and the early neuronal 
marker Sox2. We reasoned that the spatiotemporal expression profiles of these key 
developmental transcription factors coupled with the incidence of their binding sites 
within the 5’ region of Motif3 made them suitable candidates. No interactions were 
observed between these proteins and Motif3 despite several attempts (data not shown). 
A series of experiments in which the binding of nuclear extract to Motif3 sequence was 
assessed did not provide satisfactory results, as the control reaction did not reproducibly 
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create a DNA-protein complex (data not shown). Taken together, these studies were not 
sufficient to advance our in-vivo evidence of Motif3 function.   
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Fig. 7.11 – CNE1-Motif1 is bound by in-vitro synthesised Pax3 and Pax7 
In-vitro synthesised Six2 protein does not bind the Motif1 DNA probe, as evident in the control 
lane. Addition of either Pax3 or Pax7 protein results in the formation of complexes that are both 
larger and more abundant than those observed in the control reaction. DNA-protein interactions 
are not observed in reactions including Tead2, Pbx1, HoxA5 or HoxA7 protein.  
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Fig. 7.12 – CNE1-Motif1 demonstrates specificity for Pax3/7 binding 
A large DNA-protein complex is produced in the supershift control reaction, containing Motif1 
DNA probe and nuclear extract prepared from chick spinal cord tissue. Addition of either Pax3 
and Pax7 antibodies or DP312 produces a slower migrating complex, marked by the arrow 
within the autoradiogram. The inclusion of a Pax6 antibody does not produce a supershift when 
compared to the positive control lane, suggesting that this protein does not bind to the PD site 
represented by Motif1. The negative control reaction contains DNA probe in the absence of 
protein and demonstrates the non-specific bands within the autoradiogram. 
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Fig. 7.13 – Mutation of the 3’ region of Motif1 reduces its affinity for Pax7 binding 
Titration of non-labelled Motif1 double stranded DNA probe to a 4-fold excess outcompetes the 
radiolabelled EMSA probe for Pax7 binding. This is visualised in the autoradiogram as a loss of 
complex formation following the point of equilibrium at 5 ng/reaction. In contrast, excess non-
labelled Motif1EboxMut3 DNA cannot compete with the wild type sequence. These data indicate 
that this 2 bp substitution within the 3’ region of Motif1 reduces the affinity of the PD site for 
Pax7 binding. 
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Fig. 7.14 – CNE1 mediates direct autoregulation and positive feedback 
In-ovo electroporation of Pax3-FoxO RCAS is sufficient to induce both Pax3 protein expression 
and Citrine labelling in the ventral neural tube (A, B and C). Similarly, electroporation of Pax7 
RCAS ectopically induces Pax7 protein and CNE1 activity (D, E and F). 
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7.4 – CNE1 is conserved between the zebrafish Pax3 paralogs 
 
Functional dissection of CNE1 indicated that it contained a PD binding site that 
interacts with both Pax3 and Pax7 and that the integrity of this site was required for the 
correct activity of this regulatory element in spinal cord progenitors. We also 
demonstrated that CNE1 contained a putative HMG box binding site in Motif3 that 
appeared to be broadly required for its activity throughout the CNS. We aimed to extend 
our analysis of this enhancer to the zebrafish pax3b locus, in order to determine the 
conservation of these regulatory mechanisms following the whole genome duplication 
that occurred in the teleost lineage. Our previous studies were not able to identify any 
CNEs within the pax3b locus, as it was determined to be unsuitable for inclusion in 
comparative genomic alignments. Instead, we limited our search of the pax3b locus to 
intron 4, which was queried against all CNEs present in the Condor database by 
BLAST. This search identified a 38 bp region in the human genome that lies within 
CRCNE00001997, which we previously determined to be homologous to CNE1 (Greg 
Elgar, personal communication). This analysis also revealed that CNE1 was the only 
conserved region present within intron 4 of both paralogous zebrafish Pax3 loci, 
strengthening our hypothesis that this region performed a critical function in the 
transcriptional regulation of Pax3 expression. 
Our initial analysis was sufficient to determine that the region of CNE1 
homology identified by Condor BLAST was centred around the PD binding site of 
Motif1, which is 95% conserved between pax3a and pax3b. We expanded this 
alignment by adding 100 bp of 5’ and 3’ sequence from the pax3b locus to the BLAST 
hit and investigated the conservation of the remaining 3 motifs present in CNE1 using 
ClustalW2 (Fig. 7.15). These data indicated that the core of Motif2 was highly 
conserved, however pax3b exhibited a small 5’ deletion and a larger 3’ insertion within 
this region relative to pax3a. We were surprised to discover that Motif3 was not highly 
conserved in pax3b-CNE1 (40%), given the previously described requirement for this 
region in the canonical enhancer. Motif4 was determined to be 66.6% homologous, 
resulting from a 5’ insertion and a 3’ deletion in the pax3b locus. Taken together, these 
data indicated that CNE1 was poorly conserved in the pax3b locus, especially when 
compared to our previous analysis of this regulatory region in higher vertebrate 
genomes. 
 We reasoned that pax3b-CNE1 may retain some regulatory function in-vivo and 
that the differences in the architecture of this enhancer in the paralogous Pax3 loci 
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might account for the expression pattern of each transcript. A minimal 133 bp region of 
pax3b homology was defined using the location of each conserved motif, amplified 
from zebrafish genomic DNA using the primers listed in Table 2.1 and cloned into the 
PCR2.1 TOPO vector. Successful cloning was determined by sequencing before the 
insert was subcloned into the MiniTol2-Citrine vector by adding the desired restriction 
sites using the TOPO> MiniTol2 primer set listed in Table 2.1. Transgenic embryos 
injected with the defined minimal pax3b-CNE1 homology region and assessed at 24 hpf 
clearly demonstrated that this region maintained its regulatory potential (Fig. 7.16A). 
GFP staining was observed in progenitor cells within the dorsal spinal cord in all of 
these embryos (n=18). We frequently observed that transgene labelling was 
significantly reduced or absent in regions anterior to rhombomere 5, whereas pax3a-
CNE1 was shown to be active throughout the mid and hindbrain. The specificity of 
CNE1 for CNS tissues was not maintained in the pax3b enhancer, with 66% (n=12/18) 
of embryos exhibiting strong transgene expression in muscle fibres. Transverse sections 
of trunk tissue at 24 hpf revealed that GFP staining was restricted to the Pax3/7 domain 
of the dorsal spinal cord (n=16) (Fig. 7.16B). 
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Fig. 7.15 – CNE1 is poorly conserved between the paralogous Pax3 loci 
ClustalW2 alignment of sequence representing CNE1 within the pax3a and pax3b loci. Motif1 
(positions 100-114) is 95% conserved. The core of Motif2 (positions 155-175) is homologous 
between the paralogs, however pax3b exhibits a small 5’ deletion and a large 3’ insertion in 
comparison to pax3a. Motif3 (positions 48-63) is poorly conserved, whereas Motif4 (positions 
138-154) is partitioned into two blocks of homology. 
 
 
 
 
Fig. 7.16 – Pax3b CNE1 retains the primary function of the canonical enhancer 
Despite poor overall sequence homology, pax3b CNE1 activity labels cells in the dorsal spinal 
cord (A) However, transgene expression does not appear to extend anteriorly beyond the 
hindbrain (arrowhead in A) and is frequently observed in muscle fibres (mf) (A). Cross sections 
at the level of the spinal cord reveals that GFP staining is restricted to the Pax3/7 expression 
domain of dorsal progenitors (dP). 
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Chapter 8: CNE3 defines the Pax3 expression domain in the neural plate 
 
 During the course of this investigation, we were surprised to discover that none 
of the mutations introduced within CNE1 resulted in an expansion of transgene 
expression within the ventral spinal cord. These data indicated that the activity of this 
enhancer was unlikely to be modulated by the binding of transcriptional repressors. 
However, our lineage experiments performed in mice suggested that Pax3 expression 
was downregulated in the intermediate regions of the spinal cord during the early stages 
of CNS patterning. In addition, we were unable to identify any molecular interactions 
that might implicate CNE1 in the induction of Pax3 transcription within the neural 
plate. Taken together, these data suggested that additional regulatory modules 
associated with the locus might act in concert with CNE1 to define and maintain the 
expression profile of Pax3 within the CNS. 
 
8.1 – CNE3 possess a weak regulatory potential at 24 hpf 
 
 CNE3 is a 453 bp element located within the fourth intron of Pax3 that contains 
conserved homeobox and Tcf/Lef binding sites (Fig. 5.4). This region was identified as 
an interesting candidate regulatory region from our in-silico analysis, as many reports 
have demonstrated that the Wnt signaling pathway can both induce and modify Pax3 
expression, discussed in Chapter 1.4.3. Nevertheless, our initial analysis of CNE3 
activity in-vivo indicated that although CNE3 was active in the midbrain or hindbrain of 
87% transgenic zebrafish assessed at 24 hpf, (n=20/23) (Fig. 8.1A), only very mosaic 
GFP staining was observed in the trunk. 78% of embryos exhibited Citrine labelling 
within the spinal cord, however upon closer inspection only 17% of these demonstrated 
GFP labelling within neural progenitors (n=3/18). Transverse sections of CNE3 
transgenics confirmed that this region possessed a weak regulatory potential at 24 hpf, 
however it was possible to identify GFP staining within Pax3/7 expressing progenitors 
(Fig. 8.1B) (n=1/15).  
 Following our initial screen of CNEs associated with the Pax3 locus, the 
findings of a similar comparative genomics based study of Pax3 regulation was 
published (Degenhardt et al., 2010). The authors assessed the activity of a 967 bp 
conserved region, they termed Pax3-ECR2, and showed that this element was able to 
recapitulate the profile of Pax3 expression throughout the CNS of mice at E10.5 and in 
zebrafish at 24 hpf (Degenhardt et al., 2010). We subsequently determined that CNE3 is 
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entirely included within the genomic interval represented by Pax3-ECR2 (Fig. 8.2). 
These data prompted us to reassess the activity of CNE3, however the results of these 
experiments were consistent with our previous observations. Accordingly, Citrine 
expression was observed within the anterior CNS but we were unable to reproducibly 
demonstrate that CNE3 was active within spinal cord progenitors at either 24 hpf 
(n=51) or 32 hpf (n=13). 
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Fig. 8.1 – CNE3 is a weak enhancer at 24 hpf  
CNE3 transient transgenic zebrafish assessed at 24 hpf reveal consistent GFP staining in the 
midbrain (mb), however dorsal progenitor cells (dP) within the neural tube are rarely labelled 
(A). Transverse sections of trunk tissue demonstrate that CNE3 mediated transcription is 
restricted to the Pax3/7 domain of dorsal progenitors (dP), when detected (B). 
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Fig. 8.2 – CNE3 is contained within Pax3-ECR2 
ClustalW2 alignment of sequences representing Pax3-ECR2 and CNE3 in the mouse genome. 
These data demonstrate that CNE3 is homologous to the central portion of Pax3-ECR2. 
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8.2 – CNE3 is transiently active in the neural plate 
 
The activity of Pax3-ECR2 was shown to be dependent upon the integrity of 5 
Tcf/Lef sites, which when mutated in the context of a 403 bp minigene resulted in the 
loss of transgene expression in zebrafish embryos at 24 hpf (Degenhardt et al., 2010). 
These data suggested that ECR2 might facilitate the direct interaction of the Wnt 
signaling pathway with the Pax3 locus, providing a molecular mechanism of 
transcriptional induction within the CNS. Consistent with this hypothesis, ECR2 was 
shown to be active in the neural plate of stable transgenic mice at E8.5 (Degenhardt et 
al., 2010). We sought to investigate this further by using published data to validate the 
interaction of the Wnt pathway effectors with CNE3 in-vivo. Genome-wide binding of 
Tcf3 in mouse ESC revealed the direct interaction of this transcription factor with Pax3-
ECR2 and furthermore, that the peak of sequenced reads overlapped with the location of 
CNE3 (Fig. 8.3) (Marson et al., 2008). 
Taken together, these results were consistent with the conclusion that Pax3-
ECR2 mediated the transcriptional output of the Wnt signaling pathway upon the Pax3 
locus (Degenhardt et al., 2010). Furthermore, our observation that CNE3 was located 
beneath the peak of Tcf3 binding in ESC suggested that this region contained the key 
TFBS that mediated this interaction. We hypothesised that CNE3 may be temporally 
regulated during CNS development and that its dynamics may reflect the profile of Wnt 
signaling. To test this, we compared the activity of CNE3 with transgenic reporters of 
intracellular Wnt signaling during the first 24 hours of zebrafish development. 
Activated Wnt signaling was visualised using the TCFsiam transgenic line, which 
expresses eGFP under the control of a concatemer of Tcf binding sites derived from the 
promoter of the Xenopus siamois gene (Moro et al., 2012). We compared our data to 
published results documenting the activity of a second Wnt pathway reporter, 
TOPdGFP, which expresses destabilised GFP under the control of a 358 bp regulatory 
region containing 4 consensus Lef binding sites (Dorsky et al., 2002). 
 CNE3 transient transgenic embryos assessed at bud stage exhibited strong GFP 
staining within the posterior neural plate (n=10) (Fig. 8.4A). Analysis of the TCFsiam 
reporter demonstrated that the Wnt signaling pathway was activated in those cells 
marked by CNE3 mediated transcription (n=18) (Fig. 8.4E). These data were supported 
by observations of the TOPdGFP reporter, which exhibited GFP transcription 
throughout the posterior neural plate (Fig. 8.4I) (Dorsky et al., 2002). Transgene 
labelling by CNE3 was restricted within the posterior neural plate at the 6 somites stage 
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(n=7), as was GFP staining within TCFsiam embryos (n=12) (Figs. 8.4B and F). 
TopdGFP zebrafish assessed at this stage have been reported to exhibit a similar profile 
of Wnt pathway activation, however the authors also observed a domain GFP 
transcription within the midbrain hindbrain boundary that was not present in either 
CNE3 or TCFsiam embryos (Fig. 8.4J) (Dorsky et al., 2002). GFP staining was 
markedly increased within the midbrain, hindbrain and spinal cord of CNE3 transgenic 
embryos at the 18 somites stage (n=8) (Fig. 8.4C). TCFsiam embryos suggested that 
Wnt signaling active within the midbrain at this stage, however comparatively stronger 
GFP staining was observed within the posterior somites of the embryo (n=8) (Fig. 
8.4G). The Wnt pathway has been demonstrated to be activated within the midbrain, 
hindbrain and anterior spinal cord of TOPdGFP zebrafish at the 18 somite stage, 
consistent with our observations of CNE3 labelling within these tissues (Fig. 8.4K) 
(Dorsky et al., 2002). By 24 hpf, GFP staining in CNE3 transient transgenic embryos 
was downregulated in the posterior CNS but maintained in the mid and hindbrain, as 
previously described (Fig. 8.4D). In contrast, TCFsiam embryos demonstrated that the 
Wnt pathway was active within the forebrain, the lateral line primordium and the 
posterior somites at this stage (n=9) (Fig. 8.4H). 
Our analysis of the temporal dynamics of CNE3 mediated transcription revealed 
that transgene expression correlated with the activation of the Wnt signaling pathway in 
the neural plate. However during these experiments, we noted that the domain of cells 
that received Wnt signaling was not restricted along the medio-lateral axis of the early 
CNS and in the case of TOPdGFP embryos, was not limited to the neural plate (Dorsky 
et al., 2002). These results contrasted with the observed profiles of CNE3 activity and 
pax3a expression within the CNS, suggesting that the Wnt pathway alone does not 
provide sufficient positional information to establish the Pax3 expression domain. 
Given these data, we hypothesised that CNE3 also facilitated the interaction of 
repressors with the Pax3 locus and that a combination of positive and negative 
transcriptional inputs defined the domain of gene expression in the early embryo. 
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Fig. 8.3 – Tcf3 directly binds CNE3/ECR2 in mouse ESC 
UCSC genome browser plot demonstrating the binding profile of Tcf3 in mouse ESC relative to 
both Pax3-ECR2 and CNE3. These data reveal that a peak of Tcf3 binding correlates with the 
position of CNE3 in the Pax3 locus, supporting the involvement of this enhancer in the Wnt 
mediated induction of Pax3 transcription. 
ChIP-seq data published within Marson et al., 2008. 
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Fig. 8.4 – CNE3 labelling correlates with the temporal profile of Wnt signaling 
GFP staining is restricted to the posterior neural plate (pnp) of embryos assessed at bud stage 
(A). Wnt pathway activation assessed in TCFsiam embryos is active within the posterior region 
of the neural plate whereas the TOPdGFP transgene is active throughout the posterior half of 
the embryo (E and I). CNE3 remains active in the posterior neural plate at the 6 somites stage 
(B), consistent with Wnt activity assessed in TCFsiam embryos (F). TOPdGFP zebrafish report 
active Wnt signaling throughout the posterior region of the embryo and within the midbrain at 
the 6 somites stage (J). CNE3 mediated transcription is increased in the midbrain (mb), 
hindbrain (hb) and dorsal progenitors (dP) within the anterior neural tube at 18 somites (C). 
TCFsiam embryos assessed at 18 somites report Wnt signaling in the tail bud (tb) posteriorly 
and weak transgene activation in the midbrain (G); however TOPdGFP transgenics exhibit 
robust pathway activation in the midbrain and hindbrain in addition to the tail bud. By 24 hpf, 
CNE3 activity is limited to the midbrain and single cells with the neural tube (D). By contrast, 
transgene expression in TCFsiam embryos is observed in the forebrain (fb), lateral line 
primordium (llp) and the posterior somites (s) (H). Taken together, these data demonstrate that 
CNE3 activity correlates with the temporal profile of Wnt pathway activation during CNS 
development. 
Figures I, J and K were modified from Dorsky et al., 2002. 
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8.3 – Identifying putative repressor binding sites in CNE3 
 
 To advance this study, we employed comparative genomics to map the putative 
interactions of transcriptional repressors within CNE3. The 453 bp sequence of 
zebrafish CNE3 was used to identify the homologous regions in selected mammalian, 
amphibian, avian, reptilian and fish genomes by cross species BLAST searches, as 
previously described in Chapter 7.1. These experiments revealed that many vertebrate 
genomes contained a region of approximately 55 bp within CNE3 that did not share 
homology to the zebrafish enhancer, indicating that CNE3 was partitioned into two 
blocks of homology. The first region being approximately 57 bp and the second 
approximately 260 bp, we chose to select the larger homology block for further analysis 
and extracted this sequence from the desired genomes. This dataset was processed with 
the MEME suite of sequence analysis tools using the parameters described in Chapter 
2.2.4. The results of this analysis revealed the presence of 5 highly conserved 15 bp 
motifs located within the 3’ region of CNE3 (Table 8.1). 
TomTom analysis of the PSPM representing Motif1 suggested this region 
contained a putative Sox binding site, whereas Motif2 matched the binding matrices of 
the transcriptional effectors of the retinoic acid signaling pathway (Table 8.1). We 
chose not to select these motifs for further analysis because they did not include 
putative repressor binding sites. Motif3 contained a consensus homeobox binding site 
that matched the binding matrices of several Nkx class transcription factors (Table 8.1). 
Members of this gene family are key fate determinants within the ventral spinal cord 
and have been shown to function as transcriptional repressors via recruitment of 
Groucho (Muhr et al., 2001). Our in-silico analysis of Motif4 indicated that it contained 
conserved binding sites for both Tcf3 and Tcf7, consistent with the interaction of this 
enhancer with the Wnt signaling pathway (Table 8.1). Motif5 also contained a Tcf3 and 
Tcf7 binding site in its 5’ region, in addition to a 3’ consensus homeobox binding site 
(Table 8.1). Taken together, these data suggested that Motif4 and Motif5 contained 
binding sites that facilitated the interaction of the Wnt signaling pathway with CNE3, 
whereas Motif3 and Motif5 contained binding sites for putative repressors of Pax3 
transcription. 
 We chose to assess the requirement of Motif3 and Motif5 for the correct activity 
of CNE3 in-vivo. We reasoned that putative repressors would interact with CNE3 
during the early stages of neural plate patterning to define the Pax3 expression domain, 
however we were aware that the zebrafish transient transgenic assay limited our ability 
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to interpret data collected at these stages. With these considerations in mind, we chose 
to assess the effect of motif deletions within CNE3 at both the 6 somites stage and at 24 
hpf. 
 We did not observe any effect of Motif3 deletion at the 6 somites stage and 
Citrine expression was restricted to the posterior neural plate in all embryos assessed 
(n=17) (Fig. 8.5D). By contrast, 58% of Motif3 deletion transgenics exhibited Citrine 
labelling within spinal cord progenitors at 24 hpf, representing an increase in the 
activity of the enhancer relative to the wild type sequence (n=11/19). Furthermore, 82% 
of embryos expressing Citrine protein within neural progenitors demonstrated GFP 
staining in the ventral half of the spinal cord (n=9/11) (Fig. 8.5E and E’). We did not 
observe any defects in the distribution of Citrine protein in the neural plate of Motif5 
deleted transgenic embryos assessed at the 6 somites stage (n=43) (Fig. 8.5F). However, 
GFP staining was observed in the spinal cord progenitors of 88% of embryos assessed 
at 24 hpf (n=28/32), of which 71% exhibited Citrine localisation in the ventral half of 
the tissue (n=20/28) (Fig. 8.5G and G’). These data are plotted and statistically analysed 
in Fig. 8.6. 
 Taken together, these data were consistent with a model in which the Wnt 
mediated activation of CNE3 is repressed in the medial neural plate or ventral neural 
tube to establish the domain of Pax3 expression. This was visualised in our results as a 
de-repression of Citrine protein expression in neural progenitors within the ventral 
spinal cord when either Motif3 or Motif5 were deleted from CNE3. 
We next sought to determine the TFBS within these motifs that were required 
for the repression of CNE3 activity from the ventral neural tube. Our previous in-silico 
analysis of the phylogentically conserved binding sites within Motif3 indicated the 
presence of a canonical homeobox binding site and an overlapping Fox binding site 
(Table 8.1). We chose to induce mutations in both these sequences in the context of the 
wild type 453 bp enhancer by PCR using the primers listed in Table 2.4. Our analysis 
also identified a conserved homeobox binding site in Motif5, which was also mutated 
using the primer set listed in Table 2.4. We chose to assess the effects of these site 
mutations in-vivo at 24 hpf, as we were unable to define any significant changes in 
CNE3 activity at neural plate stages using the transient transgenic assay. 
 CNE3Motif3HoxMut transgenic embryos exhibited a comparable de-repression of 
transgene activity to those in which the entire Motif was deleted. Accordingly, Citrine 
protein was observed in spinal cord progenitors of 49% of transgenic embryos 
(n=29/59). Of these, 83% exhibited GFP staining in ventrally located neuronal 
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progenitors (n=24/29 (Fig. 8.7C and C’). These data were supported by experiments in 
which the predicted Fox binding site within Motif3, which overlaps the Hox site, was 
mutated. 66% (n=29/44) of CNE3Motif3FoxMut transgenics were observed to express 
Citrine protein within spinal progenitors and of these, 72% exhibited GFP staining 
within the ventral region of the tissue (n=21/29) (Fig. 8.7D and D’). 100% of 
CNE3Motif5HoxMut embryos expressed the transgene within spinal cord progenitors 
(n=21/21), 76% of which exhibited a ventral expansion of GFP staining (n=16/21) (Fig. 
8.7E and E’). Together, these data provide in-vivo evidence to suggest that the 
requirement of Motif3 and Motif5 for the repression of CNE3 activity was dependent 
upon the integrity of phylogenetically conserved Hox and Fox binding sites. 
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Name Logo (12 vertebrate genomes) 
Location 
within CNE3 
(zebrafish) 
Matching Matrices (JASPAR 
and UniPROBE) 
Motif1 
 
Bases 382-396 Gcm1, MATA1, Sox17, SOX10, Hbp1, Arid5a, h. 
Motif2 
 
Bases 206-220 
NR4A2, Esrrb, RXR::RAR, 
RORA, Klf4, tll, Nr2f2, INO2, 
Zfp187, INO4, opa, TEC1 
Motif3 
 
Bases 343-357 
Hmx, CG34031, CG11085, 
Hmx3, unc-4, B-H2, YHP1, 
Hmx2, NK7.1, B-H1, CG13424, 
CG15696, tup, hbn, slou, Hmx1, 
SPT2, Cart1, Uncx4.1, CG32532, 
Phox2b, Nkx2-5, bsh, Alx4, Lhx9, 
Ubx, En1, Nkx6-3, C15, 
ARID3A, Hoxc5, Otp, Prrx2, 
Hbp1, Dbx2, Hoxb4, repo, Dr, 
unpg, Nkx6-1, Hoxc4, Arx, Prop1, 
CG32105, Vsx1, Hoxa7, inv, 
Shox2, Rx, HGTX, Pou3f2, 
PHDP, Lim1, CG7056, Lhx5, 
Lbx2, OdsH, Pou3f4, Dfd, abd-A, 
Vsx2, TEC1, Esx1, Rhox6, al, 
Msx1, ftz, CG11294., CG4328, 
Lhx1, Pou3f1, Pou1f1, Hoxb7, 
Dll, Phox2a, Sox1, CG9876, cad, 
Scr, bap, Lhx3, Lmx1a, Elf3, 
Antp, HOXA5, YOX1, Foxa2, 
Lim3, Hoxa4, Pou4f3, Awh, btn, 
Nobox, Hoxc6, lab. 
Motif4 
 
Bases 326-340 Vnd, Bbx, Tcf3, YY1, Tcf7, pan, Gata1, TGA1A, 
Motif5 
 
Bases 359-373 
CG7056, Lmx1a, Lmx1b, Arid3a, 
Hbp1, Prrx2, Lhx5, RME1, 
YOX1, Phox2b, Lhx1, Uncx4.1, 
Sox1, Hoxa7, Prop1, Otp, Hoxb4, 
Alx4, Lhx9, Hoxa4, Tcf3, Tcf7, 
Lhx3, Ubx, Hoxb8, Lim1, al, 
Cart1, unc-4, Glis2, Hoxc4, Nkx6-
1, CG11294, Nkx6-3, Vsx1, Hmx, 
hbn, repo, Isl2, Hoxc6, Ptx1, Lef1, 
Pax7, CG32105, abd-A, Msx1, 
CG15696, Zfp187, CG34031, pan, 
Tlx2. 
 
Table 8.1 – Annotation of conserved TFBS within CNE3 
MEME analysis of 12 vertebrate CNE3 homologs reveals 5 statistically over-represented 
motifs. TomTom analysis of each motif PSPM demonstrates that Motif4 and Motif5 contain 
binding sites for Tcf/Lef transcription factors, whereas Motif3 and Motif5 include consensus 
sites for putative transcriptional repressors. 
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Fig. 8.5 – CNE3 activity is subject to transcriptional repression 
Schematic highlighting the relationship between motifs identified within CNE3 (A). Motif3 
deletion does not appear to affect the distribution of Citrine protein at the 6 somites stage (D), 
compared to wildtype sequence (B). By contrast, embryos assessed at 24 hpf exhibit an increase 
of CNE3 activity within the neural tube and labelled cells distributed across the DV axis of the 
tissue (E and E’) which are not present in wildtype transgenics (C and C’). GFP staining also 
appears to be restricted to the posterior neural plate of Motif5 deletion transgenic embryos 
assessed at the 6 somites stage (F). However, robust Citrine protein expression is observed 
throughout the DV axis of the neural tube at 24 hpf (G and G’). 
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Fig. 8.6 – Quantification of the effects of motif deletions upon CNE3 activity 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted. These data 
reveal that deletion of Motif3 results in a significant increase of CNE3 activity in the spinal 
cord. Similarly, loss of Motif5 increases the activity of CNE3 in spinal cord progenitors. These 
results are consistent with the hypothesis that Motif3 and Motif5 facilitate the interaction of 
putative transcriptional repressor with CNE3. 
Two-tail Fisher’s exact test (** = P<0.001 and * = P<0.005) 
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Fig. 8.7 – Conserved TFBS are required for CNE3 repression in-vivo 
Schematic detailing the mutations iduced within conserved binding sites associated with Motif3 
and Motif5 (A). Mutations induced within the overlapping Hox binding site within Motif3 
results in a de-repression of CNE3 activity in the neural tube, compared to the wildtype 
sequence (B, B’, C and C’). Similarly, mutation of the homeodomain binding site in Motif5 
results in GFP staining within neural progenitors distributed across the DV axis of the tissue (E 
and E’). 
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Fig. 8.8 – Quantification of the effects of site mutations upon CNE3 activity 
 
The percentages of transgenic zebrafish embryos exhibiting GFP staining in spinal cord 
progenitor cells (within the span of the yolk extension) assessed at 24 hpf is plotted. These data 
indicate that mutation of the HD or Fox binding site within Motif3 results in a significant 
increase of CNE3 activity in spinal cord progenitors. In addition, mutation of the HD binding 
site within Motif5 results in a highly significant enhancement of CNE3 activity in the posterior 
neural tube. These data highlight the requirement of defined conserved TFBS for CNE3 
repression in-vivo. 
Two-tail Fisher’s exact test (** = P<0.001 and * = P<0.005) 
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8.4 – CNE3 interacts with Nkx6.1 and Foxa2 
 
 Our in-vivo analysis of CNE3 regulation provided evidence to suggest that the 
activity of this regulatory region is subject to direct transcriptional repression, mediated 
via Motif3 and Motif5. We sought to investigate this further by determining the binding 
of candidate Pax3 repressors to CNE3 in-vitro. To this end, we designed a 48 bp EMSA 
probe that spanned the zebrafish genomic sequence containing Motifs 3, 4 and 5. The 
oligonucleotides and protocols used to create this DNA probe are described in Chapter 
2.3 and Table 2.6. Binding of putative repressors was assessed in supershift EMSAs 
using total protein, obtained from chick nuclear extracts and antibodies raised against 
ventrally expressed transcription factors. All of the antibodies raised against putative 
repressors had been previously been demonstrated to recognise the antigen in chick 
tissue. We chose to include a β-catenin antibody in this screen to assess the interactions 
of these motifs with the Wnt signaling pathway, however previous experiments 
suggested that this antibody did not recognise the nuclear localised form of the protein 
in chick tissue (Ani Kicheva, personal communication). 
 The positive control reaction for this experiment, in which the CNE3Motif3-5 
DNA probe was bound by total protein in the absence of antibodies, resulted in the 
formation of a reference complex (Fig. 8.9). Addition of β-catenin antibody to the 
reaction did not alter the migration of this complex, suggesting that either this protein 
did not interact with our probe or that the antibody employed was not suitable for its 
detection. Inclusion of an antibody against Nkx6.1 resulted in the supershift of the 
control complex and the stabilisation of a lower molecular weight complex. These data 
indicate that Nkx6.1 interacts with CNE3 Motif3-5 in this assay (Arrows in Fig. 8.9). 
No change in the migration of complexes was observed with antibodies against Nkx6.2, 
Pax6, Dbx1 or Dbx2 (Fig. 8.9). The addition of a Foxa2 antibody to the reaction 
resulted in the loss of all complexes from the autoradiogram, suggesting that complex 
formation was dependent on Foxa2 binding (Fig. 8.9). The negative control for this 
experiment, in which CNE3Motif3-5 probe was added to the reaction in the absence of 
protein, was used to determine the presence of non-specific labelling within the 
autoradiogram (Fig. 8.9). 
 The data indicated that both Nkx6.1 and Foxa2 proteins were able to bind the 
CNE3Motif3-5 probe in-vitro, in agreement with our previous in-silico annotation of 
putative binding sites for these factors within Motif3 and Motif5 (Table 8.1). We next 
aimed to assess the effect of the site mutations induced within these motifs upon the 
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binding of this putative repressor complex in-vitro. This was achieved by the creation of 
double stranded DNA probes from the oligonucleotides previously used to design 
mutations within CNE3, listed in Table 2.6. Binding of chick nuclear extract to the 
CNE3Motif3-5 probe resulted in the formation of a large DNA-protein complex in the 
positive control reaction for this experiment (Fig. 8.10). The binding of these proteins to 
CNE3 was impaired in experiments in which the homeobox or Fox binding sites in 
Motif3 were mutated (Fig. 8.10). A similar result was observed in reactions that 
contained a DNA probe in which the homeobox in Motif5 was mutated (Fig. 8.10). 
Together, these data suggest that the binding of a putative repressor complex to Motif3 
and Motif5 within CNE3 is dependent upon the integrity of both the Hox/Fox binding 
site in Motif3 and the Hox binding site in Motif5, providing a molecular basis to our in-
vivo observations. 
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Fig. 8.9 – Nkx6.1 and Foxa2 bind CNE3 in-vitro 
Supershift screen using chick nuclear extract and a DNA probe spanning Motif3-5 of CNE3. 
The positive control complex is not altered by the addition of antibodies raised against β-
catenin, Nkx6.2, Pax6, Dbx1 or Dbx2. Inclusion of Nkx6.1 antibody in the EMSA reaction 
results in the formation of a slower migrating complex and the stabilisation of a lower 
molecular weight band, indicated by arrows within the autoradiogram. Addition of Foxa2 
antibody disrupts the formation of the control complex, suggesting that the ability of the protein 
to bind DNA is impaired in the presence of the antibody. The negative control reaction contains 
DNA in the absence of protein and demonstrates the non-specific bands in the autoradiogram. 
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Fig. 8.10 – Mutations induced in CNE3 preclude the binding of putative repressors 
CNE3Motif3-5 DNA forms a complex with total protein extracted from chick neural tube 
tissue. Mutation of either the homeodomain or Fox binding sites in the 3’ region of Motif3 
results in a loss of this control complex. Similarly, mutation of the homeodomain binding site 
within Motif5 precludes the binding of a putative repressor complex. The negative control 
reaction contains Motif3-5 DNA probe in the absence of nuclear extract. 
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Chapter 9: Discussion 
 
Progenitor identity in the vertebrate neural tube is determined by the spatially 
organised expression profiles of transcription factors across the DV axis of the tissue. A 
series of selective cross-repressive interactions between these factors in the ventral 
neural tube form the basis of a GRN, which acts to define and maintain the boundaries 
between adjacent progenitor domains (Balaskas et al., 2012 ; Briscoe et al., 2000 ; 
Dessaud et al., 2008). By comparison, the regulatory interactions that act to define and 
maintain progenitor identity in the dorsal domains of the neural tube are less well 
understood. This study aimed to advance our understanding of the neural tube GRN by 
determining the regulatory logic that governs Pax3 expression during CNS 
development. Specifically, we sought to define the molecular mechanisms that induce 
Pax3 expression in the lateral regions of the neural plate and subsequently produce a 
sharp ventral boundary of gene expression at the level of the sulcus limitans. 
These questions were addressed by firstly performing a lineage tracing study, 
which assessed the formation of the Pax3 domain in the neural tube and the fate of Pax3 
expressing progenitors in the mature spinal cord. Our findings reveal that the position of 
the Pax3 expression domain is established before E9.5 in mice. Importantly, prior to 
E9.5, Pax3 is expressed in progenitors that later generate V0 interneurons, normally 
considered a ventral neuronal subtype. Our data also indicate that cell migration in the 
ventricular zone of the mouse neural tube is progressively restricted during 
development, consistent with published data obtained in chick embryos. The molecular 
basis of Pax3 expression was investigated in a comparative genomics study, which 
defined several novel tissue specific enhancers. Functional dissection of these 
regulatory regions provides evidence supporting the involvement of the Wnt signaling 
pathway in the induction of Pax3 transcription within the lateral neural plate. 
Furthermore, we discuss evidence establishing the direct input of repressors in this 
process. Finally, we demonstrate that Pax3 is subject to direct autoregulation throughout 
CNS development and positive feedback from Pax7 following neurulation. Together, 
these data support a model in which Pax3 expression in the neural tube is coordinated 
by the temporal activity of two distinct regulatory elements. 
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9.1 – The Pax3 domain is established by a switch in progenitor identity 
 
 Pax3 transcription is first reported at E8.5 of mouse development in the closing 
neural folds and the newly segregated dorsal neural tube (Goulding et al., 1991). 
Following the completion of neurulation, transcription is observed in all progenitors 
within the dorsal alar plate (Goulding et al., 1991). Given these data, we sought to use 
Pax3 as a molecular marker of the alar plate to test the hypothesis that this embryonic 
compartment is restricted to sensory fates in the functional spinal cord. Our findings 
demonstrate that Pax3 expression is not a molecular correlate of the mouse alar plate 
and provides novel insights into the cellular lineage of spinal interneurons and the 
regulatory mechanisms that establish the Pax3 domain during the early stages of CNS 
development. 
Independent analyses of Pax3Cre/+/Rosa26 mice throughout the course of neural 
tube development revealed a domain of transgene expressing cells located adjacent to 
the Pax3 ventral boundary (Figs. 3.2, 3.3 and 3.5). This observation is reproducible, 
both along the AP axis and between individual embryos. The position of these cells 
within the neural tube is consistent with the expression profile of Dbx1, a molecular 
marker of the p0 progentor domain (Pierani et al., 2001). In agreement with this 
conclusion, this domain of Pax3 progeny represents Evx1 expressing progenitors fated 
to give rise to V0 interneurons in embryos assessed at E11.75 (Fig. 3.6) (Moran-Rivard 
et al., 2001). These data indicate that progenitors of this neuronal subtype transiently 
express Pax3 within the neural plate before being respecified to a more ventral identity. 
Despite being derived from Pax3 expressing progenitors, V0 interneurons do not appear 
to require Pax3 for their development, as Evx1 expression is maintained in Pax3-/-
;Pax7-/- mouse embryos (Mansouri and Gruss, 1998). Thus, our findings provide novel 
insights into the lineage of V0 interneurons and indicate that this ventral neuronal 
subtype is derived from cells that have transiently expressed Pax3 early in development. 
Our lineage trace data demonstrate that Pax3 expression is consistently induced 
in the lateral and intermediate regions of the mouse neural plate (Figs. 3.2, 3.3 and 3.5). 
Furthermore, our findings demonstrate that isolated clones of Pax3 progeny are 
frequently observed in the ventral domains of the neural tube (Fig. 3.4). These data 
indicate that Pax3 expression in mice is induced in the intermediate neural plate before 
becoming restricted to the alar plate, in contrast to the results of previous expression 
studies (Goulding et al., 1991). Studies performed in chick embryos support this 
conclusion by revealing that Pax3 transcription is induced throughout the open neural 
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plate and subsequently limited to the neural folds prior to neurulation (Bang et al., 1997 
; Goulding et al., 1993 ; Liem et al., 1995). Furthermore, our expression studies 
performed in zebrafish indicate that pax3a transcription is induced in the intermediate 
regions of the posterior neural plate at bud stage and only becomes restricted to the 
lateral limits of the tissue at the 6 somite stage (Fig. 4.1). Together, these studies 
provide data to support a model in which Pax3 expression in the open neural plate is 
regulated by transcriptional repression. 
Our findings indicate that progenitor identity is dynamically reassigned during 
the early stages of neural plate patterning. These data are in agreement with the results 
of investigations assessing the acquisition of progenitor identity in the ventral domains 
of the neural tube. Genetic tracing of the p0 marker Dbx1 in mice reveals extensive 
transgene labelling of cells both within the endogenous expression domain and in the 
more ventral p1, p2 and pMN (Dessaud et al., 2010). Similarly, all Nkx2.2 expressing 
p3 progenitors transit through a stage in which they express the pMN marker Olig2 
(Chen et al., 2011 ; Dessaud et al., 2007). These data are consistent with a model in 
which basal plate progenitors are progressively ventralised by increasing levels of 
intracellular Shh signaling over time (Briscoe et al., 2000). Taken together, the results 
of these lineage studies demonstrate that progenitor identity is both plastic and dynamic 
at early stages of development across the DV axis of the neuroepithelium. Moreover, 
these data highlight the critical functions that transcriptional networks perform in order 
to ensure the maintenance of cell identity at later stages of development. 
 
9.2 – Progenitor dispersal is restricted during mouse CNS development 
 
Previous studies assessing clonal dispersion in the chick neuroepithelium have 
demonstrated that cell migration in the DV axis becomes restricted following tissue 
patterning (Erskine et al., 1998 ; Leber and Sanes, 1995). Our findings support these 
conclusions by demonstrating extensive cell migration across the medio-lateral axis of 
the mouse neural plate before E9.5. However, independent analyses of the Pax3 lineage 
demonstrate that once established, the position of the Pax3 expression domain remains 
constant throughout the later stages of neural tube patterning and neurogenesis. Thus, 
cell migration in the DV axis of the mouse neuroepithelium exhibits a similar temporal 
restriction to that observed in chick embryos. 
 The extent to which cells migrate within the DV axis of the neural tube is 
broadly correlated with the species-specific expression of cell adhesion molecules at the 
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presumptive sulcus limitans, discussed in Chapter 1.3. In comparison to these studies, 
the temporal expression profiles of cadherin family members during the development of 
the mouse neural tube are poorly described. Reports have shown that Cadherin7 is not 
expressed in the neural tube at any point during embryogenesis (Moore et al., 2004). 
However the mouse F-cadherin homolog, Cadherin20, is reported to be expressed 
throughout the ventral domains of the neural tube at E10.5 (Moore et al., 2004). By 
contrast, cadherin7 is expressed throughout the alar plate of the rat hindbrain whereas 
cadherin20 appears to be expressed in a complementary profile within the basal plate 
(Takahashi and Osumi, 2008). These data raise questions concerning the molecular 
basis of cadherin transcription in the neural tube and the apparent lack of conserved 
regulatory mechanisms between species. Studies in the chick neural tube provide 
evidence demonstrating that Cadherin-7 expression is positively regulated by low levels 
of Shh signaling and repressed by ectopic Pax7 in-vivo (Luo et al., 2006 ; Stamataki et 
al., 2005). Moreover, functional dissection of a conserved Cadherin7 enhancer suggests 
that these regulatory interactions may be direct (Prasad and Paulson, 2011). These 
studies provide evidence to suggest that, at least in chick embryos, the establishment of 
the Pax3/7 domain might directly affect progenitor cell migration in the neural tube by 
positioning Cadherin-7 expression at the sulcus limitans. 
 
9.3 – Conservation of non-coding sequence is predictive of functional enhancers 
 
 Previous studies investigating the regulatory logic of Pax3 expression in the 
neural tube have focused on a 1.6 kb CRM located proximal to the promoter in the 
mouse genome (Degenhart et al., 2010 ; Millewski et al., 2004 ; Natoli et al., 1997 ; 
Pruitt et al., 2004). By contrast, this investigation aimed to define the CRMs associated 
with the Pax3 locus de-novo using a stringent implementation of comparative genomics. 
Our alignments clearly demonstrate that the 1.6 kb upstream element is not conserved 
across the evolutionary span of vertebrates, suggesting that this CRM arose as a 
secondary Pax3 enhancer during mammalian evolution (Fig. 5.1). This conclusion is 
supported by a report demonstrating that deletion of this CRM from the mouse genome 
does not affect gene expression (Degenhardt et al., 2010). 
Our analysis of the Pax3 locus revealed 6 CNEs located within the large 4th 
intron of the gene, all of which correlate with regions previously identified by similar 
bioinformatics methods (Table 5.1) (Woolfe et al., 2005 ; Woolfe et al., 2007). We 
provide evidence demonstrating that 5 of these regions act as tissue specific enhancers 
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in the zebrafish embryo, emphasising the ability of comparative genomics to predict 
functional CRMs. Our alignments identified 4 CNEs that are sufficient to activate 
transcription within regions of the embryo that endogenously express Pax3. We also 
define CNE5 as an enhancer that is predominantly active in cells that do not express 
Pax3 at any point of their development. This finding raises interesting questions 
concerning the function of this CRM during embryogenesis and the possibility that 
despite its location, it may function independently of the Pax3 locus. Thus, our 
functional assessment of Pax3 CNEs indicates that the complex spatiotemporal profile 
of gene expression is produced by the combined activity of several tissue specific 
enhancers. 
Advances in post-genomic technologies have facilitated the identification of 
chromatin signatures that both define putative enhancers and predict their temporal 
activation, discussed in Chapter 1.2. We sought to determine the location of our Pax3 
CNEs relative to the distribution of H3K4Me3 and H3K27ac marks to investigate the 
correlation between putative enhancers identified by these two methods. This analysis 
was facilitated by a study that documented the profile of selected histone modifications 
across the zebrafish genome during the first 48 hours of development (Bogdanovic et 
al., 2012). Comparison of these two datasets reveals that all Pax3 CNEs are located in 
regions marked by both H3K4Me3 and H3K27ac at some point during development, 
consistent with these regions being functional enhancers and residing in areas of active 
chromatin (Fig. 9.1). This analysis builds upon the previous observation that 90% of all 
p300 peaks in the mouse genome overlap with areas of conserved sequence (Visel et al., 
2009). Together, these data reveal the predictive power of both comparative and post-
genomic methods for enhancer discovery and highlight the benefit of employing both 
techniques. 
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Fig. 9.1 –Pax3 CNEs correlate with the chromatin signatures of active enhancers 
UCSC genome browser plot of H3K4Me1 and H3K27ac ChIP-seq profiles derived from 
zebrafish embryos at 4 stages of development. The location of each CNE identified by 
comparative genomics is marked in the plot. These data reveal that each CNE is labelled by 
both H3K4Me1 and H3K27ac at some point during the first 48 hours of development. 
ChIP-seq data published within Bogdanovic et al., 2012. 
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9.4 – CNE3 mediates the induction of Pax3 transcription 
 
 Several studies have described the effect of Wnt pathway manipulation on the 
expression of Pax3 within the neural tube, discussed in Chapter 1.3. The molecular 
basis of this interaction was established by the identification of Pax3-ECR2, a 967 bp 
conserved enhancer located within the 4th intron of the gene. ECR2 activity appears to 
recapitulate Pax3 expression throughout the course of CNS development in mice 
(Degenhardt et al., 2010). Furthermore, the transcriptional activity of ECR2 is 
dependent on the integrity of 5 Tcf/Lef binding sites (Degenhardt et al., 2010). Pax3-
ECR2 is represented in our dataset as CNE3, a 453 bp element that possesses a weak 
regulatory potential in zebrafish embryos assessed at 24 hpf. We build upon the results 
of previous studies by demonstrating that the Wnt pathway effector, Tcf3, is bound to 
the region represented by both ECR2 and CNE3 in mouse ESCs (Fig. 8.3) (Marson et 
al., 2008). Furthermore, we reveal that the spatiotemporal activity of CNE3 correlates 
with that of the Wnt signaling pathway during zebrafish development (Fig. 8.4). Thus, 
our data provide support for a model in which Pax3 transcription is initiated in the 
neural plate by the direct binding of Wnt pathway effectors to ECR2/CNE3. 
 Strikingly, analysis of transgenic zebrafish embryos revealed that the profile of 
Wnt signaling in the neural plate is not patterned across the medio-lateral axis of the 
tissue (Fig. 8.4). These data are consistent with reports of Wnt activity during the early 
stages of mouse development (Maretto et al., 2003). By contrast, our expression studies 
in zebrafish (Fig. 4.1) and lineage studies in mice (Fig. 3.2) demonstrate that Pax3 
transcription is excluded from progenitors in the medial neural plate. These 
observations indicate that Wnt signaling alone does not provide sufficient positional 
information to establish the Pax3 expression domain. Our functional dissection of 
CNE3 revealed that Motif3 and Motif5 are required for the repression of transgene 
activity from medial progenitors in-vivo (Fig. 8.5). Bioinformatic analyses of these 
sequences indicated the presence of conserved homeobox and Fox binding sites, which 
when mutated results in the de-repression of CNE3 activity in-vivo (Table 8.1 and Fig. 
8.6). These data are supported by the observation that both Nkx6.1 and Foxa2 can bind 
the sequence spanning these motifs in EMSA experiments (Fig. 8.7). 
 Despite their ability to interact with CNE3 in-vitro, the in-vivo function of 
Nkx6.1 and Foxa2 in the context of Pax3 regulation requires further investigation. 
Nkx6.1 is among the first transcription factors expressed in the medial neural plate of 
zebrafish, Xenopus and chick embryos, consistent with the hypothesis that it might 
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function to repress Pax3 (Cheesman et al., 2004 ; Dichmann and Harland, 2010 ; Qiu et 
al., 1998). However, the observation that ectopic Nkx6.1 expression in the Xenopus 
neural plate does not repress Pax3 transcription suggests that our in-vitro data does not 
accurately reflect the in-vivo relationship between these proteins (Dichmann and 
Harland, 2010). Furthermore, Pax7 expression in the neural tube is not de-repressed in 
both Nkx6.1-/- and Nkx6.1-/-;Nkx6.2-/- mutants (Sander et al., 2000 ; Vallstedt et al., 
2001). One would predict that de-repression of Pax3 would result in the ventral 
expansion of Pax7, given the patterning phenotype in mice expressing Pax3 under the 
control of the Hoxb-4 enhancer A region (Tremblay et al., 1996). Similarly, Foxa2 is 
expressed in presumptive FP cells at the midline of the neural plate and throughout the 
developing endoderm (Ruiz i Altaba et al., 1995 ; Sasaki and Hogan, 1994 ; Strahle et 
al., 1993). A recent ChIP-seq study identified a peak of Foxa2 binding that overlaps 
with both ECR2 and CNE3 in ESCs differentiated to a midbrain dopaminergic identity 
(Metzakopian et al., 2012). However the same report demonstrated that, at least in the 
midbrain, loss of both Foxa1 and Foxa2 does not result in a de-repression of Pax3 
transcription (Metzakopian et al., 2012). 
 Taken together, our analysis of CNE3 supports the role of this enhancer in the 
Wnt mediated induction of Pax3 transcription within the neural plate. In addition, we 
establish a role for spatially expressed repressors in this process by defining regulatory 
motifs within CNE3 that are required for the restriction of transgene expression to 
progenitors within the lateral neural plate. Furthermore, we demonstrate that conserved 
homeobox and Fox binding sites within these motifs mediate the binding of putative 
repressors to CNE3. However, the identity of the transcription factors that bind these 
sites and their in-vivo activity in the context of Pax3 regulation requires further 
investigation. 
 
9.5 – Pax3 transcription is maintained by CNE1 at later stages of development 
 
 Our analysis of CNE3 demonstrates that this enhancer possesses a weak 
regulatory potential at 24 hpf in zebrafish embryos and rarely labels spinal cord 
progenitors (Fig.8.1). Studies of TCFsiam transgenic zebrafish reveal that progenitor 
cells within the neural tube are not subject to active Wnt signaling from the 18 somites 
stage, a conclusion supported by reports of TOPdGFP transgenics (Fig.8.4) (Dorsky et 
al., 2002). Furthermore, analysis of BAT-Gal transgenic mice indicates that the Wnt 
pathway is not transcriptionally active in the anterior regions of the neural tube at E10.5 
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(Maretto et al., 2003). These studies demonstrate that the maxima of Pax3 expression in 
spinal cord progenitors occurs in the absence of Wnt pathway activation. Moreover, 
many reports have shown that the ventral limit of Pax3 expression does not correlate 
with the boundary of candidate homeodomain or Fox repressors in the neural tube 
(Dessaud et al., 2008 ; Jessell, 2000 ; Lewis, 2006). Together, these findings indicate 
that that the activity of CNE3 is transient and does not contribute the maintenance of 
Pax3 expression at later stages of development. 
 Our study identified a second CNS specific enhancer associated with the Pax3 
locus, termed CNE1. We demonstrate that this regulatory region is transcriptionally 
active in the intermediate and lateral regions of the open neural plate and subsequently 
recapitulates Pax3 expression throughout CNS development (Figs. 6.4 and 6.5). This in-
vivo data is supported by the observation that CNE1 is marked by H3K4Me1 in the 
presence of H3K27ac at the 80% epiboly stage of zebrafish development, a chromatin 
signature indicative of transcriptionally active enhancers (Fig. 9.1) (Bogdanovic et al., 
2012 ; Creyghton et al., 2010 ; Rada-Iglesias et al., 2011). Analysis of p300 binding 
across the Pax3 locus at E11.5 demonstrates that CNE1 is the only active enhancer 
associated with the Pax3 locus and furthermore, that this interaction is specific to CNS 
derived tissues (Fig. 6.3) (Visel et al., 2009). By contrast CNE3 is not bound by p300 in 
any ChIP-seq dataset derived from E11.5 mouse tissue (Visel et al., 2009). Together, 
these data indicate that CNE1 regulates Pax3 transcription throughout development, 
whereas CNE3 is not transcriptionally active at later stages. 
 Functional dissection of CNE1 reveals that the activity of this region in-vivo is 
dependent on the presence and integrity of Motif1 (Figs. 7.2 and 7.5). We utilise a 
combination of in-silico sequence analysis and in-vitro binding data to functionally 
annotate Motif1 as a 15 bp PD binding site that appears to be preferentially occupied by 
group III Pax genes (Figs. 7.3, 7.7 and 7.8). The observation that both Pax3/7 are 
capable of binding the same DNA sequence is consistent with the fact that the PDs 
encoded by these genes share 93% homology at the amino acid level. The specificity of 
this site for Pax3/7 binding in-vitro can be attributed to the divergent PDs encoded by 
each class of Pax gene. This is exemplified by comparisons of the mouse Pax3 PD with 
that encoded by group II and group IV genes, revealing a maximum of 73% and 66% 
homology at the amino acid level, respectively. 
Previous in-vitro selex based studies have provided definitions of the consensus 
site bound by an isolated Pax3 PD fusion protein (Chalepakis and Gruss, 1995 ; Epstein 
et al., 1996). Comparison of these published sites with Motif1 reveals significant 
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homology to the 5’ portion of the PD binding site, however no consensus sequence is 
produced in the 3’ region (Fig. 9.2). This result is consistent with our previous sequence 
analysis of published Pax binding sites that originally identified Motif1 as a putative PD 
site (Fig. 7.3). Our mutagenesis series within Motif1 suggests that RBPJ mutation 
induced within the 5’ region of the PD site does not disrupt CNE1 function in-vivo (Fig. 
7.4). Furthermore, mutations induced in the 3’ region of the PD site both decrease 
CNE1 transcriptional activity in-vivo and Pax7 binding in-vitro (Figs. 7.5 and 7.9). 
These data suggest that in-vitro selex favours the identification of a 5’ half site that is 
recognised by the PDs of all Pax genes, whereas Motif1 represents a more accurate 
description of a complete Pax3/7 PD binding site. 
 Expression of an obligate transcriptional activator form of Pax3, Pax3-FoxO, 
throughout the chick neural tube results in the ectopic activation of CNE1; establishing 
the molecular basis of direct Pax3 autoregulation during CNS development (Fig. 7.10). 
Previous reports have provided evidence to suggest that positive autoregulation may be 
a common property of Pax3 transcription during development. P19 EC cells cultured in 
the presence of dimethyl sulfoxide give rise to muscle fibres that express Pax3 during 
their progenitor phase (Ridgeway and Skerjanc, 2001). Stable expression of Pax3 fused 
to the repressor domain of Engrailed results in the repression of endogenous Pax3 
transcription during this process, assessed by Northern blot (Ridgeway and Skerjanc, 
2001). In a similar experiment, electroporation of a Pax3–Engrailed fusion protein in 
the ophthalmic trigeminal placode was shown to extinguish endogenous Pax3 
expression (Dude et al., 2009). These studies provide evidence supporting the 
requirement of Pax3 autoregulation during development. This investigation builds upon 
published data by demonstrating that Pax3 transcription is subject to direct 
autoregulation throughout the process of CNS development and provides the molecular 
mechanism by which this is achieved. 
Our findings also demonstrate that ectopic Pax7 expression in-ovo induces 
CNE1 activity in the ventral neural tube, indicating that positive feedback plays a role in 
the regulation of Pax3 transcription (Fig. 7.10). This conclusion is supported studies 
demonstrating that ectopic Pax7 expression induces Pax3 transcription cell 
autonomously within the dorsal midbrain (Agoston et al., 2012 ; Matsunaga et al., 
2001). Pax7 expression in mice and chick embryos is induced in the neural tube as it 
closes (Jostes et al., 1990 ; Kawakami et al., 1997). These data are complemented by 
our analysis of pax7a and pax7b transcription during zebrafish development (Figs. 4.2 
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and 4.4). These results indicate that the Pax7 mediated positive feedback can only 
regulate Pax3 transcription following neural tube formation. 
Taken together, our analysis of CNE1 establishes this region as a novel, CNS 
specific enhancer of Pax3. We demonstrate that CNE1 is transcriptionally active within 
the lateral neural plate of zebrafish embryos and subsequently recapitulates Pax3 
expression during CNS development. We determine that the transcriptional activity of 
CNE1 in neural tube progenitors is dependent on the presence of two highly conserved 
regions, named Motif1 and Motif3. We demonstrate that Motif1 represents a novel 
Pax3/7 specific PD binding site that mediates direct autoregulation throughout CNS 
development and positive feedback from Pax7 following neurulation. 
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Fig. 9.2 – CNE1-Motif1 represents a more complete definition of the Pax3/7 PD 
binding site 
ClustalW2 alignment of CNE1-Motif1 with in-vitro selex derived Pax3 PD consensus binding 
sites. The 5’ region of each input sequence shares a high degree of homology, whereas CNE1-
Motif1 is contains 4 additional nucleotides at the 3’ terminal. Our data demonstrates that 
mutation of this 3’ region of CNE1-Motif1 disrupts enhancer activity in-vivo and reduces Pax7 
binding in-vitro. Consequently, CNE1-Motif1 represents a more accurate definition of a 
complete Pax3/7 binding site. 
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9.6 – Pax3b expression is dependent on autoregulation and positive feedback 
 
 The induction of pax3b expression in the posterior neural plate of zebrafish 
embryos is delayed in comparison to pax3a (Minchin and Hughes, 2008). Furthermore, 
pax3b transcription is dorsally restricted within the neural tube at 24 hpf and does not 
extend to the anterior limit of pax3a expression in the midbrain (Minchin and Hughes, 
2008). We sought to investigate the molecular basis of these differing expression 
profiles by comparing the architecture of CRMs associated with the zebrafish Pax3 
paralogs and their in-vivo activity. Our comparative genomics study revealed that 
conserved elements can be readily identified in alignments containing the pax3a locus, 
however inclusion of pax3b sequence precluded the discovery of CNEs, discussed in 
Chapter 5.1. These data indicate that the regulatory sequences associated with the 
zebrafish Pax3 paralogs have radically diverged following the whole genome 
duplication in the teleost lineage. Our findings are in contrast to previous studies of the 
paralogous Pax2 loci in the zebrafish and fugu genomes, which share more than 40 
common CNEs (Goode et al., 2011 ; Woofe and Elgar, 2007). 
BLAST searches of pax3b intron 4 against Condor CNEs revealed a 38 bp 
fragment that is homologous to Motif1 of Pax3-CNE1 (Fig. 7.11). This region was not 
detected during our initial comparative genomic alignments as the parameters employed 
excluded all matches of less than 40 bp. We demonstrate that pax3b CNE1 contains 
regions of measurable homology to all of the regulatory motifs that define this 
enhancer, however only Motif1 is phylogenetically conserved (Fig. 7.11). Pax3b-CNE1 
retains its activity within neural progenitors in-vivo, demonstrating that despite the 
altered structure of motifs within this CRM, it is sufficient to recapitulate the primary 
function of the canonical enhancer (Fig. 7.12). This observation can be attributed to the 
high degree to which the Pax3/7 PD binding site represented by Motif1 is conserved in 
the pax3b locus (Fig. 7.11). The observed lack of enhancer specificity for neural 
progenitors and the absence of transgene activation in anterior regions of the CNS may 
be a result of the poor conservation of the remaining motifs, particularly Motif3 which 
appears to be required for the activity of pax3a-CNE1 in-vivo. 
Our analysis of the zebrafish Pax3 paralogs reveals that CNE1 is the only 
conserved enhancer associated with the pax3b locus. Furthermore, we demonstrate that 
only the PD binding site represented by Motif1 is phylogenetically conserved between 
the Pax3 paralogs and higher vertebrates. These data imply that the initiation of pax3b 
expression in the zebrafish neural plate is dependant on positive feedback from pax3a, 
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which is expressed earlier due to the activity of CNE3. Once initiated, pax3b expression 
is subject to direct autoregulation and positive feedback from pax3a, pax7a, and pax7b. 
Together, our findings indicate that the lack of CNE3 conservation within the pax3b 
locus and the divergent architecture of CNE1 might be the main contributor to the 
observed differences in the spatiotemporal expression patterns of the zebrafish Pax3 
paralogs (Minchin and Hughes, 2008). 
 
9.7 – The pattern generating properties of autoregulation and positive feedback 
 
Our findings demonstrate that Pax3 expression is subject to direct positive 
autoregulation and positive feedback from Pax7 during CNS development. This 
mechanism of regulation is novel in the context of progenitor markers within the neural 
tube GRN, as all previous genetic interactions have been shown to facilitate 
transcriptional repression (Dessaud et al., 2008). However, previous reports have 
highlighted the properties conferred by autoregulatory and positive feedback 
mechanisms that are relevant to the coordination of transcriptional programmes during 
embryonic patterning. 
One of the best-described roles of developmental autoregulation is the 
maintenance of transcription in response to transient inductive signals, such as 
morphogens. This mechanism is exemplified by the regulation of the Drosophila gene 
Single-minded (sim), which is required for the correct development of the CNS (Nambu 
et al., 1990). Sim expression is induced in a defined stripe within the neurogenic 
ectoderm by the coordinated activities of the Dorsal gradient and the Notch signaling 
pathway (Hong et al., 2008). Accordingly, sim mutant embryos assessed at early stages 
of development do not exhibit a loss of sim transcription (Nambu et al., 1991). However 
at later embryonic stages, sim mutants reveal a striking loss of RNA transcription, 
indicating that positive autoregulation is required to transform the transient input of the 
Dorsal gradient into a stable expression state (Nambu et al., 1991). This conclusion is 
supported by data demonstrating that sim protein directly interacts with its own 
regulatory element specifically at late stages of Drosophila development (Muralidhar et 
al., 1993). Similar mechanisms, in which autoregulation maintains the transcriptional 
response to transient cues, have been shown to regulate the expression of terminal 
selector genes in nematodes (Hobert, 2011), glial cells missing during sea urchin 
development (Ransick and Davidson, 2006 ; Ransick and Davidson, 2012) and 
Distalless during Drosophila leg development (Estella et al., 2008). 
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In addition to establishing a transcriptional memory of cell identity, direct 
autoregulation has been shown to increase the expression level of key fate determinants 
during development. This point is illustrated by studies analysing the regulation fushi 
tarazu expression during Drosophila segmentation. Reporter gene expression driven by 
an upstream enhancer recapitulates gene expression during development and is lost in 
mutant embryos, suggesting that this region mediates positive autoregulation (Pick et 
al., 1990). The fushi tarazu autoregulatory enhancer contains 6 putative homeodomain 
binding sites, none of which are individually required for its activity in-vivo (Schier and 
Gehring, 1992). However, serial mutation of multiple binding sites results in a stepwise 
decrease in enhancer activity, suggesting that the primary function of autoregulation in 
this context is to increase the expression level of fushi tarazu during the process of 
Drosophila segmentation (Schier and Gehring, 1992). 
Finally, autoregulation has been shown to be capable of producing and 
maintaining sharp gene expression boundaries when coupled with positive feedback. A 
well-characterised example of this mechanism is provided by Hoxb-4 expression during 
hindbrain patterning. At early stages of development, a diffuse domain of Hoxb-4 
expression is induced by a gradient of RA that emanates from the adjacent mesoderm 
(Gould et al., 1998). Once initiated, Hoxb-4 direct autoregulation acts to both refine and 
maintain the initial domain of expression specified by RA (Gould et al., 1997). 
Moreover, Hoxb-4 protein directly regulates the expression of the RA pathway effector, 
RARβ, in the hindbrain (Serpente et al., 2005). Thus, Hoxb-4 expression is both 
dependent on the RA signaling pathway for its activation and positively regulates one of 
its major transcriptional effectors at later stages of development. This complex 
regulatory circuit acts to generate and maintain a clearly delineated domain of Hoxb-4 
expression in response to the graded activity of the RA signaling pathway. 
Taken together, the results of these studies demonstrate the ability of 
transcriptional autoregulation to convert transient inductive signals into stable 
expression states. Furthermore, these data demonstrate that diffuse gene expression 
boundaries can be refined and maintained throughout development by transcriptional 
circuits in which autoregulation is coupled to positive feedback. Given our analysis of 
CNE3 activity during CNS development and the temporal activity of the Wnt signaling 
pathway during this process, these pattern generating properties of transcriptional 
autoregulation are likely to be essential for the maintenance and refinement of the Pax3 
domain during neural tube development. 
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9.8 – Conclusions 
 
 The results obtained from this study support the established role of the Wnt 
signaling pathway in the induction of Pax3 expression in the neural plate via CNE3. 
However, this investigation is the first to describe the role of transcriptional repressors 
in this process. Furthermore, our data demonstrate that Pax3 transcription is subject to 
direct autoregulation and positive feedback from Pax7 via CNE1, a novel CNS specific 
regulatory element. Taken together, our findings indicate that the temporal activity of 
two distinct enhancers underlies the regulatory logic of Pax3 expression in the neural 
tube. 
 In this model, the expression of Pax3 is initiated in the CNS by the direct 
binding of Wnt signaling pathway effectors to the enhancer region represented by 
ECR2/CNE3 (Fig. 9.3A). This conclusion is supported by the observations that Tcf3 is 
bound to this regulatory region in mouse ESC and that mutation of Tcf/Lef sites within 
this sequence abolishes its activity in-vivo (Fig. 8.3) (Degenhardt et al., 2010 ; Marson 
et al., 2008). However, analysis of transgenic Wnt reporters demonstrates that this 
pathway alone does not provide sufficient positional information to induce Pax3 
expression in the lateral neural plate (Figs. 8.4 and 9.3A) (Dorsky et al., 2002). Our 
findings demonstrate that two highly conserved motifs within CNE3, named Motif3 and 
Motif5, are required for the repression of transgene activation in the medial regions of 
the neural plate (Fig. 8.5). Furthermore, we demonstrate that these motifs contain 
phylogenetically conserved homeobox and Fox binding sites that are both necessary for 
the repression of CNE3 activity in-vivo and sufficient for Nkx6.1 and Foxa2 binding in-
vitro (Table 8.1 and Figs. 8.6 and 8.7). Thus, our data suggest that the induction of Pax3 
transcription in the lateral neural plate is mediated by the direct binding of Wnt pathway 
effectors and transcriptional repressors to ECR2/CNE3 (Fig. 9.3A). 
 Once induced, Pax3 transcription in the neural plate becomes subject to direct 
autoregulation (Fig. 9.3B). This is evident in our data as CNE1 transcriptional activity 
in Pax3 expressing cells within the lateral neural plate of zebrafish embryos assessed at 
bud stage (Fig. 9.3B). Consequently at early stages of CNS patterning, Pax3 expression 
is regulated by Wnt mediated activation throughout the tissue and direct repression 
medially via CNE3. Cells in the lateral neural plate that express Pax3 reinforce their 
transcriptional identity by CNE1 mediated autoregulation (Fig. 9.3B). We propose that 
this complex regulatory circuit acts to establish the position of the Pax3 expression 
domain in the neural plate. This hypothesis is supported by our analysis of 
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Pax3Cre/+/Rosa26-YFP transgenic mice, which demonstrates that the Pax3 domain is 
established by a switch in cell identity before E9.5 and subsequently maintained at this 
position throughout development, discussed in Chapter 3. 
 The transcriptional activity of the Wnt pathway decreases in the neural tube as 
development progresses, evident in-vivo as a marked downregulation of Wnt reporter 
transgene expression prior to the maxima of Pax3 transcription in neural tube 
progenitors (Fig. 8.4) (Dorsky et al., 2002 ; Maretto et al., 2003). Similarly, putative HD 
and Fox transcriptional repressors do not share a boundary with Pax3 following the 
closure of the neural tube (Dessaud et al., 2008 ; Jessell, 2000 ; Lewis, 2006). These 
data indicate that the regulatory interactions mediated by CNE3 are transient and do not 
function to maintain Pax3 expression at later stages of neural tube patterning. 
Consequently, we propose that CNE1 mediated autoregulation coupled to Pax7 positive 
feedback acts to maintain the position of Pax3 ventral boundary in the absence of 
external transcriptional inputs following neurulation (Fig. 9.3C). This conclusion is 
supported by the respective profiles of CNE1 and CNE3 activity in-vivo and the finding 
that CNE1 is the only Pax3 enhancer associated with p300 binding in CNS derived 
tissues at E11.5 (Visel et al., 2009). Our data demonstrates that the Pax3-GFPI150 stable 
line recapitulates the expression profile of pax3a in the spinal cord (Fig. 4.7) and 
furthermore, that CNE1 and CNE3 are the only enhancers contained within this 
genomic interval that are active in this progenitor domain. These results strongly 
suggest that the combinatorial activity of these CRMs is sufficient to induce and 
maintain Pax3 expression in the dorsal spinal cord. 
 The primary function of developmental patterning is the assignment and 
maintenance of a unique molecular identity within a defined population of progenitors. 
This process requires the translation of transient inductive cues, such as morphogens, 
into bistable expression domains. Our studies suggest that the regulatory logic 
governing Pax3 expression is based upon the spatial interpretation of transient external 
inputs and the maintenance of transcription by PD mediated autoregulation and positive 
feedback. By contrast, the ventral neural tube GRN operates by the progressive 
assignment of cell identity over time and the refinement of expression boundaries by 
HD and bHLH mediated repression. Despite their divergent regulatory architectures, we 
propose that these transcriptional networks are capable of performing similar patterning 
functions. 
 Bistability is ensured by the ventral neural tube GRN by a regulatory logic that 
requires cells to make a binary choice of identity. For example, cells at the p3/pMN 
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boundary can either transcribe Nkx2.2 or Olig2 but are precluded from expressing both 
fate determinants (Balaskas et al., 2012). Similarly, the regulatory circuit that 
coordinates Pax3 transcription following neurulation is capable of defining bistable 
states by requiring cells to express both Pax3 and Pax7 or neither factor. Autoregulation 
coupled to positive feedback might also act to refine and maintain the ventral boundary 
of Pax3 expression in the neural tube in the absence of transcriptional repression, 
consistent with reports examining the regulation of Hoxb-4 expression in the hindbrain 
(Gould et al., 1997 ; Serpente et al., 2005). In the ventral neural tube GRN, fluctuations 
in the level of Shh signaling are buffered by a series of complex cross-repressive 
interactions that confers robustness to developmental patterning (Balaskas et al., 2012). 
We propose that Pax3 autoregulation might provide a mechanism of compensating for 
changes in the level of Wnt signaling during the early stages of neural plate patterning 
by enabling cells to maintain their transcriptional identity. Furthermore, our findings 
suggest that autoregulation coupled to positive feedback might be sufficient to maintain 
Pax3 expression independently of external inputs at later stages of development. Thus 
despite its novel architecture in the context of neural tube patterning, the regulatory 
logic that coordinates Pax3 expression is capable of both defining and maintaining cell 
identity in response to transient inductive cues. 
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Fig. 9.3 – The regulatory logic of Pax3 expression in the neural tube 
The induction of Pax3 transcription in the neural plate is mediated by the direct binding of Wnt 
pathway effectors, such as Tcf3, to the enhancer region represented by ECR2/CNE3 (A). Our 
analyses of TCFsiam embryos reveals that the transcriptional activity of the Wnt pathway is not 
patterned across the medio-lateral axis of the neural plate, whereas Pax3 expression is restricted 
to the intermediate and lateral regions of the tissue (A). Our data suggest that the direct binding 
of putative HD and Fox family transcriptional repressors to ECR2/CNE3 patterns the Wnt 
mediated induction of Pax3 expression the neural plate (A). Once expressed, Pax3 transcription 
is subject to direct autoregulation mediated by a Pax3/7 PD site within CNE1 (B). 
Consequently, Pax3 expression in the neural plate is regulated by the Wnt pathway, 
transcriptional repression and autoregulation (B) Following neurulation, the Pax3 expression 
domain is maintained by CNE1 mediated autoregulation and positive feedback from Pax7 in the 
absence of CNE3 mediated transcriptional inputs (C). 
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9.9 – Future work 
 
 The findings of this study provide novel insights into the formation of the Pax3 
expression domain within the neural tube, the cellular lineage of V0 interneurons and 
the molecular basis of Pax3 regulation in the CNS. A series of further experiments 
based on these results would both strengthen the conclusions of this study and provide 
data connecting Pax3 function to the neural tube GRN. 
 Our lineage trace data demonstrates that the position of the Pax3 domain within 
the neural tube is established before E9.5 in mice by a transcriptional switch in cell 
identity (Fig. 3.2). The findings suggest that transcription is induced within the 
intermediate region of the neural plate and subsequently becomes restricted to the 
neural folds, in contrast to the results of previous expression studies (Goulding et al., 
1991). In order to validate this hypothesis, future experiments could determine the 
position of Pax3 expressing cells relative to their lineage at early stages of mouse neural 
plate patterning. Furthermore, our lineage study reveals that cell migration within the 
DV axis of the mouse neuroepithelium is temporally restricted with similar dynamics to 
those observed in chick embryos (Erskine et al., 1998 ; Leber and Sanes, 1995). Pax3/7 
have been implicated in this process, due to their ability to directly regulate Cadherin-7 
expression at the sulcus limitans via a conserved enhancer (Luo et al., 2006 ; Prasad and 
Paulson, 2011). However, the expression profiles of Cadherin family members within 
the mouse neural tube do not appear to correlate with those observed in chick, zebrafish 
and Xenopus embryos (Espeseth et al., 1995 ; Liu et al., 2007 ; Nakagawa and Takeichi, 
1995 ; Nakagawa and Takeichi, 1998 ; Liu et al., 2007). Future studies employing 
Pax3Cre/Rosa26-YFP transgenic mice might seek to resolve these discrepancies by 
assessing the restriction of cell migration in the DV axis of the neural tube relative to 
the spatiotemporal expression profiles of Cadherin family members. 
 Functional dissection of CNE3 indicates that the Wnt mediated initiation of 
Pax3 transcription is modulated by repressors that are expressed in the medial region of 
the neural plate, discussed in Chapter 8. Our data demonstrates that both Motif3 and 
Motif5 are required for the repression of CNE3 mediated transcription from the medial 
region of the neural plate (Fig. 8.5). Furthermore, our findings reveal that conserved 
homeobox and Fox binding sites within these Motifs facilitate the binding of putative 
repressors to CNE3 (Figs. 8.5 and 8.8). We demonstrate that both Nkx6.1 and Foxa2 
can bind to DNA spanning these regulatory motifs, however the results of previous 
investigations do not support the role of the transcription factors in the regulation of 
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Pax3 expression (Dichmann and Harland, 2010 ; Metzakopian et al., 2012 ; Sander et 
al., 2000 ; Vallstedt et al., 2001). Further experiments designed to investigate the 
repression of CNE3 activity from the medial neural plate should be based on the 
interaction of candidate in-vitro synthesised proteins with Motif3 and Motif5 in 
EMSAs. In addition to Nkx6.1 and Foxa2, these experiments could include Nkx1.2, 
Cdx-1 and Cdx-2, all of which are homeodomain containing transcription factors that 
appear to be expressed in the medial neural plate (Bae et al., 2004 ; Marom et al., 1997). 
The function of putative repressors could be investigated in-vivo by ectopic expression 
of these factors in zebrafish embryos and assaying Pax3 transcription within the neural 
plate.  
 Our analysis of a second CNS specific enhancer associated with the Pax3 locus, 
CNE1, reveals that this CRM requires the presence of two conserved motifs. We 
demonstrate that Motif1 represents a novel PD binding site that facilitates direct 
autoregulation and positive feedback, discussed in Chapter 7. Future experiments could 
further validate these conclusions by ectopically expressing mouse Pax3 or Pax7 in the 
chick neural tube and assaying the transcription of endogenous Pax3 mRNA. Our 
findings also reveal that Motif3 is required for CNE1 function in-vivo (Fig. 7.2). We 
were unable to determine the regulatory interactions mediated by CNE1-Motif3 using 
both in-vitro synthesised candidate HMG binding proteins and nuclear extract. In order 
to advance our analysis of CNE1-Motif3, a series of DNA probes spanning the region 
should be used in EMSAs with both selected candidate transcription factors and nuclear 
extract. The addition of these data would complete our functional annotation of CNE1 
activity. 
 Previous reports examining the regulation of Pax3 transcription in the neural 
tube have highlighted the need to determine the requirement of putative enhancers in-
vivo (Degenhardt et al., 2010). During the course of this investigation, several attempts 
were made to assess the requirement of CNE1 and CNE3 for Pax3 expression by 
deleting these regions from the DKEY-20F20 BAC. We chose to perform these 
manipulations using the galK recombineering protocol, which has previously been 
successfully employed in the lab (Warming et al., 2005). However, we were unable to 
confirm the deletion of either CNE1 or CNE3 from DKEY-20F20. Further experiments 
should aim to assess the requirement of these enhancers for Pax3 expression in-vivo, 
however these studies cannot be performed in mice due to the presence of a redundant 
CRM located proximally to the promoter (Degenhart et al., 2010 ; Millewski et al., 2004 
; Natoli et al., 1997 ; Pruitt et al., 2004). Consequently, experiments designed to assess 
Chapter 9 – Discussion 	  
	   193 
the requirement of CNE1 and CNE3 should be performed in zebrafish embryos and 
based upon modification of the DKEY-20F20 BAC, achieved either by mutagenic PCR 
or homology mediated recombination. 
 Pax3 and Pax7 represent paralogs that are derived from a single ancestral Pax3/7 
gene (Balczarek et al., 1997). Consequently, these genes share a high degree of 
homology in their coding sequences. Despite these similarities, Pax3 and Pax7 exhibit 
distinct spatiotemporal expression patterns in the neural tube (Goulding et al., 1991 ; 
Goulding et al., 1993 ; Jostes et al., 1990 ; Kawakami et al., 1997). We sought to 
investigate the molecular basis of these divergent expression profiles by comparing the 
activity and regulation of CRMs associated with each locus. Despite employing a 
similar method of comparative genomics to that used to annotate the Pax3 locus, this 
study was unable to define any functional enhancers associated with Pax7. Moreover, 
CNE1 and CNE3 do not appear to be shared by the vertebrate group III Pax genes. 
Future studies investigating the molecular basis of Pax7 expression could be based on 
de-novo comparative genomic analysis of the locus, substituting pax7b sequence for 
fugu Pax7. These data could then be used in conjunction with p300 binding data and 
histone methylation marks to define a set of putative Pax7 regulatory elements for 
further investigation. 
 Finally, the function of Pax3 and Pax7 in the context of neural tube patterning 
remains poorly defined. During this investigation, we sought to investigate the function 
of Pax3 and Pax7 in the neural tube by ectopically expressing either full length, 
dominant active or dominant negative forms these proteins in chick embryos (Data not 
shown). The results of these experiments indicated that a high level of ectopic Pax3/7 
expression severely affects the cell cycle, neural tube morphology, patterning and 
differentiation (Data not shown). Consequently, further experiments designed to assess 
the function of Pax3 and Pax7 in the neural tube should aim to ectopically express 
transgenes at near endogenous levels. This could be achieved in mice by expressing 
constructs from either the Pax3 or Pax7 locus and in chick embryos by the use of RCAS 
retroviral vectors. Together, the results of these investigations will provide data to 
establish the function of Pax3 and Pax7 in the context of the neural tube GRN. 
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